Introduction Diabetes mellitus is a faction of metabolic illness characterized by high glucose level ensuing from defect in insulin secretion

Introduction
Diabetes mellitus is a faction of metabolic illness characterized by high glucose level ensuing from defect in insulin secretion, insulin action, or together. Diabetes mellitus is a wide-reaching unrestricted healthiness quandary that affect on new than 366 million citizens and the number is predictable to go up to 552 million by 2030PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5EYW5hZWk8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxS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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5EYW5hZWk8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxS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ADDIN EN.CITE.DATA (Danaei et al., 2011). The chronic hyperglycemia of diabetes causes both micro and macrovascular complications and diabetic nephropathy is one of the microvascular complications ADDIN EN.CITE <EndNote><Cite><Author>Cade</Author><Year>2008</Year><RecNum>35</RecNum><DisplayText><style face=”bold”>(Cade, 2008)</style></DisplayText><record><rec-number>35</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>35</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Cade, W. T.</author></authors></contributors><auth-address>Washington University School of Medicine, Campus Box 8502, 4444 Forest Park Blvd, St Louis, MO 63108, USA. [email protected]</auth-address><titles><title>Diabetes-related microvascular and macrovascular diseases in the physical therapy setting</title><secondary-title>Phys Ther</secondary-title><alt-title>Physical therapy</alt-title></titles><periodical><full-title>Phys Ther</full-title><abbr-1>Physical therapy</abbr-1></periodical><alt-periodical><full-title>Phys Ther</full-title><abbr-1>Physical therapy</abbr-1></alt-periodical><pages>1322-35</pages><volume>88</volume><number>11</number><edition>2008/09/20</edition><keywords><keyword>Animals</keyword><keyword>Diabetes Complications/mortality/*physiopathology</keyword><keyword>Exercise Therapy/methods</keyword><keyword>Humans</keyword><keyword>Peripheral Vascular Diseases/*etiology/physiopathology</keyword><keyword>*Physical Therapy Modalities</keyword><keyword>Risk Factors</keyword><keyword>Stroke/*etiology/mortality/physiopathology</keyword><keyword>*Vascular Diseases/etiology/metabolism/physiopathology</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>0031-9023</isbn><accession-num>18801863</accession-num><urls></urls><custom2>Pmc2579903</custom2><electronic-resource-num>10.2522/ptj.20080008</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Cade, 2008).

Diabetic nephropathy is a severe and progressive problem happened in diabetic patients and it is connected to an improved danger of all-cause death, cardiovascular disease, and progression of end-stage renal disease, requiring valuable renal surrogate therapy in the shape of dialysis or transplantationPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OaW5vbWl5YTwvQXV0aG9yPjxZZWFyPjIwMDk8L1llYXI+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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OaW5vbWl5YTwvQXV0aG9yPjxZZWFyPjIwMDk8L1llYXI+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ADDIN EN.CITE.DATA (Go et al., 2004;Ninomiya et al., 2009). Diabetic kidney disease is commonly defined as a get higher through urinary albumin secretion microalbuminuria (30-300mg albumin/gm creatinine) next macroalbuminuria (>300mg albumin/gm creatinine), decline glomerular filtration rate and elevation blood pressure PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TdHJhdHRvbjwvQXV0aG9yPjxZZWFyPjIwMDA8L1llYXI+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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TdHJhdHRvbjwvQXV0aG9yPjxZZWFyPjIwMDA8L1llYXI+
PFJlY051bT4zODwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0iYm9sZCI+KFN0cmF0
dG9uIGV0IGFsLiwgMjAwMCk8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJl
cj4zODwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9ImY5cHA5
YXZkcDlzNWRmZXc1dmN2cnhkZzJkZmRmMDV0NXp3MiI+Mzg8L2tleT48L2ZvcmVpZ24ta2V5cz48
cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9y
cz48YXV0aG9ycz48YXV0aG9yPlN0cmF0dG9uLCBJLiBNLjwvYXV0aG9yPjxhdXRob3I+QWRsZXIs
IEEuIEkuPC9hdXRob3I+PGF1dGhvcj5OZWlsLCBILiBBLjwvYXV0aG9yPjxhdXRob3I+TWF0dGhl
d3MsIEQuIFIuPC9hdXRob3I+PGF1dGhvcj5NYW5sZXksIFMuIEUuPC9hdXRob3I+PGF1dGhvcj5D
dWxsLCBDLiBBLjwvYXV0aG9yPjxhdXRob3I+SGFkZGVuLCBELjwvYXV0aG9yPjxhdXRob3I+VHVy
bmVyLCBSLiBDLjwvYXV0aG9yPjxhdXRob3I+SG9sbWFuLCBSLiBSLjwvYXV0aG9yPjwvYXV0aG9y
cz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkRpYWJldGVzIFRyaWFscyBVbml0LCBPeGZv
cmQgQ2VudHJlIGZvciBEaWFiZXRlcywgRW5kb2NyaW5vbG9neSBhbmQgTWV0YWJvbGlzbSwgVW5p
dmVyc2l0eSBvZiBPeGZvcmQsIFJhZGNsaWZmZSBJbmZpcm1hcnksIE94Zm9yZCBPWDIgNkhFLiBp
cmVuZS5zdHJhdHRvbkBkdHUub3guYWMudWs8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5B
c3NvY2lhdGlvbiBvZiBnbHljYWVtaWEgd2l0aCBtYWNyb3Zhc2N1bGFyIGFuZCBtaWNyb3Zhc2N1
bGFyIGNvbXBsaWNhdGlvbnMgb2YgdHlwZSAyIGRpYWJldGVzIChVS1BEUyAzNSk6IHByb3NwZWN0
aXZlIG9ic2VydmF0aW9uYWwgc3R1ZHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+Qm1qPC9zZWNv
bmRhcnktdGl0bGU+PGFsdC10aXRsZT5CTUogKENsaW5pY2FsIHJlc2VhcmNoIGVkLik8L2FsdC10
aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5CbWo8L2Z1bGwtdGl0bGU+PGFi
YnItMT5CTUogKENsaW5pY2FsIHJlc2VhcmNoIGVkLik8L2FiYnItMT48L3BlcmlvZGljYWw+PGFs
dC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkJtajwvZnVsbC10aXRsZT48YWJici0xPkJNSiAoQ2xp
bmljYWwgcmVzZWFyY2ggZWQuKTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjQwNS0x
MjwvcGFnZXM+PHZvbHVtZT4zMjE8L3ZvbHVtZT48bnVtYmVyPjcyNTg8L251bWJlcj48ZWRpdGlv
bj4yMDAwLzA4LzExPC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5DYXRhcmFjdCBFeHRyYWN0
aW9uPC9rZXl3b3JkPjxrZXl3b3JkPkNvbmZpZGVuY2UgSW50ZXJ2YWxzPC9rZXl3b3JkPjxrZXl3
b3JkPkRpYWJldGVzIE1lbGxpdHVzLCBUeXBlIDIvYmxvb2QvKmNvbXBsaWNhdGlvbnMvbW9ydGFs
aXR5PC9rZXl3b3JkPjxrZXl3b3JkPkRpYWJldGljIEFuZ2lvcGF0aGllcy8qYmxvb2QvbW9ydGFs
aXR5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5HbHljYXRlZCBI
ZW1vZ2xvYmluIEEvYW5hbHlzaXMvKm1ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+SGVhcnQg
RmFpbHVyZS9ibG9vZC9jb21wbGljYXRpb25zL21vcnRhbGl0eTwva2V5d29yZD48a2V5d29yZD5I
dW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SW5jaWRlbmNlPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8
L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TXVsdGl2YXJp
YXRlIEFuYWx5c2lzPC9rZXl3b3JkPjxrZXl3b3JkPk15b2NhcmRpYWwgSW5mYXJjdGlvbi9ibG9v
ZC9jb21wbGljYXRpb25zL21vcnRhbGl0eTwva2V5d29yZD48a2V5d29yZD5Qcm9wb3J0aW9uYWwg
SGF6YXJkcyBNb2RlbHM8L2tleXdvcmQ+PGtleXdvcmQ+UHJvc3BlY3RpdmUgU3R1ZGllczwva2V5
d29yZD48a2V5d29yZD5SaXNrPC9rZXl3b3JkPjxrZXl3b3JkPlRpbWUgRmFjdG9yczwva2V5d29y
ZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDAwPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+QXVn
IDEyPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDk1OS04MTM4IChQcmludCkmI3hE
OzA5NTktNTM1eDwvaXNibj48YWNjZXNzaW9uLW51bT4xMDkzODA0ODwvYWNjZXNzaW9uLW51bT48
dXJscz48L3VybHM+PGN1c3RvbTI+UG1jMjc0NTQ8L2N1c3RvbTI+PHJlbW90ZS1kYXRhYmFzZS1w
cm92aWRlcj5ObG08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5n
dWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=
ADDIN EN.CITE.DATA (Stratton et al., 2000).
Even though determined albuminuria is the first sign of diabetic nephropathy, albuminuria has numerous confuse issues such as apply, urinary tract infection, acute disease and cardiac breakdown. Moreover, it has be detected to take place in the urine of non-diabetic individuals, instead of the non-specificity of albuminuria for accurate prophecy of diabetic kidney disease ADDIN EN.CITE <EndNote><Cite><Author>Jain</Author><Year>2005</Year><RecNum>39</RecNum><DisplayText><style face=”bold”>(Jain et al., 2005)</style></DisplayText><record><rec-number>39</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>39</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Jain, S.</author><author>Rajput, A.</author><author>Kumar, Y.</author><author>Uppuluri, N.</author><author>Arvind, A. S.</author><author>Tatu, U.</author></authors></contributors><auth-address>Department of Biochemistry, Indian Institute of Science, Bangalore 560 012, India.</auth-address><titles><title>Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder</title><secondary-title>J Assoc Physicians India</secondary-title><alt-title>The Journal of the Association of Physicians of India</alt-title></titles><periodical><full-title>J Assoc Physicians India</full-title><abbr-1>The Journal of the Association of Physicians of India</abbr-1></periodical><alt-periodical><full-title>J Assoc Physicians India</full-title><abbr-1>The Journal of the Association of Physicians of India</abbr-1></alt-periodical><pages>513-20</pages><volume>53</volume><edition>2005/08/27</edition><keywords><keyword>Adult</keyword><keyword>Alpha-Globulins/genetics/*urine</keyword><keyword>Biomarkers/urine</keyword><keyword>Carrier Proteins/genetics/*urine</keyword><keyword>Diabetic Nephropathies/diagnosis/*urine</keyword><keyword>Glycoproteins/genetics/*urine</keyword><keyword>Humans</keyword><keyword>Middle Aged</keyword><keyword>Orosomucoid/genetics/*urine</keyword><keyword>Proteinuria/diagnosis/*urine</keyword></keywords><dates><year>2005</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0004-5772 (Print) 0004-5772</isbn><accession-num>16121805</accession-num><urls></urls><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Jain et al., 2005) and present some diabetic patients enlarge diabetic nephropathy with typical albuminuria ADDIN EN.CITE <EndNote><Cite><Author>Isaka</Author><Year>1997</Year><RecNum>40</RecNum><DisplayText><style face=”bold”>(Isaka et al., 1997)</style></DisplayText><record><rec-number>40</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>40</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Isaka, Y.</author><author>Akagi, Y.</author><author>Ando, Y.</author><author>Imai, E.</author></authors></contributors><auth-address>First Department of Medicine, Osaka University School of Medicine, Japan. [email protected]</auth-address><titles><title>Application of gene therapy to diabetic nephropathy</title><secondary-title>Kidney Int Suppl</secondary-title><alt-title>Kidney international. Supplement</alt-title></titles><periodical><full-title>Kidney Int Suppl</full-title><abbr-1>Kidney international. Supplement</abbr-1></periodical><alt-periodical><full-title>Kidney Int Suppl</full-title><abbr-1>Kidney international. Supplement</abbr-1></alt-periodical><pages>S100-3</pages><volume>60</volume><edition>1997/09/01</edition><keywords><keyword>Animals</keyword><keyword>Diabetic Nephropathies/*therapy</keyword><keyword>*Genetic Therapy</keyword><keyword>Humans</keyword></keywords><dates><year>1997</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>0098-6577 (Print) 0098-6577</isbn><accession-num>9285910</accession-num><urls></urls><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Isaka et al., 1997). Exacting these off-putting, new biomarkers that foresee diabetic nephropathy at a extremely premature phase, yet previously than the manifestation of microalbuminuria are desired for finest medical administration of diabetic patients. Recently, ingrained that a number of biomarkers are appreciably high in type II diabetic patients through normoalbuminuria compared to nondiabetic manage folks and may be used as markers for facing, specific and clear-cut guess of diabetic nephropathyPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5KYWluPC9BdXRob3I+PFllYXI+MjAwNTwvWWVhcj48UmVj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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5KYWluPC9BdXRob3I+PFllYXI+MjAwNTwvWWVhcj48UmVj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ADDIN EN.CITE.DATA (Jain et al., 2005;Gatua et al., 2011), cyclophilin A may be one of these biomarkers.

We Will Write a Custom Essay Specifically
For You For Only $13.90/page!


order now

Cyclophilin A is a cytosolic and exceedingly plentiful protein, has a beta-barrel construction by two alpha helices and a beta-sheet. Cyclophilin A is a portion of a range of intracellular functions, such as intracellular signaling, protein trafficking, & yielding the action of other proteins PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TYXRvaDwvQXV0aG9yPjxZZWFyPjIwMTA8L1llYXI+PFJl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 EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TYXRvaDwvQXV0aG9yPjxZZWFyPjIwMTA8L1llYXI+PFJl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 EN.CITE.DATA (Satoh et al., 2010). Cyclophilin A is also well predictable as a secreted enlargement factor that is inducing by oxidative stress PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5KaW48L0F1dGhvcj48WWVhcj4yMDAwPC9ZZWFyPjxSZWNO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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5KaW48L0F1dGhvcj48WWVhcj4yMDAwPC9ZZWFyPjxSZWNO
dW0+NDI8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9ImJvbGQiPihKaW4gZXQgYWwu
LCAyMDAwKTwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjQyPC9yZWMt
bnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iZjlwcDlhdmRwOXM1ZGZl
dzV2Y3ZyeGRnMmRmZGYwNXQ1encyIj40Mjwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBu
YW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3Jz
PjxhdXRob3I+SmluLCBaLiBHLjwvYXV0aG9yPjxhdXRob3I+TWVsYXJhZ25vLCBNLiBHLjwvYXV0
aG9yPjxhdXRob3I+TGlhbywgRC4gRi48L2F1dGhvcj48YXV0aG9yPllhbiwgQy48L2F1dGhvcj48
YXV0aG9yPkhhZW5kZWxlciwgSi48L2F1dGhvcj48YXV0aG9yPlN1aCwgWS4gQS48L2F1dGhvcj48
YXV0aG9yPkxhbWJldGgsIEouIEQuPC9hdXRob3I+PGF1dGhvcj5CZXJrLCBCLiBDLjwvYXV0aG9y
PjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkNlbnRlciBmb3IgQ2FyZGlv
dmFzY3VsYXIgUmVzZWFyY2gsIFVuaXZlcnNpdHkgb2YgUm9jaGVzdGVyLCBSb2NoZXN0ZXIsIE5Z
LCBVU0EuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+Q3ljbG9waGlsaW4gQSBpcyBhIHNl
Y3JldGVkIGdyb3d0aCBmYWN0b3IgaW5kdWNlZCBieSBveGlkYXRpdmUgc3RyZXNzPC90aXRsZT48
c2Vjb25kYXJ5LXRpdGxlPkNpcmMgUmVzPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5DaXJj
dWxhdGlvbiByZXNlYXJjaDwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRp
dGxlPkNpcmMgUmVzPC9mdWxsLXRpdGxlPjxhYmJyLTE+Q2lyY3VsYXRpb24gcmVzZWFyY2g8L2Fi
YnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkNpcmMgUmVzPC9m
dWxsLXRpdGxlPjxhYmJyLTE+Q2lyY3VsYXRpb24gcmVzZWFyY2g8L2FiYnItMT48L2FsdC1wZXJp
b2RpY2FsPjxwYWdlcz43ODktOTY8L3BhZ2VzPjx2b2x1bWU+ODc8L3ZvbHVtZT48bnVtYmVyPjk8
L251bWJlcj48ZWRpdGlvbj4yMDAwLzEwLzMxPC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD4x
LDItRGloeWRyb3h5YmVuemVuZS0zLDUtRGlzdWxmb25pYyBBY2lkIERpc29kaXVtIFNhbHQvcGhh
cm1hY29sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkFtaW5vcXVpbm9saW5lcy9waGFybWFjb2xvZ3k8
L2tleXdvcmQ+PGtleXdvcmQ+QW5pbWFsczwva2V5d29yZD48a2V5d29yZD5BcG9wdG9zaXMvZHJ1
ZyBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPkNhcm90aWQgQXJ0ZXJ5IEluanVyaWVzL21ldGFi
b2xpc208L2tleXdvcmQ+PGtleXdvcmQ+Q2VsbCBEaXZpc2lvbi9kcnVnIGVmZmVjdHM8L2tleXdv
cmQ+PGtleXdvcmQ+Q3ljbG9waGlsaW4gQS9hbmFseXNpcy8qbWV0YWJvbGlzbS9zZWNyZXRpb248
L2tleXdvcmQ+PGtleXdvcmQ+RW56eW1lIEFjdGl2YXRpb248L2tleXdvcmQ+PGtleXdvcmQ+RW56
eW1lIEluaGliaXRvcnMvcGhhcm1hY29sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkZyZWUgUmFkaWNh
bCBTY2F2ZW5nZXJzL3BoYXJtYWNvbG9neTwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3Jk
PjxrZXl3b3JkPk1pdG9nZW4tQWN0aXZhdGVkIFByb3RlaW4gS2luYXNlIDM8L2tleXdvcmQ+PGtl
eXdvcmQ+TWl0b2dlbi1BY3RpdmF0ZWQgUHJvdGVpbiBLaW5hc2VzL21ldGFib2xpc208L2tleXdv
cmQ+PGtleXdvcmQ+TXVzY2xlLCBTbW9vdGgsIFZhc2N1bGFyL2N5dG9sb2d5LyptZXRhYm9saXNt
L3NlY3JldGlvbjwva2V5d29yZD48a2V5d29yZD5OQURILCBOQURQSCBPeGlkb3JlZHVjdGFzZXMv
Z2VuZXRpY3MvbWV0YWJvbGlzbTwva2V5d29yZD48a2V5d29yZD4qTkFEUEggT3hpZGFzZXM8L2tl
eXdvcmQ+PGtleXdvcmQ+Tml0cm9wcnVzc2lkZTwva2V5d29yZD48a2V5d29yZD5Pbml1bSBDb21w
b3VuZHMvcGhhcm1hY29sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPipPeGlkYXRpdmUgU3RyZXNzPC9r
ZXl3b3JkPjxrZXl3b3JkPlBlcHRpZHlscHJvbHlsIElzb21lcmFzZTwva2V5d29yZD48a2V5d29y
ZD5SYXRzPC9rZXl3b3JkPjxrZXl3b3JkPlJhdHMsIFNwcmFndWUtRGF3bGV5PC9rZXl3b3JkPjxr
ZXl3b3JkPlJlYWN0aXZlIE94eWdlbiBTcGVjaWVzL21ldGFib2xpc208L2tleXdvcmQ+PGtleXdv
cmQ+UmVjb21iaW5hbnQgUHJvdGVpbnMvbWV0YWJvbGlzbTwva2V5d29yZD48a2V5d29yZD5UcmFu
c2ZlY3Rpb248L2tleXdvcmQ+PGtleXdvcmQ+VmFzY3VsYXIgRGlzZWFzZXMvZXRpb2xvZ3k8L2tl
eXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwMDwveWVhcj48cHViLWRhdGVzPjxkYXRl
Pk9jdCAyNzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAwMDktNzMzMDwvaXNibj48
YWNjZXNzaW9uLW51bT4xMTA1NTk4MzwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PHJlbW90
ZS1kYXRhYmFzZS1wcm92aWRlcj5ObG08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3Vh
Z2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=
ADDIN EN.CITE.DATA (Jin et al., 2000). Moreover, veiled cyclophilin A is connected to inflammatory or infectious diseases such as rheumatoid arthritis, asthma, and periodontitis ADDIN EN.CITE <EndNote><Cite><Author>Nigro</Author><Year>2013</Year><RecNum>43</RecNum><DisplayText><style face=”bold”>(Nigro et al., 2013)</style></DisplayText><record><rec-number>43</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>43</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Nigro, P.</author><author>Pompilio, G.</author><author>Capogrossi, M. C.</author></authors></contributors><auth-address>Centro Cardiologico Monzino-IRCCS, Laboratorio di Biologia Vascolare e Medicina Rigenerativa, Milan, Italy.</auth-address><titles><title>Cyclophilin A: a key player for human disease</title><secondary-title>Cell Death Dis</secondary-title><alt-title>Cell death &amp; disease</alt-title></titles><periodical><full-title>Cell Death Dis</full-title><abbr-1>Cell death &amp; disease</abbr-1></periodical><alt-periodical><full-title>Cell Death Dis</full-title><abbr-1>Cell death &amp; disease</abbr-1></alt-periodical><pages>e888</pages><volume>4</volume><edition>2013/11/02</edition><keywords><keyword>Animals</keyword><keyword>Arthritis, Rheumatoid/genetics/metabolism</keyword><keyword>Cardiovascular Diseases/genetics/metabolism</keyword><keyword>Cyclophilin A/genetics/*metabolism/*physiology</keyword><keyword>Humans</keyword><keyword>Neurodegenerative Diseases/genetics/metabolism</keyword></keywords><dates><year>2013</year><pub-dates><date>Oct 31</date></pub-dates></dates><accession-num>24176846</accession-num><urls></urls><custom2>Pmc3920964</custom2><electronic-resource-num>10.1038/cddis.2013.410</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Nigro et al., 2013). Engagingly, veiled cyclophilin A was also detected in diabetic patients’ plasma PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SYW1hY2hhbmRyYW48L0F1dGhvcj48WWVhcj4yMDE0PC9Z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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SYW1hY2hhbmRyYW48L0F1dGhvcj48WWVhcj4yMDE0PC9Z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ADDIN EN.CITE.DATA (Ramachandran et al., 2014) and was exposed to be buried by monocytes in answer to high glucose level PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SYW1hY2hhbmRyYW48L0F1dGhvcj48WWVhcj4yMDEyPC9Z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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SYW1hY2hhbmRyYW48L0F1dGhvcj48WWVhcj4yMDEyPC9Z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ADDIN EN.CITE.DATA (Ramachandran et al., 2012) representing that out of sight cyclophilin A could be a impending escritoire marker in type II diabetes mellitus. still, a relatively high expression level of cyclophilin A in normal kidneys ADDIN EN.CITE ;EndNote;;Cite;;Author;Ryffel;/Author;;Year;1991;/Year;;RecNum;45;/RecNum;;DisplayText;;style face=”bold”;(Ryffel et al., 1991);/style;;/DisplayText;;record;;rec-number;45;/rec-number;;foreign-keys;;key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″;45;/key;;/foreign-keys;;ref-type name=”Journal Article”;17;/ref-type;;contributors;;authors;;author;Ryffel, B.;/author;;author;Woerly, G.;/author;;author;Greiner, B.;/author;;author;Haendler, B.;/author;;author;Mihatsch, M. J.;/author;;author;Foxwell, B. M.;/author;;/authors;;/contributors;;auth-address;Sandoz Pharma Ltd, Drug Safety Assessment, Basle, Switzerland.;/auth-address;;titles;;title;Distribution of the cyclosporine binding protein cyclophilin in human tissues;/title;;secondary-title;Immunology;/secondary-title;;alt-title;Immunology;/alt-title;;/titles;;periodical;;full-title;Immunology;/full-title;;abbr-1;Immunology;/abbr-1;;/periodical;;alt-periodical;;full-title;Immunology;/full-title;;abbr-1;Immunology;/abbr-1;;/alt-periodical;;pages;399-404;/pages;;volume;72;/volume;;number;3;/number;;edition;1991/03/01;/edition;;keywords;;keyword;Amino Acid Isomerases/*analysis/blood</keyword><keyword>Animals</keyword><keyword>Blotting, Northern</keyword><keyword>Blotting, Western</keyword><keyword>Carrier Proteins/*analysis/blood</keyword><keyword>Cell Line</keyword><keyword>Cyclosporins/*metabolism</keyword><keyword>Enzyme-Linked Immunosorbent Assay</keyword><keyword>Humans</keyword><keyword>Immunoenzyme Techniques</keyword><keyword>Peptidylprolyl Isomerase</keyword><keyword>Rabbits</keyword></keywords><dates><year>1991</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0019-2805 (Print) 0019-2805</isbn><accession-num>2026447</accession-num><urls></urls><custom2>Pmc1384402</custom2><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Ryffel et al., 1991) has led to the theory that secreted cyclophilin A may be associated with solid organ damage. Serum cyclophilin A can be used as a potential biomarker of diabetic nephropathy and may be raised earlier than albuminuria.

.
Aim of The work
Revealing the power of using serum cyclophilin A as an early and consistent biomarker for diabetic nephropathy
Study objectives
• Measurement of serum cyclophilin A level in healthy individuals, patients with type II diabetes mellitus lacking nephropathy and patients with type II diabetes mellitus with nephropathy.

• Discovery if there is a association among serum cyclophilin A level, albuminuria and glomerular filtration rate.

• Discovery if there is a parallel between serum cyclophilin A level and additional risk factors.

• Finding if there is a connection between serum cyclophilin A level and the austerity of the disease.

Diabetes mellitus
1-Definition of diabetes mellitus
Diabetes mellitus(DM) is a constant sickness caused by present at birth and/or acquire lack in the manufacture of insulin by the pancreas, or by the incompetence of the insulin creation ADDIN EN.CITE <EndNote><Cite><Author>Alberti</Author><Year>2006</Year><RecNum>74</RecNum><DisplayText><style face=”bold”>(Alberti et al., 2006;Kharroubi and Darwish, 2015)</style></DisplayText><record><rec-number>74</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>74</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Alberti, Kurt George Matthew Mayer</author><author>Zimmet, Paul</author><author>Shaw, Jonathan</author></authors></contributors><titles><title>Metabolic syndrome—a new world?wide definition. A consensus statement from the international diabetes federation</title><secondary-title>Diabetic medicine</secondary-title></titles><periodical><full-title>Diabetic medicine</full-title></periodical><pages>469-480</pages><volume>23</volume><number>5</number><dates><year>2006</year></dates><isbn>1464-5491</isbn><urls></urls></record></Cite><Cite><Author>Kharroubi</Author><Year>2015</Year><RecNum>76</RecNum><record><rec-number>76</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>76</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kharroubi, Akram T</author><author>Darwish, Hisham M</author></authors></contributors><titles><title>Diabetes mellitus: The epidemic of the century</title><secondary-title>World journal of diabetes</secondary-title></titles><periodical><full-title>World journal of diabetes</full-title></periodical><pages>850</pages><volume>6</volume><number>6</number><dates><year>2015</year></dates><urls></urls></record></Cite></EndNote>(Alberti et al., 2006;Kharroubi and Darwish, 2015).

Insulin is a hormone prepared by the pancreas, all carbohydrate foods are broken down into glucose in the blood, and insulin helps glucose get a hold into the cells. Not being able to produce insulin or use it effectively leads to raised glucose levels in the blood (known as hyperglycemia). Over the long-term high glucose levels are related with break to the body and failure of various organs and tissues.

2- Prevalence of diabetes mellitus
Diabetes mellitus is in all odds one of the oldest diseases known to the human being. It was earliest reported in Egyptian manuscript about 3000 years before PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BaG1lZDwvQXV0aG9yPjxZZWFyPjIwMDI8L1llYXI+PFJl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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BaG1lZDwvQXV0aG9yPjxZZWFyPjIwMDI8L1llYXI+PFJl
Y051bT45PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJib2xkIj4oQWhtZWQsIDIw
MDIpPC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+OTwvcmVjLW51bWJl
cj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9ImY5cHA5YXZkcDlzNWRmZXc1dmN2
cnhkZzJkZmRmMDV0NXp3MiI+OTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJK
b3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRo
b3I+QWhtZWQsIEEuIE0uPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFk
ZHJlc3M+RmFjdWx0eSBvZiBNZWRpY2luZSwgVW5pdmVyc2l0eSBvZiBCYWhyIEVsZ2hhemFsLCBQ
TyBCb3ggMTAyLCBLaGFydG91bSwgU3VkYW4uIGF3YWRfc2RAaG90bWFpbC5jb208L2F1dGgtYWRk
cmVzcz48dGl0bGVzPjx0aXRsZT5IaXN0b3J5IG9mIGRpYWJldGVzIG1lbGxpdHVzPC90aXRsZT48
c2Vjb25kYXJ5LXRpdGxlPlNhdWRpIE1lZCBKPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5T
YXVkaSBtZWRpY2FsIGpvdXJuYWw8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVs
bC10aXRsZT5TYXVkaSBNZWQgSjwvZnVsbC10aXRsZT48YWJici0xPlNhdWRpIG1lZGljYWwgam91
cm5hbDwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+U2F1
ZGkgTWVkIEo8L2Z1bGwtdGl0bGU+PGFiYnItMT5TYXVkaSBtZWRpY2FsIGpvdXJuYWw8L2FiYnIt
MT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4zNzMtODwvcGFnZXM+PHZvbHVtZT4yMzwvdm9sdW1l
PjxudW1iZXI+NDwvbnVtYmVyPjxlZGl0aW9uPjIwMDIvMDQvMTY8L2VkaXRpb24+PGtleXdvcmRz
PjxrZXl3b3JkPkRpYWJldGVzIE1lbGxpdHVzLypoaXN0b3J5L3RoZXJhcHk8L2tleXdvcmQ+PGtl
eXdvcmQ+SGlzdG9yeSwgMTd0aCBDZW50dXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkhpc3RvcnksIDE4
dGggQ2VudHVyeTwva2V5d29yZD48a2V5d29yZD5IaXN0b3J5LCAxOXRoIENlbnR1cnk8L2tleXdv
cmQ+PGtleXdvcmQ+SGlzdG9yeSwgMjB0aCBDZW50dXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkhpc3Rv
cnksIEFuY2llbnQ8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjwva2V5d29yZHM+
PGRhdGVzPjx5ZWFyPjIwMDI8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5BcHI8L2RhdGU+PC9wdWIt
ZGF0ZXM+PC9kYXRlcz48aXNibj4wMzc5LTUyODQgKFByaW50KSYjeEQ7MDM3OS01Mjg0PC9pc2Ju
PjxhY2Nlc3Npb24tbnVtPjExOTUzNzU4PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjwvdXJscz48cmVt
b3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5sbTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5n
dWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkFobWVkPC9B
dXRob3I+PFllYXI+MjAwMjwvWWVhcj48UmVjTnVtPjQ5PC9SZWNOdW0+PHJlY29yZD48cmVjLW51
bWJlcj40OTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9ImY5
cHA5YXZkcDlzNWRmZXc1dmN2cnhkZzJkZmRmMDV0NXp3MiI+NDk8L2tleT48L2ZvcmVpZ24ta2V5
cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1
dG9ycz48YXV0aG9ycz48YXV0aG9yPkFobWVkLCBBLiBNLjwvYXV0aG9yPjwvYXV0aG9ycz48L2Nv
bnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkZhY3VsdHkgb2YgTWVkaWNpbmUsIFVuaXZlcnNpdHkg
b2YgQmFociBFbGdoYXphbCwgUE8gQm94IDEwMiwgS2hhcnRvdW0sIFN1ZGFuLiBhd2FkX3NkQGhv
dG1haWwuY29tPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+SGlzdG9yeSBvZiBkaWFiZXRl
cyBtZWxsaXR1czwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5TYXVkaSBNZWQgSjwvc2Vjb25kYXJ5
LXRpdGxlPjxhbHQtdGl0bGU+U2F1ZGkgbWVkaWNhbCBqb3VybmFsPC9hbHQtdGl0bGU+PC90aXRs
ZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+U2F1ZGkgTWVkIEo8L2Z1bGwtdGl0bGU+PGFiYnIt
MT5TYXVkaSBtZWRpY2FsIGpvdXJuYWw8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2Rp
Y2FsPjxmdWxsLXRpdGxlPlNhdWRpIE1lZCBKPC9mdWxsLXRpdGxlPjxhYmJyLTE+U2F1ZGkgbWVk
aWNhbCBqb3VybmFsPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzczLTg8L3BhZ2Vz
Pjx2b2x1bWU+MjM8L3ZvbHVtZT48bnVtYmVyPjQ8L251bWJlcj48ZWRpdGlvbj4yMDAyLzA0LzE2
PC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5EaWFiZXRlcyBNZWxsaXR1cy8qaGlzdG9yeS90
aGVyYXB5PC9rZXl3b3JkPjxrZXl3b3JkPkhpc3RvcnksIDE3dGggQ2VudHVyeTwva2V5d29yZD48
a2V5d29yZD5IaXN0b3J5LCAxOHRoIENlbnR1cnk8L2tleXdvcmQ+PGtleXdvcmQ+SGlzdG9yeSwg
MTl0aCBDZW50dXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkhpc3RvcnksIDIwdGggQ2VudHVyeTwva2V5
d29yZD48a2V5d29yZD5IaXN0b3J5LCBBbmNpZW50PC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwv
a2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDAyPC95ZWFyPjxwdWItZGF0ZXM+PGRh
dGU+QXByPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDM3OS01Mjg0IChQcmludCkm
I3hEOzAzNzktNTI4NDwvaXNibj48YWNjZXNzaW9uLW51bT4xMTk1Mzc1ODwvYWNjZXNzaW9uLW51
bT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5ObG08L3JlbW90ZS1kYXRh
YmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9F
bmROb3RlPgB=
ADDIN EN.CITE.DATA (Ahmed, 2002). It is reported that 366 million people had diabetes mellitus by 2011; with 2030 this will be improved to 552 million, diabetes mellitus caused 4.6 million deaths in 2011 ADDIN EN.CITE <EndNote><Cite><Author>Whiting</Author><Year>2011</Year><RecNum>81</RecNum><DisplayText><style face=”bold”>(Whiting et al., 2011)</style></DisplayText><record><rec-number>81</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>81</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Whiting, David R</author><author>Guariguata, Leonor</author><author>Weil, Clara</author><author>Shaw, Jonathan</author></authors></contributors><titles><title>IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030</title><secondary-title>Diabetes research and clinical practice</secondary-title></titles><periodical><full-title>Diabetes Res Clin Pract</full-title><abbr-1>Diabetes research and clinical practice</abbr-1></periodical><pages>311-321</pages><volume>94</volume><number>3</number><dates><year>2011</year></dates><isbn>0168-8227</isbn><urls></urls></record></Cite></EndNote>(Whiting et al., 2011).
2.1-Diabetes mellitus in Egypt
Diabetes is a fast-growing health problem in Egypt with a significant impact on morbidity, death, and healthcare resources. The International Diabetes Federation (IDF) planned Egypt between the world top 10 countries in the quantity of patients with diabetes ADDIN EN.CITE <EndNote><Cite><Author>Federation</Author><Year>2013</Year><RecNum>78</RecNum><DisplayText><style face=”bold”>(International Diabetes Federation, 2013)</style></DisplayText><record><rec-number>78</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>78</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author> International Diabetes Federation,</author></authors></contributors><titles><title>IDF diabetes atlas</title><secondary-title>Brussels: International Diabetes Federation</secondary-title></titles><periodical><full-title>Brussels: International Diabetes Federation</full-title></periodical><dates><year>2013</year></dates><urls></urls></record></Cite></EndNote>(International Diabetes Federation, 2013). In 2013, the IDF predictable that 7.5 million persons have diabetes and approximately 2.2 million have prediabetes in Egypt. In addition, information indicated that 43% of patients with diabetes and the majority patients with prediabetes in Egypt are likely undiagnosed. It is startling that diabetes frequency in Egypt has enlarged in haste within a reasonably short occasion from roughly 4.4 million in 2007 to 7.5 million in 2013 and it is projected that the amount will be jumped up to 13.1 million by 2035PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5XaGl0aW5nPC9BdXRob3I+PFllYXI+MjAxMTwvWWVhcj48
UmVjTnVtPjUwPC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJib2xkIj4oV2hpdGlu
ZyBldCBhbC4sIDIwMTE7SW50ZXJuYXRpb25hbCBEaWFiZXRlcyBGZWRlcmF0aW9uLCAyMDEzKTwv
c3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjUwPC9yZWMtbnVtYmVyPjxm
b3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iZjlwcDlhdmRwOXM1ZGZldzV2Y3ZyeGRn
MmRmZGYwNXQ1encyIj41MDwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3Vy
bmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+
V2hpdGluZywgRC4gUi48L2F1dGhvcj48YXV0aG9yPkd1YXJpZ3VhdGEsIEwuPC9hdXRob3I+PGF1
dGhvcj5XZWlsLCBDLjwvYXV0aG9yPjxhdXRob3I+U2hhdywgSi48L2F1dGhvcj48L2F1dGhvcnM+
PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5JbnRlcm5hdGlvbmFsIERpYWJldGVzIEZlZGVy
YXRpb24sIEJydXNzZWxzLCBCZWxnaXVtLiBkYXZpZEBkYXZpZHdoaXRpbmcubWUudWs8L2F1dGgt
YWRkcmVzcz48dGl0bGVzPjx0aXRsZT5JREYgZGlhYmV0ZXMgYXRsYXM6IGdsb2JhbCBlc3RpbWF0
ZXMgb2YgdGhlIHByZXZhbGVuY2Ugb2YgZGlhYmV0ZXMgZm9yIDIwMTEgYW5kIDIwMzA8L3RpdGxl
PjxzZWNvbmRhcnktdGl0bGU+RGlhYmV0ZXMgUmVzIENsaW4gUHJhY3Q8L3NlY29uZGFyeS10aXRs
ZT48YWx0LXRpdGxlPkRpYWJldGVzIHJlc2VhcmNoIGFuZCBjbGluaWNhbCBwcmFjdGljZTwvYWx0
LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkRpYWJldGVzIFJlcyBDbGlu
IFByYWN0PC9mdWxsLXRpdGxlPjxhYmJyLTE+RGlhYmV0ZXMgcmVzZWFyY2ggYW5kIGNsaW5pY2Fs
IHByYWN0aWNlPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRs
ZT5EaWFiZXRlcyBSZXMgQ2xpbiBQcmFjdDwvZnVsbC10aXRsZT48YWJici0xPkRpYWJldGVzIHJl
c2VhcmNoIGFuZCBjbGluaWNhbCBwcmFjdGljZTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBh
Z2VzPjMxMS0yMTwvcGFnZXM+PHZvbHVtZT45NDwvdm9sdW1lPjxudW1iZXI+MzwvbnVtYmVyPjxl
ZGl0aW9uPjIwMTEvMTEvMTU8L2VkaXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPkRpYWJldGVzIE1l
bGxpdHVzLyplcGlkZW1pb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+Kkdsb2JhbCBIZWFsdGg8L2tl
eXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPk1vZGVscywgU3RhdGlzdGlj
YWw8L2tleXdvcmQ+PGtleXdvcmQ+UHJldmFsZW5jZTwva2V5d29yZD48a2V5d29yZD5UaW1lIEZh
Y3RvcnM8L2tleXdvcmQ+PGtleXdvcmQ+V29ybGQgSGVhbHRoIE9yZ2FuaXphdGlvbjwva2V5d29y
ZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDExPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+RGVj
PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDE2OC04MjI3PC9pc2JuPjxhY2Nlc3Np
b24tbnVtPjIyMDc5NjgzPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1y
ZXNvdXJjZS1udW0+MTAuMTAxNi9qLmRpYWJyZXMuMjAxMS4xMC4wMjk8L2VsZWN0cm9uaWMtcmVz
b3VyY2UtbnVtPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+TmxtPC9yZW1vdGUtZGF0YWJhc2Ut
cHJvdmlkZXI+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxB
dXRob3I+RmVkZXJhdGlvbjwvQXV0aG9yPjxZZWFyPjIwMTM8L1llYXI+PFJlY051bT43ODwvUmVj
TnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+Nzg8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5
IGFwcD0iRU4iIGRiLWlkPSJmOXBwOWF2ZHA5czVkZmV3NXZjdnJ4ZGcyZGZkZjA1dDV6dzIiPjc4
PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8
L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj4gSW50ZXJuYXRpb25hbCBE
aWFiZXRlcyBGZWRlcmF0aW9uLDwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0
bGVzPjx0aXRsZT5JREYgZGlhYmV0ZXMgYXRsYXM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QnJ1
c3NlbHM6IEludGVybmF0aW9uYWwgRGlhYmV0ZXMgRmVkZXJhdGlvbjwvc2Vjb25kYXJ5LXRpdGxl
PjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkJydXNzZWxzOiBJbnRlcm5hdGlvbmFs
IERpYWJldGVzIEZlZGVyYXRpb248L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxkYXRlcz48eWVh
cj4yMDEzPC95ZWFyPjwvZGF0ZXM+PHVybHM+PC91cmxzPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5v
dGU+
ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5XaGl0aW5nPC9BdXRob3I+PFllYXI+MjAxMTwvWWVhcj48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ADDIN EN.CITE.DATA (Whiting et al., 2011;International Diabetes Federation, 2013).

3-Classification of diabetes
Categorization of diabetes is imperative for decisive rehabilitation, but a quantity of folks cannot be evidently classify as having type I or type II diabetes at the time of verdict. The conventional models of type II diabetes taking place just in adults and type I diabetes barely in offspring are no longer perfect, as both diseases happen in the both. Intermittently, patients with type II diabetes may nearby with diabetic ketoacidosis (DKA) PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5EYWJlbGVhPC9BdXRob3I+PFllYXI+MjAxNDwvWWVhcj48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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5EYWJlbGVhPC9BdXRob3I+PFllYXI+MjAxNDwvWWVhcj48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ADDIN EN.CITE.DATA (Dabelea et al., 2014).
Offspring with type I diabetes classically at hand with the trademark symptoms of polyuria /polydipsia, and around one-third nearby with DKA PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OZXd0b248L0F1dGhvcj48WWVhcj4yMDA0PC9ZZWFyPjxS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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OZXd0b248L0F1dGhvcj48WWVhcj4yMDA0PC9ZZWFyPjxS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ADDIN EN.CITE.DATA (Newton and Raskin, 2004) .The inception of type I diabetes may be more changeable in adults, and they may not there with the typical symptoms seen in kids. Even though difficulties in characteristic diabetes type may arise in all age-groups at onset, the correct judgment becomes more noticeable over time. In both type I and type II diabetes, different heritable and ecological factors can result in the progressive loss of ?-cell mass and/or meaning that manifests clinically as hyperglycemia ADDIN EN.CITE <EndNote><Cite><Author>Skyler</Author><Year>2017</Year><RecNum>53</RecNum><DisplayText><style face=”bold”>(Skyler et al., 2017)</style></DisplayText><record><rec-number>53</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>53</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Skyler, J. S.</author><author>Bakris, G. L.</author><author>Bonifacio, E.</author></authors></contributors><auth-address>Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL. The University of Chicago Medicine, Chicago, IL.</auth-address><titles><title>Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis</title></titles><pages>241-255</pages><volume>66</volume><number>2</number><dates><year>2017</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0012-1797</isbn><accession-num>27980006</accession-num><urls></urls><electronic-resource-num>10.2337/db16-0806</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider></record></Cite></EndNote>(Skyler et al., 2017).

3.1-Type I diabetes; Insulin-dependent, populace with type 1 diabetes are possibly roughly 10 % of all effects of diabetes. Type I diabetes is caused by insulin absence due to demolition of pancreatic ?-cells predominantly through an autoimmune effect, which is itself triggered by dissimilar factors. It is normally regarded as mounting rapidly in infantile people, but it can transpire in any age group.

3.1.1- Risk factors for type I diabetes
Even if the exact foundation of type I diabetes is unidentified, factors that may be enlarged risk incorporate;
3.1.1.1 – relatives history (family factors): peril increases if a parent or sibling has type I diabetes ADDIN EN.CITE <EndNote><Cite><Author>Bonifacio</Author><Year>2004</Year><RecNum>265</RecNum><DisplayText><style face=”bold”>(Bonifacio et al., 2004)</style></DisplayText><record><rec-number>265</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>265</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Bonifacio, Ezio</author><author>Hummel, Michael</author><author>Walter, Markus</author><author>Schmid, Sandra</author><author>Ziegler, Anette-G</author></authors></contributors><titles><title>IDDM1 and multiple family history of type 1 diabetes combine to identify neonates at high risk for type 1 diabetes</title><secondary-title>Diabetes Care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>2695-2700</pages><volume>27</volume><number>11</number><dates><year>2004</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(Bonifacio et al., 2004).

3.1.1.2 – Environmental factors:  such as revelation to a viral infection likely acting several part in type I diabetes ADDIN EN.CITE <EndNote><Cite><Author>Åkerblom</Author><Year>2002</Year><RecNum>267</RecNum><DisplayText><style face=”bold”>(Åkerblom et al., 2002)</style></DisplayText><record><rec-number>267</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>267</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Åkerblom, Hans K</author><author>Vaarala, Outi</author><author>Hyöty, Heikki</author><author>Ilonen, Jorma</author><author>Knip, Mikael</author></authors></contributors><titles><title>Environmental factors in the etiology of type 1 diabetes</title><secondary-title>American Journal of Medical Genetics Part A</secondary-title></titles><periodical><full-title>American Journal of Medical Genetics Part A</full-title></periodical><pages>18-29</pages><volume>115</volume><number>1</number><dates><year>2002</year></dates><isbn>1096-8628</isbn><urls></urls></record></Cite></EndNote>(Åkerblom et al., 2002).

3.1.1.3 -The incidence of destructive impervious system cells (autoantibodies):  occasionally folks members of community with type I diabetes are tested for the existence of diabetes autoantibodies. If somebody has these autoantibodies, so has an augmented risk of upward type I diabetes. But not each person who has these autoantibodies develops diabetes ADDIN EN.CITE <EndNote><Cite><Author>Ziegler</Author><Year>1999</Year><RecNum>266</RecNum><DisplayText><style face=”bold”>(Ziegler et al., 1999)</style></DisplayText><record><rec-number>266</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>266</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Ziegler, Anette-G</author><author>Hummel, Michael</author><author>Schenker, Michael</author><author>Bonifacio, Ezio</author></authors></contributors><titles><title>Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study</title><secondary-title>Diabetes</secondary-title></titles><periodical><full-title>Diabetes</full-title><abbr-1>Diabetes</abbr-1></periodical><pages>460-468</pages><volume>48</volume><number>3</number><dates><year>1999</year></dates><isbn>0012-1797</isbn><urls></urls></record></Cite></EndNote>(Ziegler et al., 1999).

3.1.1.4 -nutritional factors:  comprise low vitamin D utilization, early publicity to cow’s milk PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5LbmlwPC9BdXRob3I+PFllYXI+MjAxMDwvWWVhcj48UmVj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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5LbmlwPC9BdXRob3I+PFllYXI+MjAxMDwvWWVhcj48UmVj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ADDIN EN.CITE.DATA (Knip et al., 2010), and coverage to cereals before 4 months of age. None of these factors has been shown to frankly source type I diabetes.

3.1.1.5-Geography: certain countries, such as Finland and Sweden, have advanced rates of type I diabetes ADDIN EN.CITE <EndNote><Cite><Author>LaPorte</Author><Year>1985</Year><RecNum>268</RecNum><DisplayText><style face=”bold”>(LaPorte et al., 1985)</style></DisplayText><record><rec-number>268</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>268</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>LaPorte, Ronald E</author><author>Tajima, Naoko</author><author>Åkerblom, Hans K</author><author>Berlin, Nina</author><author>Brosseau, James</author><author>Christy, Morten</author><author>Drash, Allan L</author><author>Fishbein, Howard</author><author>Green, Anders</author><author>Hamman, Richard</author></authors></contributors><titles><title>Geographic differences in the risk of insulin-dependent diabetes mellitus: the importance of registries</title><secondary-title>Diabetes care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>101-107</pages><volume>8</volume><number>Supplement 1</number><dates><year>1985</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(LaPorte et al., 1985).

3.2-Type II diabetes (Noninsulin-dependent diabetes” or “adult-onset diabetes,” account for 90–95% of all diabetes ADDIN EN.CITE <EndNote><Cite><Author>Association</Author><Year>2017</Year><RecNum>82</RecNum><DisplayText><style face=”bold”>(American Diabetes Association, 2017)</style></DisplayText><record><rec-number>82</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>82</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>American Diabetes Association, </author></authors></contributors><titles><title>2. Classification and diagnosis of diabetes</title><secondary-title>Diabetes Care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>S11-S24</pages><volume>40</volume><number>Supplement 1</number><dates><year>2017</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(American Diabetes Association, 2017). Type II diabetes is caused by progressive beating of ?-cell insulin emission recurrently on the environment of insulin conflict). Pancreatic ?-cell utility is retained to a definite quantity so insulin injections are rarely necessary for endurance.

3.2.1- Risk factors for and type II diabetes
Researchers don’t wholly appreciate why some public enlarge type II diabetes and others don’t. It’s apparent that confident factors enlarge the risk, nonetheless, including;
3.2.1.1-Overweight/Obesity; require of keep fit and detrimental meal arrangement choices can front to fatness, or build it inferior. Being overweight makes insulin resistance and can also lead to many other health harms ADDIN EN.CITE <EndNote><Cite><Author>Yaturu</Author><Year>2011</Year><RecNum>270</RecNum><DisplayText><style face=”bold”>(Yaturu, 2011)</style></DisplayText><record><rec-number>270</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>270</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Yaturu, Subhashini</author></authors></contributors><titles><title>Obesity and type 2 diabetes</title><secondary-title>Journal of Diabetes Mellitus</secondary-title></titles><periodical><full-title>Journal of Diabetes Mellitus</full-title></periodical><pages>79</pages><volume>1</volume><number>04</number><dates><year>2011</year></dates><urls></urls></record></Cite></EndNote>(Yaturu, 2011).

3.2.1.2-Inactivity; substantial doings helps in manage body burden, uses up glucose as power and makes body cells more susceptible to insulin ADDIN EN.CITE <EndNote><Cite><Author>Colberg</Author><Year>2010</Year><RecNum>271</RecNum><DisplayText><style face=”bold”>(Colberg et al., 2010)</style></DisplayText><record><rec-number>271</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>271</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Colberg, S. R.</author><author>Sigal, R. J.</author><author>Fernhall, B.</author><author>Regensteiner, J. G.</author><author>Blissmer, B. J.</author><author>Rubin, R. R.</author><author>Chasan-Taber, L.</author><author>Albright, A. L.</author><author>Braun, B.</author></authors></contributors><auth-address>Human Movement Sciences Department, Old Dominion University, Norfolk, Virginia, USA. [email protected]</auth-address><titles><title>Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement</title><secondary-title>Diabetes Care</secondary-title><alt-title>Diabetes care</alt-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><alt-periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></alt-periodical><pages>e147-67</pages><volume>33</volume><number>12</number><edition>2010/12/01</edition><keywords><keyword>Diabetes Mellitus, Type 2/diagnosis/*physiopathology/*prevention &amp; control</keyword><keyword>Exercise/*physiology</keyword><keyword>Humans</keyword></keywords><dates><year>2010</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0149-5992</isbn><accession-num>21115758</accession-num><urls></urls><custom2>Pmc2992225</custom2><electronic-resource-num>10.2337/dc10-9990</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Colberg et al., 2010).

3.2.1.3-Family history; the risk increases if a parent or sibling has type II diabetes PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TY290dDwvQXV0aG9yPjxZZWFyPjIwMTM8L1llYXI+PFJl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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TY290dDwvQXV0aG9yPjxZZWFyPjIwMTM8L1llYXI+PFJl
Y051bT4yNzI8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9ImJvbGQiPihTY290dCBl
dCBhbC4sIDIwMTMpPC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+Mjcy
PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iZjlwcDlhdmRw
OXM1ZGZldzV2Y3ZyeGRnMmRmZGYwNXQ1encyIj4yNzI8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVm
LXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48
YXV0aG9ycz48YXV0aG9yPlNjb3R0LCBSLiBBLjwvYXV0aG9yPjxhdXRob3I+TGFuZ2VuYmVyZywg
Qy48L2F1dGhvcj48YXV0aG9yPlNoYXJwLCBTLiBKLjwvYXV0aG9yPjxhdXRob3I+RnJhbmtzLCBQ
LiBXLjwvYXV0aG9yPjxhdXRob3I+Um9sYW5kc3NvbiwgTy48L2F1dGhvcj48YXV0aG9yPkRyb2dh
biwgRC48L2F1dGhvcj48YXV0aG9yPnZhbiBkZXIgU2Nob3V3LCBZLiBULjwvYXV0aG9yPjxhdXRo
b3I+RWtlbHVuZCwgVS48L2F1dGhvcj48YXV0aG9yPktlcnJpc29uLCBOLiBELjwvYXV0aG9yPjxh
dXRob3I+QXJkYW5heiwgRS48L2F1dGhvcj48YXV0aG9yPkFycmlvbGEsIEwuPC9hdXRob3I+PGF1
dGhvcj5CYWxrYXUsIEIuPC9hdXRob3I+PGF1dGhvcj5CYXJyaWNhcnRlLCBBLjwvYXV0aG9yPjxh
dXRob3I+QmFycm9zbywgSS48L2F1dGhvcj48YXV0aG9yPkJlbmRpbmVsbGksIEIuPC9hdXRob3I+
PGF1dGhvcj5CZXVsZW5zLCBKLiBXLjwvYXV0aG9yPjxhdXRob3I+Qm9laW5nLCBILjwvYXV0aG9y
PjxhdXRob3I+ZGUgTGF1em9uLUd1aWxsYWluLCBCLjwvYXV0aG9yPjxhdXRob3I+RGVsb3VrYXMs
IFAuPC9hdXRob3I+PGF1dGhvcj5GYWdoZXJhenppLCBHLjwvYXV0aG9yPjxhdXRob3I+R29uemFs
ZXosIEMuPC9hdXRob3I+PGF1dGhvcj5HcmlmZmluLCBTLiBKLjwvYXV0aG9yPjxhdXRob3I+R3Jv
b3AsIEwuIEMuPC9hdXRob3I+PGF1dGhvcj5IYWxramFlciwgSi48L2F1dGhvcj48YXV0aG9yPkh1
ZXJ0YSwgSi4gTS48L2F1dGhvcj48YXV0aG9yPkthYWtzLCBSLjwvYXV0aG9yPjxhdXRob3I+S2hh
dywgSy4gVC48L2F1dGhvcj48YXV0aG9yPktyb2doLCBWLjwvYXV0aG9yPjxhdXRob3I+Tmlsc3Nv
biwgUC4gTS48L2F1dGhvcj48YXV0aG9yPk5vcmF0LCBULjwvYXV0aG9yPjxhdXRob3I+T3ZlcnZh
ZCwgSy48L2F1dGhvcj48YXV0aG9yPlBhbmljbywgUy48L2F1dGhvcj48YXV0aG9yPlJvZHJpZ3Vl
ei1TdWFyZXosIEwuPC9hdXRob3I+PGF1dGhvcj5Sb21hZ3VlcmEsIEQuPC9hdXRob3I+PGF1dGhv
cj5Sb21pZXUsIEkuPC9hdXRob3I+PGF1dGhvcj5TYWNlcmRvdGUsIEMuPC9hdXRob3I+PGF1dGhv
cj5TYW5jaGV6LCBNLiBKLjwvYXV0aG9yPjxhdXRob3I+U3Bpamtlcm1hbiwgQS4gTS48L2F1dGhv
cj48YXV0aG9yPlRldWNoZXIsIEIuPC9hdXRob3I+PGF1dGhvcj5Uam9ubmVsYW5kLCBBLjwvYXV0
aG9yPjxhdXRob3I+VHVtaW5vLCBSLjwvYXV0aG9yPjxhdXRob3I+dmFuIGRlciwgQS4gRGw8L2F1
dGhvcj48YXV0aG9yPldhcmssIFAuIEEuPC9hdXRob3I+PGF1dGhvcj5NY0NhcnRoeSwgTS4gSS48
L2F1dGhvcj48YXV0aG9yPlJpYm9saSwgRS48L2F1dGhvcj48YXV0aG9yPldhcmVoYW0sIE4uIEou
PC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPlRoZSBsaW5r
IGJldHdlZW4gZmFtaWx5IGhpc3RvcnkgYW5kIHJpc2sgb2YgdHlwZSAyIGRpYWJldGVzIGlzIG5v
dCBleHBsYWluZWQgYnkgYW50aHJvcG9tZXRyaWMsIGxpZmVzdHlsZSBvciBnZW5ldGljIHJpc2sg
ZmFjdG9yczogdGhlIEVQSUMtSW50ZXJBY3Qgc3R1ZHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+
RGlhYmV0b2xvZ2lhPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5EaWFiZXRvbG9naWE8L2Fs
dC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5EaWFiZXRvbG9naWE8L2Z1
bGwtdGl0bGU+PGFiYnItMT5EaWFiZXRvbG9naWE8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1w
ZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkRpYWJldG9sb2dpYTwvZnVsbC10aXRsZT48YWJici0xPkRp
YWJldG9sb2dpYTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjYwLTk8L3BhZ2VzPjx2
b2x1bWU+NTY8L3ZvbHVtZT48bnVtYmVyPjE8L251bWJlcj48ZWRpdGlvbj4yMDEyLzEwLzEyPC9l
ZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5BZ2VkPC9r
ZXl3b3JkPjxrZXl3b3JkPkFnZWQsIDgwIGFuZCBvdmVyPC9rZXl3b3JkPjxrZXl3b3JkPkJvZHkg
TWFzcyBJbmRleDwva2V5d29yZD48a2V5d29yZD5DYXNlLUNvbnRyb2wgU3R1ZGllczwva2V5d29y
ZD48a2V5d29yZD5Db2hvcnQgU3R1ZGllczwva2V5d29yZD48a2V5d29yZD5Dcm9zcy1TZWN0aW9u
YWwgU3R1ZGllczwva2V5d29yZD48a2V5d29yZD5EaWFiZXRlcyBNZWxsaXR1cywgVHlwZSAyLypl
cGlkZW1pb2xvZ3kvZXRobm9sb2d5L2V0aW9sb2d5L2dlbmV0aWNzPC9rZXl3b3JkPjxrZXl3b3Jk
PkV1cm9wZS9lcGlkZW1pb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+KkZhbWlseSBIZWFsdGgvZXRo
bm9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5Gb2xsb3ct
VXAgU3R1ZGllczwva2V5d29yZD48a2V5d29yZD5HZW5ldGljIFByZWRpc3Bvc2l0aW9uIHRvIERp
c2Vhc2U8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkluY2lkZW5j
ZTwva2V5d29yZD48a2V5d29yZD4qTGlmZSBTdHlsZS9ldGhub2xvZ3k8L2tleXdvcmQ+PGtleXdv
cmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5N
b3RoZXJzPC9rZXl3b3JkPjxrZXl3b3JkPipNb3RvciBBY3Rpdml0eTwva2V5d29yZD48a2V5d29y
ZD5SaXNrIEZhY3RvcnM8L2tleXdvcmQ+PGtleXdvcmQ+V2Fpc3QgQ2lyY3VtZmVyZW5jZTwva2V5
d29yZD48a2V5d29yZD5Zb3VuZyBBZHVsdDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVh
cj4yMDEzPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+SmFuPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0
ZXM+PGlzYm4+MDAxMi0xODZ4PC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIzMDUyMDUyPC9hY2Nlc3Np
b24tbnVtPjx1cmxzPjwvdXJscz48Y3VzdG9tMj5QbWM0MDM4OTE3PC9jdXN0b20yPjxjdXN0b202
PkVtczU4NTk0PC9jdXN0b202PjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDA3L3MwMDEy
NS0wMTItMjcxNS14PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48cmVtb3RlLWRhdGFiYXNlLXBy
b3ZpZGVyPk5sbTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1
YWdlPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==
ADDIN EN.CITE.DATA (Scott et al., 2013).
3.2.1.4-Race; Even though it’s indistinct why, people of certain races- including blacks, Hispanics, American Indians and Asian-Americans are at elevated risk ADDIN EN.CITE <EndNote><Cite><Author>Harris</Author><Year>2001</Year><RecNum>274</RecNum><DisplayText><style face=”bold”>(Harris, 2001)</style></DisplayText><record><rec-number>274</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>274</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Harris, Maureen I</author></authors></contributors><titles><title>Racial and ethnic differences in health care access and health outcomes for adults with type 2 diabetes</title><secondary-title>Diabetes care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>454-459</pages><volume>24</volume><number>3</number><dates><year>2001</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(Harris, 2001).

3.2.1.5-Age; The risk increases when in receipt of older, at age 45, the peril starts to climb, and behind age 65, risk increases exponentially. This may perhaps be since the penchant to implement less, mislay strength throng and gain power but type II diabetes is also superior than ever noticeably between children, teenagers and younger adults ADDIN EN.CITE <EndNote><Cite><Author>Fletcher</Author><Year>2002</Year><RecNum>275</RecNum><DisplayText><style face=”bold”>(Fletcher et al., 2002)</style></DisplayText><record><rec-number>275</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>275</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Fletcher, B.</author><author>Gulanick, M.</author><author>Lamendola, C.</author></authors></contributors><auth-address>University of North Florida, Department of Nursing Jacksonville Beach, USA.</auth-address><titles><title>Risk factors for type 2 diabetes mellitus</title><secondary-title>J Cardiovasc Nurs</secondary-title><alt-title>The Journal of cardiovascular nursing</alt-title></titles><periodical><full-title>J Cardiovasc Nurs</full-title><abbr-1>The Journal of cardiovascular nursing</abbr-1></periodical><alt-periodical><full-title>J Cardiovasc Nurs</full-title><abbr-1>The Journal of cardiovascular nursing</abbr-1></alt-periodical><pages>17-23</pages><volume>16</volume><number>2</number><edition>2002/01/22</edition><keywords><keyword>Age Factors</keyword><keyword>Diabetes Mellitus, Type 2/*etiology/genetics/nursing/*prevention &amp; control</keyword><keyword>Genetic Predisposition to Disease</keyword><keyword>Humans</keyword><keyword>Insulin Resistance</keyword><keyword>Obesity</keyword><keyword>Risk Factors</keyword></keywords><dates><year>2002</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>0889-4655 (Print) 0889-4655</isbn><accession-num>11800065</accession-num><urls></urls><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Fletcher et al., 2002).

3.2.1.6- Gestational diabetes; If gestational diabetes residential through pregnancy, the risk of developing type II diabetes increases later and if the baby weighing more 4 kilograms birth, also has a danger of type II diabetes ADDIN EN.CITE <EndNote><Cite><Author>Fletcher</Author><Year>2002</Year><RecNum>275</RecNum><DisplayText><style face=”bold”>(Fletcher et al., 2002)</style></DisplayText><record><rec-number>275</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>275</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Fletcher, B.</author><author>Gulanick, M.</author><author>Lamendola, C.</author></authors></contributors><auth-address>University of North Florida, Department of Nursing Jacksonville Beach, USA.</auth-address><titles><title>Risk factors for type 2 diabetes mellitus</title><secondary-title>J Cardiovasc Nurs</secondary-title><alt-title>The Journal of cardiovascular nursing</alt-title></titles><periodical><full-title>J Cardiovasc Nurs</full-title><abbr-1>The Journal of cardiovascular nursing</abbr-1></periodical><alt-periodical><full-title>J Cardiovasc Nurs</full-title><abbr-1>The Journal of cardiovascular nursing</abbr-1></alt-periodical><pages>17-23</pages><volume>16</volume><number>2</number><edition>2002/01/22</edition><keywords><keyword>Age Factors</keyword><keyword>Diabetes Mellitus, Type 2/*etiology/genetics/nursing/*prevention &amp; control</keyword><keyword>Genetic Predisposition to Disease</keyword><keyword>Humans</keyword><keyword>Insulin Resistance</keyword><keyword>Obesity</keyword><keyword>Risk Factors</keyword></keywords><dates><year>2002</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>0889-4655 (Print) 0889-4655</isbn><accession-num>11800065</accession-num><urls></urls><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Fletcher et al., 2002).

3.2.1.7- Polycystic ovary syndrome;  For women, having polycystic ovary illness a common provision characterized by asymmetrical menstrual periods, numerous cysts variety in the ovaries, excess hair growth, obesity and one hopeful reason is insulin resistance that increases the possibility of type II diabetes PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5HYW1iaW5lcmk8L0F1dGhvcj48WWVhcj4yMDEyPC9ZZWFy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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5HYW1iaW5lcmk8L0F1dGhvcj48WWVhcj4yMDEyPC9ZZWFy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ADDIN EN.CITE.DATA (Gambineri et al., 2012).

3.2.1.8-High blood pressure; Having blood pressure over 140/90 millimeters of mercury (mm Hg) is associated to an amplified jeopardy of type II diabetes ADDIN EN.CITE <EndNote><Cite><Author>Gress</Author><Year>2000</Year><RecNum>278</RecNum><DisplayText><style face=”bold”>(Gress et al., 2000)</style></DisplayText><record><rec-number>278</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>278</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Gress, Todd W</author><author>Nieto, F Javier</author><author>Shahar, Eyal</author><author>Wofford, Marion R</author><author>Brancati, Frederick L</author></authors></contributors><titles><title>Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus</title><secondary-title>New England Journal of Medicine</secondary-title></titles><periodical><full-title>New England Journal of Medicine</full-title></periodical><pages>905-912</pages><volume>342</volume><number>13</number><dates><year>2000</year></dates><isbn>0028-4793</isbn><urls></urls></record></Cite></EndNote>(Gress et al., 2000).

3.2.1.9-Abnormal cholesterol and triglyceride levels; Have squat levels of high-density lipoprotein (HDL), or “fine,” cholesterol; the danger of type II diabetes is elevated. Triglycerides are a dissimilar type of fat accepted in the blood, group with elevated levels of triglycerides have an augmented danger of type II diabetes ADDIN EN.CITE <EndNote><Cite><Author>Boden</Author><Year>2004</Year><RecNum>279</RecNum><DisplayText><style face=”bold”>(Boden and Laakso, 2004)</style></DisplayText><record><rec-number>279</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>279</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Boden, Guenther</author><author>Laakso, Markku</author></authors></contributors><titles><title>Lipids and glucose in type 2 diabetes: what is the cause and effect?</title><secondary-title>Diabetes care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>2253-2259</pages><volume>27</volume><number>9</number><dates><year>2004</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(Boden and Laakso, 2004).

3.3- Gestational diabetes mellitus (GDM) (diabetes diagnosed in the next or third trimester of pregnancy that was not clearly overt diabetes prior to gestation). It risks to the pregnancy itself comprise innate malformations, increased incarceration weight, an imperative risk of perinatal mortality and augmented hazard to woman of increasing diabetes type II afterward in living ADDIN EN.CITE <EndNote><Cite><Author>Bellamy</Author><Year>2009</Year><RecNum>281</RecNum><DisplayText><style face=”bold”>(Bellamy et al., 2009)</style></DisplayText><record><rec-number>281</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>281</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Bellamy, Leanne</author><author>Casas, Juan-Pablo</author><author>Hingorani, Aroon D</author><author>Williams, David</author></authors></contributors><titles><title>Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis</title><secondary-title>The Lancet</secondary-title></titles><periodical><full-title>The Lancet</full-title></periodical><pages>1773-1779</pages><volume>373</volume><number>9677</number><dates><year>2009</year></dates><isbn>0140-6736</isbn><urls></urls></record></Cite></EndNote>(Bellamy et al., 2009).
3.3.1-Risk factors for gestational diabetes
Any expectant female preserve enlarge gestational diabetes, but various women at better risk than others. danger factors for gestational diabetes comprise ADDIN EN.CITE <EndNote><Cite><Author>Buchanan</Author><Year>2005</Year><RecNum>280</RecNum><DisplayText><style face=”bold”>(Buchanan and Xiang, 2005)</style></DisplayText><record><rec-number>280</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>280</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Buchanan, T. A.</author><author>Xiang, A. H.</author></authors></contributors><auth-address>Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, California 90089-9317, USA. [email protected]</auth-address><titles><title>Gestational diabetes mellitus</title><secondary-title>J Clin Invest</secondary-title><alt-title>The Journal of clinical investigation</alt-title></titles><alt-periodical><full-title>The Journal of clinical investigation</full-title></alt-periodical><pages>485-91</pages><volume>115</volume><number>3</number><edition>2005/03/15</edition><keywords><keyword>Blood Glucose/analysis</keyword><keyword>*Diabetes, Gestational/classification/etiology/physiopathology</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Insulin/blood</keyword><keyword>Insulin Resistance/physiology</keyword><keyword>Islets of Langerhans/metabolism</keyword><keyword>Mass Screening</keyword><keyword>Pregnancy</keyword><keyword>Risk Factors</keyword></keywords><dates><year>2005</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0021-9738 (Print) 0021-9738</isbn><accession-num>15765129</accession-num><urls></urls><custom2>Pmc1052018</custom2><electronic-resource-num>10.1172/jci24531</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Buchanan and Xiang, 2005);
3.3.1.1-Age: Women adult than age 25 are at amplified risk.

3.3.1.2-Family or personal history; the danger increases for type II diabetes if a lock relatives constituent such as a parent or sibling, has type II diabetes.
3.3.1.1-Weight; Being obese before pregnancy increases the peril of GDM
3.3.1.4-Race: For reasons that aren’t obvious, women who are black, Hispanic, American Indian or Asian are extra probable to enlarge gestational diabetes.

3.4- Specific types of diabetes (owing other reasons, e.g., monogenic diabetes syndromes (such as neonatal diabetes and maturity-onset diabetes of the young MODY), diseases of the exocrine pancreas (such as cystic fibrosis), and treatment- or chemical-induced diabetes (such as with glucocorticoid use, in the behavior of HIV/AIDS, or after organ transplantation) ADDIN EN.CITE <EndNote><Cite><Author>Association</Author><Year>2017</Year><RecNum>82</RecNum><DisplayText><style face=”bold”>(American Diabetes Association, 2017)</style></DisplayText><record><rec-number>82</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>82</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>American Diabetes Association, </author></authors></contributors><titles><title>2. Classification and diagnosis of diabetes</title><secondary-title>Diabetes Care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>S11-S24</pages><volume>40</volume><number>Supplement 1</number><dates><year>2017</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(American Diabetes Association, 2017).

4-Criteria for the finding of prediabetes and diabetes
Prediabetes Diabetes
A1C 5.7-6.4% ?6.5%**
FPG 100–125 mg/dl (5.6-6.9 mmol/L) ?126 mg/dl (7.0 mmol/L)**
OGTT* 140-199 mg/dl( 7.8-11.0 mmol/L) ?200 mg/dl (11.1 mmol/L)**
RPG ?200 mg/dl (11.1 mmol/L)***
Table (1) diagnosis of diabetes ADDIN EN.CITE <EndNote><Cite><Author>Association</Author><Year>2017</Year><RecNum>82</RecNum><DisplayText><style face=”bold”>(American Diabetes Association, 2017)</style></DisplayText><record><rec-number>82</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>82</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>American Diabetes Association, </author></authors></contributors><titles><title>2. Classification and diagnosis of diabetes</title><secondary-title>Diabetes Care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>S11-S24</pages><volume>40</volume><number>Supplement 1</number><dates><year>2017</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(American Diabetes Association, 2017)
**verify outcome with duplicate testing.

***Diagnostic in patients with recognized symptoms of hyperglycemia
A1C, glycated hemoglobin; FPG, fasting plasma glucose; OGTT, oral glucose tolerance test, RPG, random plasma glucose
5-Signs and symptoms of diabetes
Diabetes type II Diabetes type I BMI is in the overweight or obese range. Body mass index (BMI)
is mostly within the normal range or low. Common physical attributes
Slow, sometimes taking years and often presenting without early symptoms Rapid, often presenting acutely with ketoacidosis Onset
sever thirst and hunger,
Frequent urination, Nausea,
Rapid weight loss, fatigue,
sever weakness, Vomiting,
Irritability, Blurred vision,
Skin infections, Sores healed slowly, Dry, itchy skin, Feet pins, needles or numbness Sever thirst and hunger
Frequent urination, Nausea,
Rapid weight loss, fatigue,
sever weakness,
vomiting and Irritability
Warning signs
Table (2) some signs and symptoms of possible complications of type I and type II diabetes mellitus diabetes announced by the American Diabetes Association in 2015.

6-Complications of diabetes
On one occasion hyperglycemia happens, patients with all types of diabetes are at hazard for developing the same complications, even though rates of sequence may change. Hyperglycemia owing to insulin insufficiency or insulin thoughtlessness as an outcome of insulin resistance or on the way out insulin building can lead to a reduce in glucose transport into the liver, muscle cells, and fat cells, causing diabetes complications.
People accessible with category II DM are extra subject to dissimilar forms of both little- and long-term complications, which routinely lead to their impulsive decease as of delicate initiation, not on time approval and mainly resource-poor growing countries similar to Africa ADDIN EN.CITE <EndNote><Cite><Author>Azevedo</Author><Year>2008</Year><RecNum>83</RecNum><DisplayText><style face=”bold”>(Azevedo and Alla, 2008)</style></DisplayText><record><rec-number>83</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>83</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Azevedo, Mario</author><author>Alla, Sridevi</author></authors></contributors><titles><title>Diabetes in sub-saharan Africa: kenya, mali, mozambique, Nigeria, South Africa and zambia</title><secondary-title>International journal of diabetes in developing countries</secondary-title></titles><periodical><full-title>International journal of diabetes in developing countries</full-title></periodical><pages>101</pages><volume>28</volume><number>4</number><dates><year>2008</year></dates><urls></urls></record></Cite></EndNote>(Azevedo and Alla, 2008). Complications of Diabetes can be divided into two main parts ADDIN EN.CITE <EndNote><Cite><Author>Marcovecchio</Author><Year>2017</Year><RecNum>283</RecNum><DisplayText><style face=”bold”>(Marcovecchio, 2017)</style></DisplayText><record><rec-number>283</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>283</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Marcovecchio, L</author></authors></contributors><titles><title>Complications of acute and chronic hyperglycaemia</title><secondary-title>US Endocrinology</secondary-title></titles><periodical><full-title>US Endocrinology</full-title></periodical><dates><year>2017</year></dates><urls></urls></record></Cite></EndNote>(Marcovecchio, 2017):
6.1- Short-Term Complications (severe Complications)
6.1.1- Diabetic Ketoacidosis;
DKA rarely occurs impulsively in type II diabetes; when seen, it typically arises in connection with the stress of another disease such as infection or with the use of definite drugs (e.g., corticosteroids, atypical antipsychotics, and sodium–glucose cotransporter 2 inhibitors) PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5VbXBpZXJyZXo8L0F1dGhvcj48WWVhcj4yMDE2PC9ZZWFy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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5VbXBpZXJyZXo8L0F1dGhvcj48WWVhcj4yMDE2PC9ZZWFy
PjxSZWNOdW0+NjE8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9ImJvbGQiPihVbXBp
ZXJyZXogYW5kIEtvcnl0a293c2tpLCAyMDE2O0ZhZGluaSBldCBhbC4sIDIwMTcpPC9zdHlsZT48
L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+NjE8L3JlYy1udW1iZXI+PGZvcmVpZ24t
a2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJmOXBwOWF2ZHA5czVkZmV3NXZjdnJ4ZGcyZGZkZjA1
dDV6dzIiPjYxPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0
aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5VbXBpZXJy
ZXosIEcuPC9hdXRob3I+PGF1dGhvcj5Lb3J5dGtvd3NraSwgTS48L2F1dGhvcj48L2F1dGhvcnM+
PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EaXZpc2lvbiBvZiBFbmRvY3Jpbm9sb2d5IGFu
ZCBNZXRhYm9saXNtLCBFbW9yeSBVbml2ZXJzaXR5IFNjaG9vbCBvZiBNZWRpY2luZSwgNDkgSmVz
c2UgSGlsbCBKciBEcml2ZSwgQXRsYW50YSwgR2VvcmdpYSAzMDMwMywgVVNBLiYjeEQ7RGl2aXNp
b24gb2YgRW5kb2NyaW5vbG9neSBhbmQgTWV0YWJvbGlzbSwgVW5pdmVyc2l0eSBvZiBQaXR0c2J1
cmdoLCAzNjAxIEZpZnRoIEF2ZW51ZSwgU3VpdGUgNTYwLCBQaXR0c2J1cmdoLCBQZW5uc3lsdmFu
aWEgMTUyMTMsIFVTQS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5EaWFiZXRpYyBlbWVy
Z2VuY2llcyAtIGtldG9hY2lkb3NpcywgaHlwZXJnbHljYWVtaWMgaHlwZXJvc21vbGFyIHN0YXRl
IGFuZCBoeXBvZ2x5Y2FlbWlhPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPk5hdCBSZXYgRW5kb2Ny
aW5vbDwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+TmF0dXJlIHJldmlld3MuIEVuZG9jcmlu
b2xvZ3k8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5OYXQgUmV2
IEVuZG9jcmlub2w8L2Z1bGwtdGl0bGU+PGFiYnItMT5OYXR1cmUgcmV2aWV3cy4gRW5kb2NyaW5v
bG9neTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+TmF0
IFJldiBFbmRvY3Jpbm9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+TmF0dXJlIHJldmlld3MuIEVuZG9j
cmlub2xvZ3k8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4yMjItMzI8L3BhZ2VzPjx2
b2x1bWU+MTI8L3ZvbHVtZT48bnVtYmVyPjQ8L251bWJlcj48ZWRpdGlvbj4yMDE2LzAyLzIwPC9l
ZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5EZWh5ZHJhdGlvbi9jb21wbGljYXRpb25zPC9rZXl3
b3JkPjxrZXl3b3JkPkRpYWJldGVzIE1lbGxpdHVzLCBUeXBlIDEvKmNvbXBsaWNhdGlvbnM8L2tl
eXdvcmQ+PGtleXdvcmQ+RGlhYmV0ZXMgTWVsbGl0dXMsIFR5cGUgMi8qY29tcGxpY2F0aW9uczwv
a2V5d29yZD48a2V5d29yZD5EaWFiZXRpYyBLZXRvYWNpZG9zaXMvZGlhZ25vc2lzLypldGlvbG9n
eS90aGVyYXB5PC9rZXl3b3JkPjxrZXl3b3JkPkVtZXJnZW5jaWVzPC9rZXl3b3JkPjxrZXl3b3Jk
PkZsdWlkIFRoZXJhcHkvbWV0aG9kczwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+
PGtleXdvcmQ+SHlwZXJnbHljZW1pYyBIeXBlcm9zbW9sYXIgTm9ua2V0b3RpYyBDb21hL2RpYWdu
b3Npcy8qZXRpb2xvZ3kvdGhlcmFweTwva2V5d29yZD48a2V5d29yZD5IeXBvZ2x5Y2VtaWEvKmNo
ZW1pY2FsbHkgaW5kdWNlZC9kaWFnbm9zaXMvdGhlcmFweTwva2V5d29yZD48a2V5d29yZD5IeXBv
Z2x5Y2VtaWMgQWdlbnRzLyphZHZlcnNlIGVmZmVjdHMvdGhlcmFwZXV0aWMgdXNlPC9rZXl3b3Jk
PjxrZXl3b3JkPkluc3VsaW4vYWR2ZXJzZSBlZmZlY3RzL3RoZXJhcGV1dGljIHVzZTwva2V5d29y
ZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE2PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+QXBy
PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTc1OS01MDI5PC9pc2JuPjxhY2Nlc3Np
b24tbnVtPjI2ODkzMjYyPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1y
ZXNvdXJjZS1udW0+MTAuMTAzOC9ucmVuZG8uMjAxNi4xNTwvZWxlY3Ryb25pYy1yZXNvdXJjZS1u
dW0+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5ObG08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRl
cj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5G
YWRpbmk8L0F1dGhvcj48WWVhcj4yMDE3PC9ZZWFyPjxSZWNOdW0+NjI8L1JlY051bT48cmVjb3Jk
PjxyZWMtbnVtYmVyPjYyPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk
Yi1pZD0iZjlwcDlhdmRwOXM1ZGZldzV2Y3ZyeGRnMmRmZGYwNXQ1encyIj42Mjwva2V5PjwvZm9y
ZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48
Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+RmFkaW5pLCBHLiBQLjwvYXV0aG9yPjxhdXRo
b3I+Qm9ub3JhLCBCLiBNLjwvYXV0aG9yPjxhdXRob3I+QXZvZ2FybywgQS48L2F1dGhvcj48L2F1
dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIE1lZGljaW5l
LCBVbml2ZXJzaXR5IG9mIFBhZG92YSwgVmlhIEdpdXN0aW5pYW5pIDIsIDM1MTI4LCBQYWRvdmEs
IEl0YWx5LiBnaWFucGFvbG8uZmFkaW5pQHVuaXBkLml0LiYjeEQ7RGVwYXJ0bWVudCBvZiBNZWRp
Y2luZSwgVW5pdmVyc2l0eSBvZiBQYWRvdmEsIFZpYSBHaXVzdGluaWFuaSAyLCAzNTEyOCwgUGFk
b3ZhLCBJdGFseS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5TR0xUMiBpbmhpYml0b3Jz
IGFuZCBkaWFiZXRpYyBrZXRvYWNpZG9zaXM6IGRhdGEgZnJvbSB0aGUgRkRBIEFkdmVyc2UgRXZl
bnQgUmVwb3J0aW5nIFN5c3RlbTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5EaWFiZXRvbG9naWE8
L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkRpYWJldG9sb2dpYTwvYWx0LXRpdGxlPjwvdGl0
bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkRpYWJldG9sb2dpYTwvZnVsbC10aXRsZT48YWJi
ci0xPkRpYWJldG9sb2dpYTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1
bGwtdGl0bGU+RGlhYmV0b2xvZ2lhPC9mdWxsLXRpdGxlPjxhYmJyLTE+RGlhYmV0b2xvZ2lhPC9h
YmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MTM4NS0xMzg5PC9wYWdlcz48dm9sdW1lPjYw
PC92b2x1bWU+PG51bWJlcj44PC9udW1iZXI+PGVkaXRpb24+MjAxNy8wNS8xNDwvZWRpdGlvbj48
ZGF0ZXM+PHllYXI+MjAxNzwveWVhcj48cHViLWRhdGVzPjxkYXRlPkF1ZzwvZGF0ZT48L3B1Yi1k
YXRlcz48L2RhdGVzPjxpc2JuPjAwMTItMTg2eDwvaXNibj48YWNjZXNzaW9uLW51bT4yODUwMDM5
NjwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEw
LjEwMDcvczAwMTI1LTAxNy00MzAxLTg8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjxyZW1vdGUt
ZGF0YWJhc2UtcHJvdmlkZXI+TmxtPC9yZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+PGxhbmd1YWdl
PmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT4A
ADDIN EN.CITE.DATA (Umpierrez and Korytkowski, 2016;Fadini et al., 2017). Ketoacidosis is mainly a complication of type I diabetes. Earlier than the sighting of insulin, more than 50 % of diabetic patients die’s of ketoacidosis. Nowadays, even if it is avoidable, after that also virtually 2% diabetic patients die of ketoacidosis. Patient has ketoacidosis requires an imperative treatment. Diabetic ketoacidosis occurs in patients with provide insulin deficiency collective with glucagon overload. This leads to the release of free fatty acids into plasma. These free fatty acids are in use up by the liver where the enzyme acetyl co-enzyme –A, oxidizes the free fatty acid into ketone bodies.  
6.1.2- Hyperosmolar Nonketotic Coma
Hyperosmolar nonketotic coma is chiefly seen in patients anguish from Type II diabetes with extreme hyperglycemia and lack of fluids but no ketoacidosis ADDIN EN.CITE <EndNote><Cite><Author>Rosenbloom</Author><Year>1996</Year><RecNum>285</RecNum><DisplayText><style face=”bold”>(Rosenbloom and Hanas, 1996)</style></DisplayText><record><rec-number>285</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>285</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Rosenbloom, Arlan L</author><author>Hanas, Ragnar</author></authors></contributors><titles><title>Diabetic ketoacidosis (DKA): treatment guidelines</title><secondary-title>Clinical pediatrics</secondary-title></titles><periodical><full-title>Clinical pediatrics</full-title></periodical><pages>261-266</pages><volume>35</volume><number>5</number><dates><year>1996</year></dates><isbn>0009-9228</isbn><urls></urls></record></Cite></EndNote>(Rosenbloom and Hanas, 1996). It is caused by strict lack of fluids due to permanent deletion of sugar in urine known as hyperglycemic dieresis. The loss of glucose in urine is force that the patient is incapable to drink enough water to preserve urinary fluid loss. The usual clinical features of ketoacidosis like acetone smelling breath are lacking. But there are major central nervous system symbols present. Blood sugar is particularly high. The mortality rate in hyperosmolar non-kenotic coma is more than 50% ADDIN EN.CITE <EndNote><Cite><Author>Liamis</Author><Year>2000</Year><RecNum>284</RecNum><DisplayText><style face=”bold”>(Liamis et al., 2000)</style></DisplayText><record><rec-number>284</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>284</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Liamis, G</author><author>Gianoutsos, C</author><author>Elisaf, MS</author></authors></contributors><titles><title>Hyperosmolar nonketotic syndrome with hypernatremia: how can we monitor treatment?</title></titles><dates><year>2000</year></dates><isbn>1262-3636</isbn><urls></urls></record></Cite></EndNote>(Liamis et al., 2000).

6.1.3- Hypoglycemia
Hypoglycemia is usually seen in patients anguish from Type I diabetes. It may happen when excessive quantity of insulin is administered to tolerant, leading to fall in blood glucose level. The symptoms of Hypoglycemia are weakness, intense starvation, sweating, palpitation, headache, nervousness, irritability, cold skin, high beat speed, diplopia and mind misunderstanding. Yet if Hypoglycemia is not treated, person’s death can take place ADDIN EN.CITE <EndNote><Cite><Author>Kalra</Author><Year>2013</Year><RecNum>286</RecNum><DisplayText><style face=”bold”>(Kalra et al., 2013)</style></DisplayText><record><rec-number>286</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>286</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kalra, S.</author><author>Mukherjee, J. J.</author><author>Venkataraman, S.</author><author>Bantwal, G.</author><author>Shaikh, S.</author><author>Saboo, B.</author><author>Das, A. K.</author><author>Ramachandran, A.</author></authors></contributors><auth-address>Bharti Research Institute of Diabetes and Endocrinology, Karnal, Haryana, India.</auth-address><titles><title>Hypoglycemia: The neglected complication</title><secondary-title>Indian J Endocrinol Metab</secondary-title><alt-title>Indian journal of endocrinology and metabolism</alt-title></titles><periodical><full-title>Indian J Endocrinol Metab</full-title><abbr-1>Indian journal of endocrinology and metabolism</abbr-1></periodical><alt-periodical><full-title>Indian J Endocrinol Metab</full-title><abbr-1>Indian journal of endocrinology and metabolism</abbr-1></alt-periodical><pages>819-34</pages><volume>17</volume><number>5</number><edition>2013/10/02</edition><dates><year>2013</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>2230-8210 (Print) 2230-9500</isbn><accession-num>24083163</accession-num><urls></urls><custom2>Pmc3784865</custom2><electronic-resource-num>10.4103/2230-8210.117219</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Kalra et al., 2013).

6.2- Long-Term Complications (persistent complications)
Long-term complications can be avoided by maintaining blood glucose level in a hale and hearty range throughout food planning, physical activity, and medications. These complications increase over a lot of years and they all relate to how blood glucose levels can involve blood vessels. By the time, high blood glucose can break the body’s blood vessels, both small and large. Demolish up the small blood vessels causes microvascular complications; smash up the large vessels causes macrovascular complications PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TYXJ3YXI8L0F1dGhvcj48WWVhcj4yMDEwPC9ZZWFyPjxS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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TYXJ3YXI8L0F1dGhvcj48WWVhcj4yMDEwPC9ZZWFyPjxS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ADDIN EN.CITE.DATA (Sarwar et al., 2010). 
6.2.1-Macrovascular Complications
 (Including: Heart, Brain, and Blood Vessels), type II diabetes can also involve the large blood vessels, causing plaque to ultimately construct up and potentially leading to a heart attack, stroke or vessel blockage in the legs (peripheral vascular disease). Heart sickness and stroke as a result of diabetes can be prevented by running diabetes well; blood stress should be below control, and take attention to cholesterol level.
6.2.2-Microvascular Complications
(Including: damage to Eye, Kidney, and Nerve), tiny blood vessels can be injured by always high blood glucose over time. Smashed blood vessels don’t deliver blood as well as they should, so that leads to other problems, exclusively with the eyes, kidneys, and nerves.

6.2.2.1-Eyes; Blood glucose levels out of range for a long period of instance can source cataracts and or retinopathy in the eyes. Both can cause blindness. To avoid eye problems linked to diabetes; maintenance blood glucose level within range and have annual eye check-up.6.2.2.2-Nerves; Nerve injury caused by diabetes is also known as diabetic neuropathy. at what time blood vessels are injured, the nerves will eventually be smashed. In type II diabetes, some people will already demonstrate signs of nerve injure when they are diagnosed. Maintaining blood glucose level under control can avoid further nerve injury.

6.2.2.3-Kidneys; elevated blood glucose level for extended time can cause kidney illness (diabetic nephropathy) leads to impaired kidney function, dialysis and/or kidney transplant. Uncontrolled (or badly controlled) diabetes can cause kidneys damage then develop into not capable of cleaning the blood appropriately.

Diabetic nephropathy
Definition of diabetic nephropathy
Diabetic nephropathy (DN) represents an imperative reason of persistent kidney disease (CKD) that frequently leads to end-stage renal illness (ESRD). Diabetes mellitus (DM) is a numerous disease and DN is one of its chief complications. It is respected that up to 40% of the patients with type I and type II DM presents DN ADDIN EN.CITE <EndNote><Cite><Author>MacIsaac</Author><Year>2014</Year><RecNum>88</RecNum><DisplayText><style face=”bold”>(MacIsaac et al., 2014)</style></DisplayText><record><rec-number>88</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>88</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>MacIsaac, Richard J</author><author>Ekinci, Elif I</author><author>Jerums, George</author></authors></contributors><titles><title>Markers of and risk factors for the development and progression of diabetic kidney disease</title><secondary-title>American journal of kidney diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>S39-S62</pages><volume>63</volume><number>2</number><dates><year>2014</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite></EndNote>(MacIsaac et al., 2014).
Diabetic nephropathy is a clinical disease characterized by the following ADDIN EN.CITE <EndNote><Cite><Author>Tang</Author><Year>2016</Year><RecNum>28</RecNum><DisplayText><style face=”bold”>(Tang et al., 2016)</style></DisplayText><record><rec-number>28</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>28</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Tang, S. C.</author><author>Chan, G. C.</author><author>Lai, K. N.</author></authors></contributors><auth-address>Division of Nephrology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong. Division of Nephrology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong; Nephrology Department, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.</auth-address><titles><title>Recent advances in managing and understanding diabetic nephropathy</title><secondary-title>F1000Res</secondary-title><alt-title>F1000Research</alt-title></titles><periodical><full-title>F1000Res</full-title><abbr-1>F1000Research</abbr-1></periodical><alt-periodical><full-title>F1000Res</full-title><abbr-1>F1000Research</abbr-1></alt-periodical><volume>5</volume><edition>2016/06/16</edition><dates><year>2016</year></dates><isbn>2046-1402 (Print) 2046-1402</isbn><accession-num>27303648</accession-num><urls></urls><custom2>Pmc4892357</custom2><electronic-resource-num>10.12688/f1000research.7693.1</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Tang et al., 2016):
Persistent albuminuria (>300 mg/day or >200 ?g/min) that is inveterate at least 2 occasions 3-6 months apart
Progressive decrease in the glomerular filtration rate (GFR)
High arterial blood pressure
Proteinuria was primary documented in diabetes mellitus in the tardy 18th century. In the 1930s, Kimmelstiel and Wilson described the typical lesions of nodular glomerulosclerosis in diabetes linked with proteinuria and hypertension. Early treatment can stop or avoid the inception of diabetic nephropathy. This has time after time been revealed in both type I and type II diabetes mellitus, so standard follow-up for diabetic patients is a retort in managing diabetic nephropathy productively.

Recently, it is renowned that microalbuminuria is not always projecting of diabetic nephropathy PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Fa2luY2k8L0F1dGhvcj48WWVhcj4yMDEzPC9ZZWFyPjxS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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Fa2luY2k8L0F1dGhvcj48WWVhcj4yMDEzPC9ZZWFyPjxS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ADDIN EN.CITE.DATA (Ekinci et al., 2013). All the same, a majority of the cases of diabetic nephropathy presents with proteinuria, which gradually gets not as good as as the disease progresses, and is roughly regularly linked with hypertension.

Etiology of diabetic nephropathy
The correct reason of diabetic nephropathy is unknown, but various postulated mechanisms are hyperglycemia (causing hyperfiltration and renal injury), advanced glycation products, and activation of cytokines.
Glycemic control reflects the balance between food intake, gluconeogenesis, tissue uptake or employment through storage as glycogen or fat and oxidation. This equilibrium is keeping up by insulin making from the ? cells in the pancreas. Insulin regulates serum glucose during its actions on the liver, skeletal muscle and fat tissue. While there is insulin confrontation, insulin cannot repress hepatic gluconeogenesis which guides to hyperglycemia, amplified lipolysis and decrease in the disposal of glucose causing hyperlipidemia. At what time there is insulin conflict, the pancreas is obligatory to amplify its insulin production, which stresses the ? cells, eventually resultant in ?-cell tiredness.
The elevated blood glucose levels and high levels of drenched fatty acids create an inflammatory average, causing activation of the instinctive immune system, which consequences induction of the nuclear transcription factor-kappa B (NF-?B), and liberate of inflammatory mediators, counting, interleukin (IL)-1 and tumor necrosis factor alpha (TNF-?), promoting systemic insulin resistance and ?-cell destroy as a result of autoimmune insulitis. Hyperglycemia, high serum levels of free fatty acids and IL-1 lead to glucotoxicity, lipotoxicity, and IL-1 toxicity, consequential in apoptotic ?-cell death.

Hyperglycemia also increases the appearance of transforming growth factor-beta (TGF-?) in the glomeruli and of matrix proteins, particularly encouraged via this cytokine. TGF-? and vascular endothelial growth factor (VEGF) may distribute to the cellular hypertrophy, improved collagen synthesis and may stimulate the vascular changes observed in people with diabetic nephropathy PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DaGlhcmVsbGk8L0F1dGhvcj48WWVhcj4yMDA5PC9ZZWFy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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DaGlhcmVsbGk8L0F1dGhvcj48WWVhcj4yMDA5PC9ZZWFy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ADDIN EN.CITE.DATA (Chiarelli et al., 2009;Rask-Madsen and King, 2010).  Hyperglycemia also can activate protein kinase C (PKC), which may distribute in renal disease and other vascular complications of diabetes ADDIN EN.CITE <EndNote><Cite><Author>Ziyadeh</Author><Year>2004</Year><RecNum>92</RecNum><DisplayText><style face=”bold”>(Ziyadeh, 2004)</style></DisplayText><record><rec-number>92</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>92</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Ziyadeh, Fuad N</author></authors></contributors><titles><title>Mediators of diabetic renal disease: the case for TGF-? as the major mediator</title><secondary-title>Journal of the American Society of Nephrology</secondary-title></titles><periodical><full-title>Journal of the American Society of Nephrology</full-title></periodical><pages>S55-S57</pages><volume>15</volume><number>1 suppl</number><dates><year>2004</year></dates><isbn>1046-6673</isbn><urls></urls></record></Cite></EndNote>(Ziyadeh, 2004). 
Familial or maybe yet genetic factors as well take in a role. Definite ethnic groups, mainly African Americans, persons of Hispanic source, and American Indians, may be mainly inclined to renal disease as a complication of diabetes. It has been argued that the heritable tendency to diabetes is so common in Western societies and even more so in minorities. Some evidence has accrued for a polymorphism in the gene for the angiotensin-converting enzyme (ACE) in also predisposing to nephropathy or accelerating its way; however, perfect inherited markers have up till now to be recognized. Lately, the role of epigenetic alteration in the pathogenesis of diabetic nephropathy has been elucidated ADDIN EN.CITE <EndNote><Cite><Author>Deshpande</Author><Year>2013</Year><RecNum>93</RecNum><DisplayText><style face=”bold”>(Deshpande et al., 2013)</style></DisplayText><record><rec-number>93</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>93</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Deshpande, Supriya D</author><author>Putta, Sumanth</author><author>Wang, Mei</author><author>Lai, Jennifer Y</author><author>Bitzer, Markus</author><author>Nelson, Robert G</author><author>Lanting, Linda L</author><author>Kato, Mitsuo</author><author>Natarajan, Rama</author></authors></contributors><titles><title>Transforming Growth Factor-?–Induced Cross Talk Between p53 and a MicroRNA in the Pathogenesis of Diabetic Nephropathy</title><secondary-title>Diabetes</secondary-title></titles><periodical><full-title>Diabetes</full-title><abbr-1>Diabetes</abbr-1></periodical><pages>3151-3162</pages><volume>62</volume><number>9</number><dates><year>2013</year></dates><isbn>0012-1797</isbn><urls></urls></record></Cite></EndNote>(Deshpande et al., 2013).

Epidemiology of diabetic nephropathy
Through the 1950s, kidney disease was plainly renowned as a frequent complication of diabetes. Diabetic nephropathy affects approximately one third of people with type I or type II diabetes mellitus ADDIN EN.CITE <EndNote><Cite><Author>Reutens</Author><Year>2011</Year><RecNum>290</RecNum><DisplayText><style face=”bold”>(Reutens and Atkins, 2011)</style></DisplayText><record><rec-number>290</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>290</key></foreign-keys><ref-type name=”Book Section”>5</ref-type><contributors><authors><author>Reutens, Anne T</author><author>Atkins, Robert C</author></authors></contributors><titles><title>Epidemiology of diabetic nephropathy</title><secondary-title>Diabetes and the Kidney</secondary-title></titles><pages>1-7</pages><volume>170</volume><dates><year>2011</year></dates><publisher>Karger Publishers</publisher><urls></urls></record></Cite></EndNote>(Reutens and Atkins, 2011).

Egyptian statics
In a cross-sectional study on the Egyptian diabetes, 42% of diabetic patients had nephropathy ADDIN EN.CITE <EndNote><Cite><Author>Herman</Author><Year>1998</Year><RecNum>98</RecNum><DisplayText><style face=”bold”>(Herman et al., 1998)</style></DisplayText><record><rec-number>98</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>98</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Herman, WH</author><author>Aubert, RE</author><author>Engelgau, MM</author><author>Thompson, TJ</author><author>Ali, MA</author><author>Sous, ES</author><author>Hegazy, M</author><author>Badran, A</author><author>Kenny, SJ</author><author>Gunter, EW</author></authors></contributors><titles><title>Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications</title><secondary-title>Diabetic Medicine</secondary-title></titles><periodical><full-title>Diabetic medicine</full-title></periodical><pages>1045-1051</pages><volume>15</volume><number>12</number><dates><year>1998</year></dates><isbn>0742-3071</isbn><urls></urls></record></Cite></EndNote>(Herman et al., 1998).

Several factors can raise the danger of diabetic nephropathy
-Hyperglycemia:  glucose is a consequential and clinically pertinent indicator for the metabolic indiscretion that guides to nephropathy ADDIN EN.CITE <EndNote><Cite><Author>Cooper</Author><Year>1998</Year><RecNum>307</RecNum><DisplayText><style face=”bold”>(Cooper, 1998)</style></DisplayText><record><rec-number>307</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>307</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Cooper, Mark E</author></authors></contributors><titles><title>Pathogenesis, prevention, and treatment of diabetic nephropathy</title><secondary-title>The Lancet</secondary-title></titles><periodical><full-title>The Lancet</full-title></periodical><pages>213-219</pages><volume>352</volume><number>9123</number><dates><year>1998</year></dates><isbn>0140-6736</isbn><urls></urls></record></Cite></EndNote>(Cooper, 1998)
-Sex distribution: Men show quicker development of diabetic nephropathy and more often undertake dialysis treatment PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5kZSBIYXV0ZWNsb2NxdWU8L0F1dGhvcj48WWVhcj4yMDE0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=
ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5kZSBIYXV0ZWNsb2NxdWU8L0F1dGhvcj48WWVhcj4yMDE0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=
ADDIN EN.CITE.DATA (de Hauteclocque et al., 2014). Though, diabetic women have a higher humanity danger than diabetic men through persistent dialysis treatment PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DYXJyZXJvPC9BdXRob3I+PFllYXI+MjAxMTwvWWVhcj48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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DYXJyZXJvPC9BdXRob3I+PFllYXI+MjAxMTwvWWVhcj48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ADDIN EN.CITE.DATA (Carrero et al., 2011;Hecking et al., 2014).

-Hypertension: The danger of diabetic complications was powerfully linked with raised blood pressure ADDIN EN.CITE <EndNote><Cite><Author>Adler</Author><Year>2000</Year><RecNum>298</RecNum><DisplayText><style face=”bold”>(Adler et al., 2000)</style></DisplayText><record><rec-number>298</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>298</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Adler, Amanda I</author><author>Stratton, Irene M</author><author>Neil, H Andrew W</author><author>Yudkin, John S</author><author>Matthews, David R</author><author>Cull, Carole A</author><author>Wright, Alex D</author><author>Turner, Robert C</author><author>Holman, Rury R</author></authors></contributors><titles><title>Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study</title><secondary-title>Bmj</secondary-title></titles><periodical><full-title>Bmj</full-title><abbr-1>BMJ (Clinical research ed.)</abbr-1></periodical><pages>412-419</pages><volume>321</volume><number>7258</number><dates><year>2000</year></dates><isbn>0959-8138</isbn><urls></urls></record></Cite></EndNote>(Adler et al., 2000).

-Obesity: Contributed to enlarged proteinuria at an premature stage of diabetic nephropathy ADDIN EN.CITE <EndNote><Cite><Author>Chen</Author><Year>2013</Year><RecNum>301</RecNum><DisplayText><style face=”bold”>(Chen et al., 2013)</style></DisplayText><record><rec-number>301</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>301</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Chen, H. M.</author><author>Shen, W. W.</author><author>Ge, Y. C.</author><author>Zhang, Y. D.</author><author>Xie, H. L.</author><author>Liu, Z. H.</author></authors></contributors><titles><title>The relationship between obesity and diabetic nephropathy in China</title><secondary-title>BMC Nephrol</secondary-title><alt-title>BMC nephrology</alt-title></titles><periodical><full-title>BMC Nephrol</full-title><abbr-1>BMC nephrology</abbr-1></periodical><alt-periodical><full-title>BMC Nephrol</full-title><abbr-1>BMC nephrology</abbr-1></alt-periodical><pages>69</pages><volume>14</volume><edition>2013/03/26</edition><keywords><keyword>Adult</keyword><keyword>Aged</keyword><keyword>Aged, 80 and over</keyword><keyword>*Body Mass Index</keyword><keyword>China/ethnology</keyword><keyword>Diabetic Nephropathies/*diagnosis/*ethnology/physiopathology</keyword><keyword>Female</keyword><keyword>Follow-Up Studies</keyword><keyword>Glomerular Filtration Rate/physiology</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Obesity/*diagnosis/*ethnology/physiopathology</keyword><keyword>Retrospective Studies</keyword></keywords><dates><year>2013</year><pub-dates><date>Mar 25</date></pub-dates></dates><isbn>1471-2369</isbn><accession-num>23521842</accession-num><urls></urls><custom2>Pmc3614546</custom2><electronic-resource-num>10.1186/1471-2369-14-69</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Chen et al., 2013).

-Smoking: Renal function refuses quicker in smokers than nonsmokers with type II DN ADDIN EN.CITE <EndNote><Cite><Author>Chuahirun</Author><Year>2002</Year><RecNum>294</RecNum><DisplayText><style face=”bold”>(Chuahirun and Wesson, 2002)</style></DisplayText><record><rec-number>294</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>294</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Chuahirun, Temduang</author><author>Wesson, Donald E</author></authors></contributors><titles><title>Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition</title><secondary-title>American Journal of Kidney Diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>376-382</pages><volume>39</volume><number>2</number><dates><year>2002</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite></EndNote>(Chuahirun and Wesson, 2002).

-Race: African American, Mexican American, Native American, Asian and Caucasian are further at risk to increase diabetic nephropathy PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Zb3VuZzwvQXV0aG9yPjxZZWFyPjIwMDM8L1llYXI+PFJl
Y051bT4zMDM8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9ImJvbGQiPihZb3VuZyBl
dCBhbC4sIDIwMDMpPC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+MzAz
PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iZjlwcDlhdmRw
OXM1ZGZldzV2Y3ZyeGRnMmRmZGYwNXQ1encyIj4zMDM8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVm
LXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48
YXV0aG9ycz48YXV0aG9yPllvdW5nLCBCLiBBLjwvYXV0aG9yPjxhdXRob3I+TWF5bmFyZCwgQy48
L2F1dGhvcj48YXV0aG9yPkJveWtvLCBFLiBKLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1
dG9ycz48YXV0aC1hZGRyZXNzPkVwaWRlbWlvbG9naWMgUmVzZWFyY2ggYW5kIEluZm9ybWF0aW9u
IENlbnRlciwgRGVwYXJ0bWVudCBvZiBWZXRlcmFucyBBZmZhaXJzIFB1Z2V0IFNvdW5kIEhlYWx0
aCBDYXJlIFN5c3RlbSwgU2VhdHRsZSwgV2FzaGluZ3RvbiA5ODEwOCwgVVNBLiB5b3VuZ2JAdS53
YXNoaW5ndG9uLmVkdTwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlJhY2lhbCBkaWZmZXJl
bmNlcyBpbiBkaWFiZXRpYyBuZXBocm9wYXRoeSwgY2FyZGlvdmFzY3VsYXIgZGlzZWFzZSwgYW5k
IG1vcnRhbGl0eSBpbiBhIG5hdGlvbmFsIHBvcHVsYXRpb24gb2YgdmV0ZXJhbnM8L3RpdGxlPjxz
ZWNvbmRhcnktdGl0bGU+RGlhYmV0ZXMgQ2FyZTwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+
RGlhYmV0ZXMgY2FyZTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxl
PkRpYWJldGVzIENhcmU8L2Z1bGwtdGl0bGU+PGFiYnItMT5EaWFiZXRlcyBjYXJlPC9hYmJyLTE+
PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5EaWFiZXRlcyBDYXJlPC9m
dWxsLXRpdGxlPjxhYmJyLTE+RGlhYmV0ZXMgY2FyZTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+
PHBhZ2VzPjIzOTItOTwvcGFnZXM+PHZvbHVtZT4yNjwvdm9sdW1lPjxudW1iZXI+ODwvbnVtYmVy
PjxlZGl0aW9uPjIwMDMvMDcvMjk8L2VkaXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9r
ZXl3b3JkPjxrZXl3b3JkPkFmcmljYW4gQW1lcmljYW5zL3N0YXRpc3RpY3MgJmFtcDsgbnVtZXJp
Y2FsIGRhdGE8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5DYXJkaW92
YXNjdWxhciBEaXNlYXNlcy8qZXRobm9sb2d5Lyptb3J0YWxpdHk8L2tleXdvcmQ+PGtleXdvcmQ+
RGlhYmV0aWMgTmVwaHJvcGF0aGllcy8qZXRobm9sb2d5Lyptb3J0YWxpdHk8L2tleXdvcmQ+PGtl
eXdvcmQ+RXRobmljIEdyb3Vwcy9zdGF0aXN0aWNzICZhbXA7IG51bWVyaWNhbCBkYXRhPC9rZXl3
b3JkPjxrZXl3b3JkPkV1cm9wZWFuIENvbnRpbmVudGFsIEFuY2VzdHJ5IEdyb3VwL3N0YXRpc3Rp
Y3MgJmFtcDsgbnVtZXJpY2FsIGRhdGE8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3Jk
PjxrZXl3b3JkPkhpc3BhbmljIEFtZXJpY2Fucy9zdGF0aXN0aWNzICZhbXA7IG51bWVyaWNhbCBk
YXRhPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5JbmRpYW5zLCBO
b3J0aCBBbWVyaWNhbi9zdGF0aXN0aWNzICZhbXA7IG51bWVyaWNhbCBkYXRhPC9rZXl3b3JkPjxr
ZXl3b3JkPkxvbmdpdHVkaW5hbCBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdv
cmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+UHJldmFsZW5jZTwva2V5
d29yZD48a2V5d29yZD5Qcm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlJpc2sg
RmFjdG9yczwva2V5d29yZD48a2V5d29yZD5WZXRlcmFucy8qc3RhdGlzdGljcyAmYW1wOyBudW1l
cmljYWwgZGF0YTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDAzPC95ZWFyPjxw
dWItZGF0ZXM+PGRhdGU+QXVnPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDE0OS01
OTkyIChQcmludCkmI3hEOzAxNDktNTk5MjwvaXNibj48YWNjZXNzaW9uLW51bT4xMjg4Mjg2ODwv
YWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5ObG08
L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29y
ZD48L0NpdGU+PC9FbmROb3RlPgB=
ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Zb3VuZzwvQXV0aG9yPjxZZWFyPjIwMDM8L1llYXI+PFJl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ADDIN EN.CITE.DATA (Young et al., 2003)
-Family predisposition: ancestral history of arterial pressure enlarges the susceptibility to renal disease and cardiovascular disease in patients with diabetes ADDIN EN.CITE <EndNote><Cite><Author>Jayakumar</Author><Year>2012</Year><RecNum>299</RecNum><DisplayText><style face=”bold”>(Jayakumar, 2012)</style></DisplayText><record><rec-number>299</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>299</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Jayakumar, R. V.</author></authors></contributors><titles><title>Risk factors in diabetic nephropathy</title><secondary-title>International Journal of Diabetes in Developing Countries</secondary-title></titles><periodical><full-title>International journal of diabetes in developing countries</full-title></periodical><pages>1-3</pages><volume>32</volume><number>1</number><dates><year>2012</year><pub-dates><date>March 01</date></pub-dates></dates><isbn>1998-3832</isbn><label>Jayakumar2012</label><work-type>journal article</work-type><urls><related-urls><url>https://doi.org/10.1007/s13410-011-0055-x</url></related-urls></urls><electronic-resource-num>10.1007/s13410-011-0055-x</electronic-resource-num></record></Cite></EndNote>(Jayakumar, 2012)
-Age distribution; Long period of diabetes can enlarge the danger of nephropathy PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5WaXN3YW5hdGhhbjwvQXV0aG9yPjxZZWFyPjIwMTI8L1ll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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5WaXN3YW5hdGhhbjwvQXV0aG9yPjxZZWFyPjIwMTI8L1ll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ADDIN EN.CITE.DATA (Viswanathan et al., 2012).

Signs and Symptoms of diabetic nephropathy
Premature symbols and symptoms of kidney disease in patients with diabetes are classically remarkable. Nevertheless, a vast array of symbols and symptoms planned lower may evident when kidney disease has developed ADDIN EN.CITE <EndNote><Cite><Author>Steinman</Author><Year>2009</Year><RecNum>100</RecNum><DisplayText><style face=”bold”>(Steinman and Parker, 2009)</style></DisplayText><record><rec-number>100</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>100</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Steinman, Theodore</author><author>Parker, Thomas</author></authors></contributors><titles><title>NATIONAL KIDNEY FOUNDATION 2009 SPRING CLINICAL MEETINGS MARCH 25-29, 2009 GAYLORD OPRYLAND NASHVILLE, TN, USA</title><secondary-title>American Journal of Kidney Diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><volume>53</volume><number>1</number><dates><year>2009</year></dates><urls></urls></record></Cite></EndNote>(Steinman and Parker, 2009);
Albumin or protein in the urine
Elevated blood pressure
Ankle and leg enlargement, leg cramps
Going to the bathroom more repeatedly at nighttime
Elevated levels of blood urea nitrogen (BUN) and serum creatinine
Failure of appetite
Distress stomach
Morning illness, nausea, and vomiting
Weakness, paleness, and anemia
Easily extend infections
Mystification and problem thoughts
Natural History of diabetic nephropathy
The natural history of diabetic nephropathy varies due to the type of diabetes and when microalbuminuria (distanced as 30 -300 mg albumin in the urine per day) is present. 80% of untreated, people who have type I diabetes and microalbuminuria will developed to overt nephropathy (i.e. progress to proteinuria characterized by >300 mg albumin excreted daily), although only 20–40% of those with type II diabetes above a period of 15 years will develop ADDIN EN.CITE <EndNote><Cite><Author>Kovacs</Author><Year>2009</Year><RecNum>309</RecNum><DisplayText><style face=”bold”>(Kovacs, 2009)</style></DisplayText><record><rec-number>309</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>309</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kovacs, G. L.</author></authors></contributors><titles><title>6. Diabetic Nephropathy</title><secondary-title>Ejifcc</secondary-title><alt-title>Ejifcc</alt-title></titles><periodical><full-title>Ejifcc</full-title><abbr-1>Ejifcc</abbr-1></periodical><alt-periodical><full-title>Ejifcc</full-title><abbr-1>Ejifcc</abbr-1></alt-periodical><pages>41-53</pages><volume>20</volume><number>1</number><edition>2009/04/01</edition><dates><year>2009</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1650-3414 (Print) 1650-3414</isbn><accession-num>27683326</accession-num><urls></urls><custom2>Pmc4975269</custom2><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Kovacs, 2009). Mortality among dialysis patients with diabetes is 22% higher in the first year following the beginning of dialysis and 15% higher at 5 years of dialysis patients without diabetes ADDIN EN.CITE <EndNote><Cite><Author>Remuzzi</Author><Year>2002</Year><RecNum>102</RecNum><DisplayText><style face=”bold”>(Remuzzi et al., 2002)</style></DisplayText><record><rec-number>102</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>102</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Remuzzi, Giuseppe</author><author>Schieppati, Arrigo</author><author>Ruggenenti, Piero</author></authors></contributors><titles><title>Nephropathy in patients with type 2 diabetes</title><secondary-title>New England Journal of Medicine</secondary-title></titles><periodical><full-title>New England Journal of Medicine</full-title></periodical><pages>1145-1151</pages><volume>346</volume><number>15</number><dates><year>2002</year></dates><isbn>0028-4793</isbn><urls></urls></record></Cite></EndNote>(Remuzzi et al., 2002).
Firstly, diabetic nephropathy has several distinct phases of development; functional changes take place in the nephron at the level of the glomerulus, including glomerular hyperfiltration and hyperperfusion, previous to the beginning of any assessable clinical changes. Afterward, thickening of the glomerular cellular membrane, glomerular hypertrophy, and mesangial expansion occurred and GFR remains prominent ADDIN EN.CITE <EndNote><Cite><Author>Marshall</Author><Year>2004</Year><RecNum>103</RecNum><DisplayText><style face=”bold”>(Marshall, 2004)</style></DisplayText><record><rec-number>103</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>103</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Marshall, Sally M</author></authors></contributors><titles><title>Recent advances in diabetic nephropathy</title><secondary-title>Postgraduate Medical Journal</secondary-title></titles><periodical><full-title>Postgraduate Medical Journal</full-title></periodical><pages>624-633</pages><volume>80</volume><number>949</number><dates><year>2004</year></dates><isbn>0032-5473</isbn><urls></urls></record></Cite></EndNote>(Marshall, 2004).

Then, approximately 15 years after the diagnosis of diabetes, overt albuminuria or macroalbuminuria is determined (>300 mg/gm creatinine) and the higher rates of GFR returned to regular which is a obvious signal that detects the beginning of progressive renal deficiency. Within 5 years of the beginning of albuminuria about half of the individuals will have accomplished a 50% declining in the GFR and increasing of their serum creatinine ADDIN EN.CITE <EndNote><Cite><Author>Kovacs</Author><Year>2009</Year><RecNum>310</RecNum><DisplayText><style face=”bold”>(Kovacs, 2009)</style></DisplayText><record><rec-number>310</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>310</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kovacs, G. L.</author></authors></contributors><titles><title>6. Diabetic Nephropathy</title><secondary-title>Ejifcc</secondary-title><alt-title>Ejifcc</alt-title></titles><periodical><full-title>Ejifcc</full-title><abbr-1>Ejifcc</abbr-1></periodical><alt-periodical><full-title>Ejifcc</full-title><abbr-1>Ejifcc</abbr-1></alt-periodical><pages>41-53</pages><volume>20</volume><number>1</number><edition>2009/04/01</edition><dates><year>2009</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1650-3414 (Print) 1650-3414</isbn><accession-num>27683326</accession-num><urls></urls><custom2>Pmc4975269</custom2><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Kovacs, 2009). By 3 to 4 years, 50 % of the patients who practiced the decrease of GFR will improve to ESRD. Hypertension is urbanized at or immediately previous to the time of beginning of overt albuminuria, which accelerates the evolution of renal disease ADDIN EN.CITE <EndNote><Cite><Author>Marshall</Author><Year>2004</Year><RecNum>103</RecNum><DisplayText><style face=”bold”>(Marshall, 2004)</style></DisplayText><record><rec-number>103</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>103</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Marshall, Sally M</author></authors></contributors><titles><title>Recent advances in diabetic nephropathy</title><secondary-title>Postgraduate Medical Journal</secondary-title></titles><periodical><full-title>Postgraduate Medical Journal</full-title></periodical><pages>624-633</pages><volume>80</volume><number>949</number><dates><year>2004</year></dates><isbn>0032-5473</isbn><urls></urls></record></Cite></EndNote>(Marshall, 2004).

Normality of albuminuria and its Category
Category Urinary albumin per minute
(?g/ min ) Urinary albumin excretion per day
(mg / day) Urinary Albumin creatinine ratio
(mg / gm )
Normal <20 <30 <30
Micro-albuminuria 20-200 30-300 30-300
Macro-albuminuria >200 >300 >300
Table (3) showing the reference ranges of urinary albumin excretion ADDIN EN.CITE <EndNote><Cite><Author>Wilson</Author><Year>1990</Year><RecNum>105</RecNum><DisplayText><style face=”bold”>(Wilson and Luetscher, 1990)</style></DisplayText><record><rec-number>105</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>105</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wilson, D. M.</author><author>Luetscher, J. A.</author></authors></contributors><auth-address>Department of Pediatrics, Stanford University School of Medicine, Calif.</auth-address><titles><title>Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus</title><secondary-title>N Engl J Med</secondary-title><alt-title>The New England journal of medicine</alt-title></titles><periodical><full-title>N Engl J Med</full-title><abbr-1>The New England journal of medicine</abbr-1></periodical><alt-periodical><full-title>N Engl J Med</full-title><abbr-1>The New England journal of medicine</abbr-1></alt-periodical><pages>1101-6</pages><volume>323</volume><number>16</number><edition>1990/10/18</edition><keywords><keyword>Adolescent</keyword><keyword>Adult</keyword><keyword>Albuminuria/blood</keyword><keyword>Child</keyword><keyword>Diabetes Mellitus, Type 1/blood/*complications</keyword><keyword>Diabetic Nephropathies/blood/diagnosis</keyword><keyword>Diabetic Retinopathy/blood/diagnosis</keyword><keyword>Enzyme Precursors/*blood</keyword><keyword>Follow-Up Studies</keyword><keyword>Humans</keyword><keyword>Prospective Studies</keyword><keyword>Reference Values</keyword><keyword>Regression Analysis</keyword><keyword>Renin/*blood</keyword><keyword>Risk Factors</keyword></keywords><dates><year>1990</year><pub-dates><date>Oct 18</date></pub-dates></dates><isbn>0028-4793 (Print) 0028-4793</isbn><accession-num>2215578</accession-num><urls></urls><electronic-resource-num>10.1056/nejm199010183231604</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Wilson and Luetscher, 1990)
According to table (3);
-Healthy persons having albuminuria <30 mg / gm creatinine
-Macroalbuminuric persons having albuminuria from 30-300 mg / gm creatinine
-Macroalbuminuric persons having albuminuria >300 mg / gm creatinine
It is inveterate that persons with diabetes and microalbuminuria who had have histological alterations were proposed to extend into explicit nephropathy ADDIN EN.CITE <EndNote><Cite><Author>Mauer</Author><Year>1984</Year><RecNum>107</RecNum><DisplayText><style face=”bold”>(Mauer et al., 1984;Steinke et al., 2005)</style></DisplayText><record><rec-number>107</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>107</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Mauer, S Michael</author><author>Steffes, Michael W</author><author>Ellis, Eileen N</author><author>Sutherland, DE</author><author>Brown, David M</author><author>Goetz, Fredrick C</author></authors></contributors><titles><title>Structural-functional relationships in diabetic nephropathy</title><secondary-title>The Journal of clinical investigation</secondary-title></titles><periodical><full-title>The Journal of clinical investigation</full-title></periodical><pages>1143-1155</pages><volume>74</volume><number>4</number><dates><year>1984</year></dates><isbn>0021-9738</isbn><urls></urls></record></Cite><Cite><Author>Steinke</Author><Year>2005</Year><RecNum>109</RecNum><record><rec-number>109</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>109</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Steinke, Julia M</author><author>Sinaiko, Alan R</author><author>Kramer, Michael S</author><author>Suissa, Samy</author><author>Chavers, Blanche M</author><author>Mauer, Michael</author></authors></contributors><titles><title>The early natural history of nephropathy in type 1 diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients</title><secondary-title>Diabetes</secondary-title></titles><periodical><full-title>Diabetes</full-title><abbr-1>Diabetes</abbr-1></periodical><pages>2164-2171</pages><volume>54</volume><number>7</number><dates><year>2005</year></dates><isbn>0012-1797</isbn><urls></urls></record></Cite></EndNote>(Mauer et al., 1984;Steinke et al., 2005). Microalbuminuria, nevertheless, has a variable way; its development to macroalbuminuria (>300 mg per day) is impulsive and does not forever guide to the progress of nephropathy ADDIN EN.CITE <EndNote><Cite><Author>Steinke</Author><Year>2005</Year><RecNum>109</RecNum><DisplayText><style face=”bold”>(Steinke et al., 2005)</style></DisplayText><record><rec-number>109</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>109</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Steinke, Julia M</author><author>Sinaiko, Alan R</author><author>Kramer, Michael S</author><author>Suissa, Samy</author><author>Chavers, Blanche M</author><author>Mauer, Michael</author></authors></contributors><titles><title>The early natural history of nephropathy in type 1 diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients</title><secondary-title>Diabetes</secondary-title></titles><periodical><full-title>Diabetes</full-title><abbr-1>Diabetes</abbr-1></periodical><pages>2164-2171</pages><volume>54</volume><number>7</number><dates><year>2005</year></dates><isbn>0012-1797</isbn><urls></urls></record></Cite></EndNote>(Steinke et al., 2005).
What is more, the rate of kidney function refuse after the expansion of nephropathy is extremely patchy between patients and is prejudiced by added factors, counting blood pressure and glycemic control. In addition to the renal hemodynamic alterations, patients with overt diabetic nephropathy (importunate proteinuria and declining glomerular filtration rate) commonly enlarge systemic hypertension.

Pathophysiology of diabetic nephropathy
The pathophysiological mechanisms in the expansion of DN are multifactorial. Hyperglycemia is the initiating incident which causes structural and practical changes such as glomerular hyperfiltration, glomerular and tubular epithelial hypertrophy, and microalbuminuria, followed by the enlargement of glomerular basement membrane thickening, amassing of mesangial matrix and blatant proteinuria, and last but not least glomerulosclerosis and ESRD ADDIN EN.CITE <EndNote><Cite><Author>Vinod</Author><Year>2012</Year><RecNum>146</RecNum><DisplayText><style face=”bold”>(Vinod, 2012)</style></DisplayText><record><rec-number>146</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>146</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Vinod, PB</author></authors></contributors><titles><title>Pathophysiology of diabetic nephropathy</title><secondary-title>Clinical Queries: Nephrology</secondary-title></titles><periodical><full-title>Clinical Queries: Nephrology</full-title></periodical><pages>121-126</pages><volume>1</volume><number>2</number><dates><year>2012</year></dates><isbn>2211-9477</isbn><urls></urls></record></Cite></EndNote>(Vinod, 2012).

Microscopic changes
Glomerular basement membrane (GBM) thickening is the initial electron microscopic abrasion pragmatic in patients with diabetic nephropathy PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5UZXJ2YWVydDwvQXV0aG9yPjxZZWFyPjIwMTA8L1llYXI+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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5UZXJ2YWVydDwvQXV0aG9yPjxZZWFyPjIwMTA8L1llYXI+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ADDIN EN.CITE.DATA (Tervaert et al., 2010;Caramori et al., 2013;Ponchiardi et al., 2013). Mesangial development, caused by cell improvement and their improved environment discharge, is the most generally pragmatic histopathological scratch by light microscopy. In a while, nodular glomerulosclerosis with classic Kimmelstein-Wilson nodules can be pragmatic. While not wholly pathogonomic, nodular sclerosis is an particularly specific yet less sensitive lesion of DN. Glomerular lesions occur together with explicit vascular lesions as well as arterial hyalinosis. Tubulointerstitial changes (fibrosis) are not definite for DN, and they contain accretion of activated myofibroblasts, uncharacteristic collagen, provocative cells, and loss of vessel
architecture ADDIN EN.CITE <EndNote><Cite><Author>Nath</Author><Year>1992</Year><RecNum>115</RecNum><DisplayText><style face=”bold”>(Nath, 1992)</style></DisplayText><record><rec-number>115</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>115</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Nath, Karl A</author></authors></contributors><titles><title>Tubulointerstitial changes as a major determinant in the progression of renal damage</title><secondary-title>American Journal of Kidney Diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>1-17</pages><volume>20</volume><number>1</number><dates><year>1992</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite></EndNote>(Nath, 1992).-850900330835
Figure (1); Cross?sections of characteristic glomeruli from normal human kidney and from patients with budding, apparent and superior stages of diabetic nephropathy discolored with intermittent acid Schiff reagent (PAS) ADDIN EN.CITE <EndNote><Cite><Author>Wahab</Author><Year>2005</Year><RecNum>317</RecNum><DisplayText><style face=”bold”>(Wahab et al., 2005)</style></DisplayText><record><rec-number>317</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>317</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wahab, NA</author><author>Schaefer, L</author><author>Weston, BS</author><author>Yiannikouris, O</author><author>Wright, A</author><author>Babelova, A</author><author>Schaefer, R</author><author>Mason, RM</author></authors></contributors><titles><title>Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli</title><secondary-title>Diabetologia</secondary-title></titles><periodical><full-title>Diabetologia</full-title><abbr-1>Diabetologia</abbr-1></periodical><pages>2650-2660</pages><volume>48</volume><number>12</number><dates><year>2005</year></dates><isbn>0012-186X</isbn><urls></urls></record></Cite></EndNote>(Wahab et al., 2005). Blood is drinkable crosswise the glomerular capillary basement membranes (?) into the urinary space (*) from where the remains drains into the tubular system. The vessel clump is supported by the mesangium collected of mesangial cells and extracellular matrix (?). With just beginning disease, there is a spread development of mesangial matrix (?), strong pink staining), but or else normal cellularity and vasculature. At presently stages (manifest and advanced), further mesangial expansion leads to escalating diffuse and nodular sclerosis with infringement on and occlusion of capillary lumina and progressive defeat of cells.

8.2- Stages of diabetic nephropathy
Stage Pathological characters Clinical characters
Stage I Occurred at the 0nset 0f diabetes (Early hypertr0phy and hyperfuncti0n), kidneys size increased, it is P0tentially reversible GFR; N0rmal or Increased
Urinary albumin secretion; Normal(< 30 mg/day)
Blood pressure; N0rmal
Stage II (Gl0merular lesi0n) with0ut clinical disease, with thickening 0f basement membrane & mesangial pr0liferati0n, may be reversible, many patients c0ntinue in this stage f0r life GFR; N0rmal
Urinary albumin secreti0n; Normal(< 30 mg/day)
Blood pressure; N0rmal
Stage III (Incipient diabetic nephr0pathy 0r microalbuminuria stage) represents the first clinically detectable sign Appr0ximately 40% 0f patients reach this stage, lesi0n pr0gressi0n may be st0pped, s0metimes reversible. GFR; Decreased
Urinary albumin secreti0n;
(30-300 mg/day)
Blood pressure; N0rmal or increased
Stage IV (0vert diabetic nephr0pathy or macroalbuminuria stage), it is the stage 0f chr0nic kidney disease (CKD) with irreversible pr0teinuria. GFR; < 60 ml/min/1.73 m2
Urinary albumin secretion;
(>300 mg/day)
Bl00d pressure; Sustained hypertensi0n
Stage V End-stage renal disease (ESRD), about 50% of patients needing dialysis 0r transplant t0 reserve life. GFR <15 ml/min/1.73 m2
Table (4); showing stages of diabetic nephropathy ADDIN EN.CITE <EndNote><Cite><Author>Mogensen</Author><Year>2000</Year><RecNum>110</RecNum><DisplayText><style face=”bold”>(Mogensen, 2000;Parchwani and Upadhyah, 2012)</style></DisplayText><record><rec-number>110</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>110</key></foreign-keys><ref-type name=”Book Section”>5</ref-type><contributors><authors><author>Mogensen, Carl Erik</author></authors></contributors><titles><title>Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas</title><secondary-title>The Kidney and Hypertension in Diabetes Mellitus</secondary-title></titles><pages>655-706</pages><dates><year>2000</year></dates><publisher>Springer</publisher><urls></urls></record></Cite><Cite><Author>Parchwani</Author><Year>2012</Year><RecNum>111</RecNum><record><rec-number>111</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>111</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Parchwani, Deepak N</author><author>Upadhyah, Amit A</author></authors></contributors><titles><title>Diabetic nephropathy: progression and pathophysiology</title></titles><dates><year>2012</year></dates><urls></urls></record></Cite></EndNote>(Mogensen, 2000;Parchwani and Upadhyah, 2012).
.
8.3- pathways and factors illustrate diabetic nephropathy hypothesis;

Hemodynamic pathways
Metabolic pathway

High pressure
• RAAS
• VEGF
• TGF-?
• Endothelin
Hyperglycemia
• AGE
• PKC pathway
• Polyol pathway
• Oxidative stress

Intracellular signaling molecules and ROS

TGF-?, VEGF, IL-1, IL-6, IL-18, TNF-?

• ECM accumulation
• GBM thickening
• Glomerulosclerosis

Diabetic nephropathy

Figure (2); Pathways involved in the development of diabetic kidney disease ADDIN EN.CITE <EndNote><Cite><Author>Vinod</Author><Year>2012</Year><RecNum>123</RecNum><DisplayText><style face=”bold”>(Vinod, 2012)</style></DisplayText><record><rec-number>123</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>123</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Vinod, PB</author></authors></contributors><titles><title>Pathophysiology of diabetic nephropathy</title><secondary-title>Clinical Queries: Nephrology</secondary-title></titles><periodical><full-title>Clinical Queries: Nephrology</full-title></periodical><pages>121-126</pages><volume>1</volume><number>2</number><dates><year>2012</year></dates><isbn>2211-9477</isbn><urls></urls></record></Cite></EndNote>(Vinod, 2012).

AGE (advanced glycation end products), IL-1 (interleukin-1), IL-6(interleukin-6), IL-18(interleukin-18), PKC (protein kinase C), RAAS (renin- angiotensin aldosterone system), ROS (reactive oxygen species), TGF-? (transforming growth factor-beta), TNF-? (tumor necrotic factor-alpha), VEGF (vascular endothelial growth factor), Extracellular matrix (ECM), Glomerular basement membrane (GBM)
8.3.1-Hemodynamic pathways
Glomerular hemodynamic alters happen very premature in DN, including hyperfiltration and hyperperfusion. There is a reduce in both afferent and efferent arteriolar argument which is more on the afferent face leading to improved glomerular capillary pressure that enhances trans-capillary hydraulic pressure gradient as well as an amplify in glomerular plasma flow injuries. Hyperperfusion and hyperfiltration are also occurred due to factors such as prostanoids, nitric oxide, atrial natriuretic factor, growth hormone, glucagon, insulin and angiotensin-II (ANG-II) ADDIN EN.CITE <EndNote><Cite><Author>Hostetter</Author><Year>2003</Year><RecNum>116</RecNum><DisplayText><style face=”bold”>(Hostetter, 2003)</style></DisplayText><record><rec-number>116</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>116</key></foreign-keys><ref-type name=”Conference Proceedings”>10</ref-type><contributors><authors><author>Hostetter, Thomas H</author></authors></contributors><titles><title>Hyperfiltration and glomerulosclerosis</title><secondary-title>Seminars in nephrology</secondary-title></titles><pages>194-199</pages><volume>23</volume><number>2</number><dates><year>2003</year></dates><publisher>Elsevier</publisher><isbn>0270-9295</isbn><urls></urls></record></Cite></EndNote>(Hostetter, 2003). The changes leading to glomerulosclerosis are raised intraglomerular pressure, amplified in mesangial cell matrix construction and thickening of glomerular basement membrane ADDIN EN.CITE <EndNote><Cite><Author>Wolf</Author><Year>1999</Year><RecNum>121</RecNum><DisplayText><style face=”bold”>(Wolf and Ziyadeh, 1999;Wolf, 2003)</style></DisplayText><record><rec-number>121</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>121</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wolf, Gunter</author><author>Ziyadeh, Fuad N</author></authors></contributors><titles><title>Molecular mechanisms of diabetic renal hypertrophy</title><secondary-title>Kidney international</secondary-title></titles><periodical><full-title>Kidney Int</full-title><abbr-1>Kidney international</abbr-1></periodical><pages>393-405</pages><volume>56</volume><number>2</number><dates><year>1999</year></dates><isbn>0085-2538</isbn><urls></urls></record></Cite><Cite><Author>Wolf</Author><Year>2003</Year><RecNum>117</RecNum><record><rec-number>117</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>117</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wolf, Gunter</author></authors></contributors><titles><title>Growth factors and the development of diabetic nephropathy</title><secondary-title>Current diabetes reports</secondary-title></titles><periodical><full-title>Current diabetes reports</full-title></periodical><pages>485-490</pages><volume>3</volume><number>6</number><dates><year>2003</year></dates><isbn>1534-4827</isbn><urls></urls></record></Cite></EndNote>(Wolf and Ziyadeh, 1999; Wolf, 2003). Hyperglycemia stimulates the synthesis of ANG-II, which exert hemodynamic, trophic, inflammatory and profibrinogenic effects on renal cells ADDIN EN.CITE <EndNote><Cite><Author>Wolf</Author><Year>2003</Year><RecNum>117</RecNum><DisplayText><style face=”bold”>(Chen et al., 2001;Wolf, 2003)</style></DisplayText><record><rec-number>117</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>117</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wolf, Gunter</author></authors></contributors><titles><title>Growth factors and the development of diabetic nephropathy</title><secondary-title>Current diabetes reports</secondary-title></titles><periodical><full-title>Current diabetes reports</full-title></periodical><pages>485-490</pages><volume>3</volume><number>6</number><dates><year>2003</year></dates><isbn>1534-4827</isbn><urls></urls></record></Cite><Cite><Author>Chen</Author><Year>2001</Year><RecNum>119</RecNum><record><rec-number>119</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>119</key></foreign-keys><ref-type name=”Book Section”>5</ref-type><contributors><authors><author>Chen, Sheldon</author><author>Wolf, Gunter</author><author>Ziyadeh, Fuad N</author></authors></contributors><titles><title>The renin-angiotensin system in diabetic nephropathy</title><secondary-title>The Renin-angiotensin System and Progression of Renal Diseases</secondary-title></titles><pages>212-221</pages><volume>135</volume><dates><year>2001</year></dates><publisher>Karger Publishers</publisher><urls></urls></record></Cite></EndNote>(Chen et al., 2001; Wolf, 2003).

The factors that mediate hyperfiltration injury contain vascular endothelial growth factors (VEGF) and cytokines such as transforming growth factor-beta (TGF-?) ADDIN EN.CITE <EndNote><Cite><Author>Wolf</Author><Year>1999</Year><RecNum>120</RecNum><DisplayText><style face=”bold”>(Wolf and Ziyadeh, 1999)</style></DisplayText><record><rec-number>120</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>120</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wolf, Gunter</author><author>Ziyadeh, Fuad N</author></authors></contributors><titles><title>Molecular mechanisms of diabetic renal hypertrophy</title><secondary-title>Kidney international</secondary-title></titles><periodical><full-title>Kidney Int</full-title><abbr-1>Kidney international</abbr-1></periodical><pages>393-405</pages><volume>56</volume><number>2</number><dates><year>1999</year></dates><isbn>0085-2538</isbn><urls></urls></record></Cite></EndNote>(Wolf and Ziyadeh, 1999). Hemodynamic stress causes structural changes in kidney cells caused by local activation of cytokines and growth factors. Also, an increase in reabsorption of sodium chloride in kidney cells leads to enlarge the glomerular filtration rate causing tubules hypertrophy ADDIN EN.CITE <EndNote><Cite><Author>Thomson</Author><Year>2004</Year><RecNum>122</RecNum><DisplayText><style face=”bold”>(Thomson et al., 2004)</style></DisplayText><record><rec-number>122</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>122</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Thomson, Scott C</author><author>Vallon, Volker</author><author>Blantz, Roland C</author></authors></contributors><titles><title>Kidney function in early diabetes: the tubular hypothesis of glomerular filtration</title><secondary-title>American Journal of Physiology-Renal Physiology</secondary-title></titles><periodical><full-title>American Journal of Physiology-Renal Physiology</full-title></periodical><pages>F8-F15</pages><volume>286</volume><number>1</number><dates><year>2004</year></dates><isbn>1931-857X</isbn><urls></urls></record></Cite></EndNote>(Thomson et al., 2004).

8.3.2-Metabolic pathways
The glucose transport activity is an important modulator of extracellular creation of mesangial cells. Glucose transporter-1 (GLUT-1) is a key regulator of glucose entrance into kidney cells; glucose activates various metabolic pathways leading to mesangial expansion, mesangial cell matrix manufacture, mesangial cell apoptosis and structural changes ADDIN EN.CITE <EndNote><Cite><Author>Mishra</Author><Year>2005</Year><RecNum>124</RecNum><DisplayText><style face=”bold”>(Mishra et al., 2005)</style></DisplayText><record><rec-number>124</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>124</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Mishra, Rangnath</author><author>Emancipator, Steven N</author><author>Kern, Timothy</author><author>Simonson, Michael S</author></authors></contributors><titles><title>High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells</title><secondary-title>Kidney international</secondary-title></titles><periodical><full-title>Kidney Int</full-title><abbr-1>Kidney international</abbr-1></periodical><pages>82-93</pages><volume>67</volume><number>1</number><dates><year>2005</year></dates><isbn>0085-2538</isbn><urls></urls></record></Cite></EndNote>(Mishra et al., 2005). If there is overexpression of GLUT-1, comparable changes will be induced in the renal cells even if the glucose levels are normal ADDIN EN.CITE <EndNote><Cite><Author>Heilig</Author><Year>1995</Year><RecNum>125</RecNum><DisplayText><style face=”bold”>(Heilig et al., 1995)</style></DisplayText><record><rec-number>125</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>125</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Heilig, Charles W</author><author>Concepcion, Luis A</author><author>Riser, Bruce L</author><author>Freytag, Svend O</author><author>Zhu, Min</author><author>Cortes, Pedro</author></authors></contributors><titles><title>Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype</title><secondary-title>The Journal of clinical investigation</secondary-title></titles><periodical><full-title>The Journal of clinical investigation</full-title></periodical><pages>1802-1814</pages><volume>96</volume><number>4</number><dates><year>1995</year></dates><isbn>0021-9738</isbn><urls></urls></record></Cite></EndNote>(Heilig et al., 1995). Mesangial cells express insulin-sensitive extracellular glucose transporters-4 (GLUT-4) as well as a brain type of glucose transporters (GLUT-1) through which extreme glucose could easily go in the cells in an insulin-independent manner ADDIN EN.CITE <EndNote><Cite><Author>Haneda</Author><Year>2003</Year><RecNum>126</RecNum><DisplayText><style face=”bold”>(Heilig et al., 2001;Haneda et al., 2003)</style></DisplayText><record><rec-number>126</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>126</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Haneda, Masakazu</author><author>Koya, Daisuke</author><author>Isono, Motohide</author><author>Kikkawa, Ryuichi</author></authors></contributors><titles><title>Overview of glucose signaling in mesangial cells in diabetic nephropathy</title><secondary-title>Journal of the American Society of Nephrology</secondary-title></titles><periodical><full-title>Journal of the American Society of Nephrology</full-title></periodical><pages>1374-1382</pages><volume>14</volume><number>5</number><dates><year>2003</year></dates><isbn>1046-6673</isbn><urls></urls></record></Cite><Cite><Author>Heilig</Author><Year>2001</Year><RecNum>127</RecNum><record><rec-number>127</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>127</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Heilig, Charles W</author><author>Kreisberg, Jeffrey I</author><author>Freytag, Svend</author><author>Murakami, Takashi</author><author>Ebina, Yousuke</author><author>Guo, Lirong</author><author>Heilig, Kathleen</author><author>Loberg, Robert</author><author>Qu, Xuan</author><author>Jin, Ying</author></authors></contributors><titles><title>Antisense GLUT-1 protects mesangial cells from glucose induction of GLUT-1 and fibronectin expression</title><secondary-title>American Journal of Physiology-Renal Physiology</secondary-title></titles><periodical><full-title>American Journal of Physiology-Renal Physiology</full-title></periodical><pages>F657-F666</pages><volume>280</volume><number>4</number><dates><year>2001</year></dates><isbn>1522-1466</isbn><urls></urls></record></Cite></EndNote>(Heilig et al., 2001; Haneda et al., 2003). Non-enzymatic glycosylation that create superior glycosylation end yield (AGE), activation of protein kinase C (PKC), and hastening of the polyol pathway along with hemodynamic changes outcome in the inauguration of VEGF, TGF-?, interleukin-1 (IL-1), interleukin-6 (IL-6) and interleukin-18 (IL-18) and tumor necrosis factor alpha (TNF-?). All these pathways act in unison leading to augmented albumin permeability in GBM and extracellular matrix (ECM) accrual, ensuing in growing proteinuria, glomerulosclerosis and to end with tubulointerstitial fibrosis.

8.3.3- Oxidative stress
Comm0nly, metab0lic activity within the nephr0n produces many reactive oxygen species (R0S) that are counterbalanced by a large number of antioxidant enzymes and free radical scavenging systems. R0S mediate many negative biological effects, counting per0xidation of cell membrane lipids, oxidati0n of pr0teins, renal vas0constriction and injure to de0xyribonucleic acid (DNA). Unluckily, hyperglycemia tips the poise towards the production of ROS, most can be generated in the mitochondria ADDIN EN.CITE <EndNote><Cite><Author>Nishikawa</Author><Year>2007</Year><RecNum>128</RecNum><DisplayText><style face=”bold”>(Nishikawa et al., 2007)</style></DisplayText><record><rec-number>128</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>128</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Nishikawa, Takeshi</author><author>Kukidome, Daisuke</author><author>Sonoda, Kazuhiro</author><author>Fujisawa, Kazuo</author><author>Matsuhisa, Takako</author><author>Motoshima, Hiroyuki</author><author>Matsumura, Takeshi</author><author>Araki, Eiichi</author></authors></contributors><titles><title>Impact of mitochondrial ROS production on diabetic vascular complications</title><secondary-title>Diabetes research and clinical practice</secondary-title></titles><periodical><full-title>Diabetes Res Clin Pract</full-title><abbr-1>Diabetes research and clinical practice</abbr-1></periodical><pages>S41-S45</pages><volume>77</volume><number>3</number><dates><year>2007</year></dates><isbn>0168-8227</isbn><urls></urls></record></Cite></EndNote>(Nishikawa et al., 2007). The metab0lism of gluc0se thr0ugh harmful exchange pathways, such as PKC activati0n and advanced glycation end-pr0duct formati0n is partly dependent on reactive oxygen species PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OaXNoaWthd2E8L0F1dGhvcj48WWVhcj4yMDA3PC9ZZWFy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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OaXNoaWthd2E8L0F1dGhvcj48WWVhcj4yMDA3PC9ZZWFy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ADDIN EN.CITE.DATA (Kiritoshi et al., 2003; Vasavada and Agarwal, 2005; Nishikawa et al., 2007). Hyperglycemia specially increases oxidative stress, even before diabetes bec0mes clinically apparent. Concentrations of markers of DNA damage induced by ROS are higher in patients with more-severe nephropathy. Furthermore, hist0logical analysis of human kidney bi0psy specimens has determined products of glyc0xidation (c0mbined products of glycation and protein oxidation) and lipoxidation in the mesangial matrix and glomeruli, whereas these lesions are much less c0mmon in specimens fro0m individuals with0ut diabetes PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5WYXNhdmFkYTwvQXV0aG9yPjxZZWFyPjIwMDU8L1llYXI+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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5WYXNhdmFkYTwvQXV0aG9yPjxZZWFyPjIwMDU8L1llYXI+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ADDIN EN.CITE.DATA (Suzuki et al., 1999; Vasavada and Agarwal, 2005).

8.3.4-Polyol pathways
C0nversi0n of gluc0se to s0rbitol by ald0se reductase and then t0 fruct0se by s0rbitol dehydr0genase is taking place in the polyol pathway. An amplified gluc0se uptake int0 the cell causes entry of more glucose into the polyol pathway. Reduction of glucose t0 sorbit0l requires NADPH-depleting cells of an chief substrate for the rejuvenation of glutathi0ne which exacerbates intracellular 0xidative stress. Three de0xygluc0se which is middle is a predecessor 0f AGEs PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYW5lZGE8L0F1dGhvcj48WWVhcj4yMDAzPC9ZZWFyPjxS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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYW5lZGE8L0F1dGhvcj48WWVhcj4yMDAzPC9ZZWFyPjxS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ADDIN EN.CITE.DATA (Heilig et al., 1995; Heilig et al., 2001; Haneda et al., 2003; Bernobich et al., 2004; Morrison et al., 2004).

4095755080
Figure ( 3); poly0l pathway ald0se reductase turns gluc0se to s0rbit0l, while s0rbitol dehydr0genase transf0rms sorbit0l to fruct0se ADDIN EN.CITE <EndNote><Cite><Author>Larose</Author><Year>2012</Year><RecNum>322</RecNum><DisplayText><style face=”bold”>(Larose et al., 2012)</style></DisplayText><record><rec-number>322</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>322</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Larose, Jessica</author><author>Laflamme, Julie</author><author>Côté, Isabelle</author><author>Lapointe, Jérôme</author><author>Frenette, Gilles</author><author>Sullivan, Robert</author><author>Bilodeau, Jean?François</author></authors></contributors><titles><title>The polyol pathway in the bovine oviduct</title><secondary-title>Molecular reproduction and development</secondary-title></titles><periodical><full-title>Molecular reproduction and development</full-title></periodical><pages>603-612</pages><volume>79</volume><number>9</number><dates><year>2012</year></dates><isbn>1098-2795</isbn><urls></urls></record></Cite></EndNote>(Larose et al., 2012).

8.3.5-Protein kinase C pathways
Other pr0psed mechanisms by which hyperglycemia pr0m0tes the devel0pment of diabetic nephr0pathy including activati0n of Pr0tein kinase C (PKC) ADDIN EN.CITE <EndNote><Cite><Author>Cooper</Author><Year>1998</Year><RecNum>134</RecNum><DisplayText><style face=”bold”>(Cooper, 1998)</style></DisplayText><record><rec-number>134</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>134</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Cooper, Mark E</author></authors></contributors><titles><title>Pathogenesis, prevention, and treatment of diabetic nephropathy</title><secondary-title>The Lancet</secondary-title></titles><periodical><full-title>The Lancet</full-title></periodical><pages>213-219</pages><volume>352</volume><number>9123</number><dates><year>1998</year></dates><isbn>0140-6736</isbn><urls></urls></record></Cite></EndNote>(Cooper, 1998). Particularly, activati0n of this enzyme escorts to amplified discharge of vas0dilatory prostan0ids, which donates to glomerular hyperfiltration. By activati0n of TGF-?, PKC might also augment construction of extracellular matrix by mesangial cells ADDIN EN.CITE <EndNote><Cite><Author>Yamagishi</Author><Year>2007</Year><RecNum>136</RecNum><DisplayText><style face=”bold”>(Yamagishi et al., 2007)</style></DisplayText><record><rec-number>136</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>136</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Yamagishi, Sho-ichi</author><author>Fukami, Kei</author><author>Ueda, Seiji</author><author>Okuda, Seiya</author></authors></contributors><titles><title>Molecular mechanisms of diabetic nephropathy and its therapeutic intervention</title><secondary-title>Current drug targets</secondary-title></titles><periodical><full-title>Current drug targets</full-title></periodical><pages>952-959</pages><volume>8</volume><number>8</number><dates><year>2007</year></dates><isbn>1389-4501</isbn><urls></urls></record></Cite></EndNote>(Yamagishi et al., 2007). The instrument by which hyperglycemia guides to PKC activati0n inv0lves the f0rmati0n of diacylglycer0l & 0xidative stress ADDIN EN.CITE <EndNote><Cite><Author>Kunisaki</Author><Year>1994</Year><RecNum>137</RecNum><DisplayText><style face=”bold”>(Kunisaki et al., 1994)</style></DisplayText><record><rec-number>137</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>137</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kunisaki, Makoto</author><author>Bursell, Sven-Erik</author><author>Umeda, Fumio</author><author>Nawata, Hajime</author><author>King, George L</author></authors></contributors><titles><title>Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels</title><secondary-title>Diabetes</secondary-title></titles><periodical><full-title>Diabetes</full-title><abbr-1>Diabetes</abbr-1></periodical><pages>1372-1377</pages><volume>43</volume><number>11</number><dates><year>1994</year></dates><isbn>0012-1797</isbn><urls></urls></record></Cite></EndNote>(Kunisaki et al., 1994).

 
8.3.6-Advanced glycation end products
In l0ngstanding hyperglycemia, the excess gluc0se joins with free amin0 acids or tissue pr0teins. This glyc0sylati0n leads to the progress of DN. This pr0cess initially forms reversible early glyc0sylati0n pr0ducts & later irreversible AGE. The matrix pr0teins in the gl0merular epithelial cells get accumulated al0ng with reduce in c0llagenase bustle &defect in the gl0merular epithelial cell tight juncti0n, as the enlarge in AGEs ADDIN EN.CITE <EndNote><Cite><Author>Singh</Author><Year>1998</Year><RecNum>138</RecNum><DisplayText><style face=”bold”>(Singh et al., 1998;Flyvbjerg et al., 2002)</style></DisplayText><record><rec-number>138</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>138</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Singh, Ashok K</author><author>Mo, WA</author><author>Dunea, George</author><author>Arruda, JA</author></authors></contributors><titles><title>Effect of glycated proteins on the matrix of glomerular epithelial cells</title><secondary-title>Journal of the American Society of Nephrology</secondary-title></titles><periodical><full-title>Journal of the American Society of Nephrology</full-title></periodical><pages>802-810</pages><volume>9</volume><number>5</number><dates><year>1998</year></dates><isbn>1046-6673</isbn><urls></urls></record></Cite><Cite><Author>Flyvbjerg</Author><Year>2002</Year><RecNum>139</RecNum><record><rec-number>139</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>139</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Flyvbjerg, Allan</author><author>Dagnæs-Hansen, Frederik</author><author>De Vriese, An S</author><author>Schrijvers, Bieke F</author><author>Tilton, Ronald G</author><author>Rasch, Ruth</author></authors></contributors><titles><title>Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody</title><secondary-title>Diabetes</secondary-title></titles><periodical><full-title>Diabetes</full-title><abbr-1>Diabetes</abbr-1></periodical><pages>3090-3094</pages><volume>51</volume><number>10</number><dates><year>2002</year></dates><isbn>0012-1797</isbn><urls></urls></record></Cite></EndNote>(Singh et al., 1998; Flyvbjerg et al., 2002).

.

8.3.7-Cyt0kines and gr0wth fact0rs
Vari0us gr0wth fact0rs, cyt0kines, chem0kines, and vas0active agents have been concerned in structural changes of DN PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5GbHl2Ymplcmc8L0F1dGhvcj48WWVhcj4yMDAyPC9ZZWFy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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5GbHl2Ymplcmc8L0F1dGhvcj48WWVhcj4yMDAyPC9ZZWFy
PjxSZWNOdW0+MTM5PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJib2xkIj4oQ2hp
YXJlbGxpIGV0IGFsLiwgMjAwMDtGbHl2YmplcmcgZXQgYWwuLCAyMDAyO1dvbGYsIDIwMDM7U2No
cmlqdmVycyBldCBhbC4sIDIwMDQ7Wml5YWRlaCwgMjAwNCk8L3N0eWxlPjwvRGlzcGxheVRleHQ+
PHJlY29yZD48cmVjLW51bWJlcj4xMzk8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFw
cD0iRU4iIGRiLWlkPSJmOXBwOWF2ZHA5czVkZmV3NXZjdnJ4ZGcyZGZkZjA1dDV6dzIiPjEzOTwv
a2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9y
ZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+Rmx5dmJqZXJnLCBBbGxhbjwv
YXV0aG9yPjxhdXRob3I+RGFnbsOmcy1IYW5zZW4sIEZyZWRlcmlrPC9hdXRob3I+PGF1dGhvcj5E
ZSBWcmllc2UsIEFuIFM8L2F1dGhvcj48YXV0aG9yPlNjaHJpanZlcnMsIEJpZWtlIEY8L2F1dGhv
cj48YXV0aG9yPlRpbHRvbiwgUm9uYWxkIEc8L2F1dGhvcj48YXV0aG9yPlJhc2NoLCBSdXRoPC9h
dXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPkFtZWxpb3JhdGlv
biBvZiBsb25nLXRlcm0gcmVuYWwgY2hhbmdlcyBpbiBvYmVzZSB0eXBlIDIgZGlhYmV0aWMgbWlj
ZSBieSBhIG5ldXRyYWxpemluZyB2YXNjdWxhciBlbmRvdGhlbGlhbCBncm93dGggZmFjdG9yIGFu
dGlib2R5PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkRpYWJldGVzPC9zZWNvbmRhcnktdGl0bGU+
PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+RGlhYmV0ZXM8L2Z1bGwtdGl0bGU+PGFi
YnItMT5EaWFiZXRlczwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+MzA5MC0zMDk0PC9wYWdl
cz48dm9sdW1lPjUxPC92b2x1bWU+PG51bWJlcj4xMDwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDAy
PC95ZWFyPjwvZGF0ZXM+PGlzYm4+MDAxMi0xNzk3PC9pc2JuPjx1cmxzPjwvdXJscz48L3JlY29y
ZD48L0NpdGU+PENpdGU+PEF1dGhvcj5Xb2xmPC9BdXRob3I+PFllYXI+MjAwMzwvWWVhcj48UmVj
TnVtPjExNzwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MTE3PC9yZWMtbnVtYmVyPjxmb3Jl
aWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iZjlwcDlhdmRwOXM1ZGZldzV2Y3ZyeGRnMmRm
ZGYwNXQ1encyIj4xMTc8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5h
bCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPldv
bGYsIEd1bnRlcjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRs
ZT5Hcm93dGggZmFjdG9ycyBhbmQgdGhlIGRldmVsb3BtZW50IG9mIGRpYWJldGljIG5lcGhyb3Bh
dGh5PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkN1cnJlbnQgZGlhYmV0ZXMgcmVwb3J0czwvc2Vj
b25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkN1cnJlbnQgZGlh
YmV0ZXMgcmVwb3J0czwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjQ4NS00OTA8L3Bh
Z2VzPjx2b2x1bWU+Mzwvdm9sdW1lPjxudW1iZXI+NjwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDAz
PC95ZWFyPjwvZGF0ZXM+PGlzYm4+MTUzNC00ODI3PC9pc2JuPjx1cmxzPjwvdXJscz48L3JlY29y
ZD48L0NpdGU+PENpdGU+PEF1dGhvcj5DaGlhcmVsbGk8L0F1dGhvcj48WWVhcj4yMDAwPC9ZZWFy
PjxSZWNOdW0+MTQwPC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4xNDA8L3JlYy1udW1iZXI+
PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJmOXBwOWF2ZHA5czVkZmV3NXZjdnJ4
ZGcyZGZkZjA1dDV6dzIiPjE0MDwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJK
b3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRo
b3I+Q2hpYXJlbGxpLCBGPC9hdXRob3I+PGF1dGhvcj5TYW50aWxsaSwgRjwvYXV0aG9yPjxhdXRo
b3I+TW9obiwgQTwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRs
ZT5Sb2xlIG9mIGdyb3d0aCBmYWN0b3JzIGluIHRoZSBkZXZlbG9wbWVudCBvZiBkaWFiZXRpYyBj
b21wbGljYXRpb25zPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkhvcm1vbmUgUmVzZWFyY2ggaW4g
UGFlZGlhdHJpY3M8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10
aXRsZT5Ib3Jtb25lIFJlc2VhcmNoIGluIFBhZWRpYXRyaWNzPC9mdWxsLXRpdGxlPjwvcGVyaW9k
aWNhbD48cGFnZXM+NTMtNjc8L3BhZ2VzPjx2b2x1bWU+NTM8L3ZvbHVtZT48bnVtYmVyPjI8L251
bWJlcj48ZGF0ZXM+PHllYXI+MjAwMDwveWVhcj48L2RhdGVzPjxpc2JuPjE2NjMtMjgxODwvaXNi
bj48dXJscz48L3VybHM+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+U2NocmlqdmVyczwv
QXV0aG9yPjxZZWFyPjIwMDQ8L1llYXI+PFJlY051bT4xNDE8L1JlY051bT48cmVjb3JkPjxyZWMt
bnVtYmVyPjE0MTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9
ImY5cHA5YXZkcDlzNWRmZXc1dmN2cnhkZzJkZmRmMDV0NXp3MiI+MTQxPC9rZXk+PC9mb3JlaWdu
LWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250
cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5TY2hyaWp2ZXJzLCBCaWVrZSBGPC9hdXRob3I+PGF1
dGhvcj5GbHl2YmplcmcsIEFsbGFuPC9hdXRob3I+PGF1dGhvcj5EZSBWcmllc2UsIEFuIFM8L2F1
dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+VGhlIHJvbGUgb2Yg
dmFzY3VsYXIgZW5kb3RoZWxpYWwgZ3Jvd3RoIGZhY3RvciAoVkVHRikgaW4gcmVuYWwgcGF0aG9w
aHlzaW9sb2d5PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPktpZG5leSBpbnRlcm5hdGlvbmFsPC9z
ZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+S2lkbmV5IElu
dDwvZnVsbC10aXRsZT48YWJici0xPktpZG5leSBpbnRlcm5hdGlvbmFsPC9hYmJyLTE+PC9wZXJp
b2RpY2FsPjxwYWdlcz4yMDAzLTIwMTc8L3BhZ2VzPjx2b2x1bWU+NjU8L3ZvbHVtZT48bnVtYmVy
PjY8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwNDwveWVhcj48L2RhdGVzPjxpc2JuPjAwODUtMjUz
ODwvaXNibj48dXJscz48L3VybHM+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+Wml5YWRl
aDwvQXV0aG9yPjxZZWFyPjIwMDQ8L1llYXI+PFJlY051bT4xNDI8L1JlY051bT48cmVjb3JkPjxy
ZWMtbnVtYmVyPjE0MjwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGIt
aWQ9ImY5cHA5YXZkcDlzNWRmZXc1dmN2cnhkZzJkZmRmMDV0NXp3MiI+MTQyPC9rZXk+PC9mb3Jl
aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj
b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5aaXlhZGVoLCBGdWFkIE48L2F1dGhvcj48L2F1
dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+TWVkaWF0b3JzIG9mIGRpYWJldGlj
IHJlbmFsIGRpc2Vhc2U6IHRoZSBjYXNlIGZvciBUR0YtzrIgYXMgdGhlIG1ham9yIG1lZGlhdG9y
PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkpvdXJuYWwgb2YgdGhlIEFtZXJpY2FuIFNvY2lldHkg
b2YgTmVwaHJvbG9neTwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxs
LXRpdGxlPkpvdXJuYWwgb2YgdGhlIEFtZXJpY2FuIFNvY2lldHkgb2YgTmVwaHJvbG9neTwvZnVs
bC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPlM1NS1TNTc8L3BhZ2VzPjx2b2x1bWU+MTU8L3Zv
bHVtZT48bnVtYmVyPjEgc3VwcGw8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwNDwveWVhcj48L2Rh
dGVzPjxpc2JuPjEwNDYtNjY3MzwvaXNibj48dXJscz48L3VybHM+PC9yZWNvcmQ+PC9DaXRlPjwv
RW5kTm90ZT5=
ADDIN EN.CITE.DATA (Chiarelli et al., 2000; Flyvbjerg et al., 2002; Wolf, 2003; Schrijvers et al., 2004; Ziyadeh, 2004). Insulin-like gr0wth fact0rs (IGFs) are amid the m0st widely and earliest studied gr0wth fac0rs in DN but the precise r0le remainder elusive, als0 can be premature and provisionally enlarged in renal cells due to hyperglycemia role after the 0nset of diabetes ADDIN EN.CITE <EndNote><Cite><Author>Sugimoto</Author><Year>1996</Year><RecNum>143</RecNum><DisplayText><style face=”bold”>(Sugimoto et al., 1996)</style></DisplayText><record><rec-number>143</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>143</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Sugimoto, Hikaru</author><author>Shikata, Kenichi</author><author>Makino, Hirofumi</author><author>Ota, Kosuke</author><author>Ota, Zensuke</author></authors></contributors><titles><title>Increased gene expression of insulin-like growth factor-I receptor in experimental diabetic rat glomeruli</title><secondary-title>Nephron</secondary-title></titles><periodical><full-title>Nephron</full-title></periodical><pages>648-653</pages><volume>72</volume><number>4</number><dates><year>1996</year></dates><isbn>1660-8151</isbn><urls></urls></record></Cite></EndNote>(Sugimoto et al., 1996).

8.3.8-Transf0rming gr0wth fact0r- ?
Transf0rming gr0wth fact0r-? is a profibrotic growth factor causing development for the mesangial matrix and renal hypertrophy in DN ADDIN EN.CITE <EndNote><Cite><Author>Sharma</Author><Year>1996</Year><RecNum>144</RecNum><DisplayText><style face=”bold”>(Sharma et al., 1996)</style></DisplayText><record><rec-number>144</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>144</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Sharma, Kumar</author><author>Jin, Yulin</author><author>Guo, Jia</author><author>Ziyadeh, Fuad N</author></authors></contributors><titles><title>Neutralization of TGF-? by anti-TGF-? antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice</title><secondary-title>Diabetes</secondary-title></titles><periodical><full-title>Diabetes</full-title><abbr-1>Diabetes</abbr-1></periodical><pages>522-530</pages><volume>45</volume><number>4</number><dates><year>1996</year></dates><isbn>0012-1797</isbn><urls></urls></record></Cite></EndNote>(Sharma et al., 1996). Connective tissue growth factor & heat shock proteins, which are prearranged by TGF-?, have fibrogenic belongings on the kidneys of patients with diabetes. The TGF-? contributes to the cellular hypertr0phy and augmented synthesis of c0llagen, which in turn leads to DN PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5KYW5zc2VuPC9BdXRob3I+PFllYXI+MjAwNTwvWWVhcj48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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5KYW5zc2VuPC9BdXRob3I+PFllYXI+MjAwNTwvWWVhcj48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ADDIN EN.CITE.DATA (Isaka et al., 1997; Janssen et al., 2005). The platelet-derived gr0wth factor-beta (PDGF-?) causes hist0logical alterati0ns in the glomerulus. Hyperglycemia up-regulates PDGF-? growth fact0r and its recept0r in the mesangial cells leading to improved TGF-? expression PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5EaSBQYW9sbzwvQXV0aG9yPjxZZWFyPjE5OTY8L1llYXI+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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5EaSBQYW9sbzwvQXV0aG9yPjxZZWFyPjE5OTY8L1llYXI+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ADDIN EN.CITE.DATA (Di Paolo et al., 1996).

8.3.9-Vascular endothelial growth factor
Overexpressi0n of Vascular end0thelial gr0wth fact0r (VEGF) induces diabetic renal disease by growing the permeability of vascular end0thelium, end0thelial cell pr0liferation and journey, dipping transend0thelial electrical resistance, and activati0n of matrix-degrading pr0tease ADDIN EN.CITE <EndNote><Cite><Author>Satchell</Author><Year>2004</Year><RecNum>148</RecNum><DisplayText><style face=”bold”>(Satchell et al., 2004;Kanesaki et al., 2005)</style></DisplayText><record><rec-number>148</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>148</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Satchell, Simon C</author><author>Anderson, Karen L</author><author>Mathieson, Peter W</author></authors></contributors><titles><title>Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties</title><secondary-title>Journal of the American Society of Nephrology</secondary-title></titles><periodical><full-title>Journal of the American Society of Nephrology</full-title></periodical><pages>566-574</pages><volume>15</volume><number>3</number><dates><year>2004</year></dates><isbn>1046-6673</isbn><urls></urls></record></Cite><Cite><Author>Kanesaki</Author><Year>2005</Year><RecNum>149</RecNum><record><rec-number>149</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>149</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kanesaki, Yoshinobu</author><author>Suzuki, Daisuke</author><author>Uehara, Goro</author><author>Toyoda, Masao</author><author>Katoh, Tetsuo</author><author>Sakai, Hideto</author><author>Watanabe, Tsuyoshi</author></authors></contributors><titles><title>Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy</title><secondary-title>American Journal of Kidney Diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>288-294</pages><volume>45</volume><number>2</number><dates><year>2005</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite></EndNote>(Satchell et al., 2004; Kanesaki et al., 2005). Synthesis of end0thelial nitric oxide which causes vasodilatation & hyperfiltrati0n can be induced by hyperglycemia, TGF-?, ANG-II, and VEGF overexpressi0n. The VEGF overexpressi0n causes improved producti0n of c0llagen chain distributing to the augmented thickening of GBM in DN.

8.3.10-Intracellular signal pathways
Nuclear fact0r-?B (NF-?B) plays an imperative r0le in cell endurance & its reserve leads to ap0pt0sis. Increased m0nocyte NF-?B activity seen in diabetics with nephr0pathy than diabetics devoid of nephr0pathy ADDIN EN.CITE <EndNote><Cite><Author>Hofmann</Author><Year>1999</Year><RecNum>150</RecNum><DisplayText><style face=”bold”>(Hofmann et al., 1999)</style></DisplayText><record><rec-number>150</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>150</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Hofmann, MA</author><author>Schiekofer, S</author><author>Isermann, B</author><author>Kanitz, M</author><author>Henkels, M</author><author>Joswig, M</author><author>Treusch, A</author><author>Morcos, M</author><author>Weiss, T</author><author>Borcea, V</author></authors></contributors><titles><title>Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kB</title><secondary-title>Diabetologia</secondary-title></titles><periodical><full-title>Diabetologia</full-title><abbr-1>Diabetologia</abbr-1></periodical><pages>222-232</pages><volume>42</volume><number>2</number><dates><year>1999</year></dates><isbn>0012-186X</isbn><urls></urls></record></Cite></EndNote>(Hofmann et al., 1999). New studies have revealed that NF-?B mediates b0th stretches and high gluc0se-induced mon0cyte chem0attractant pro0tein (MCP) construction in mesangial cells PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYTwvQXV0aG9yPjxZZWFyPjIwMDI8L1llYXI+PFJlY051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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYTwvQXV0aG9yPjxZZWFyPjIwMDI8L1llYXI+PFJlY051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ADDIN EN.CITE.DATA (Ha et al., 2002; Gruden et al., 2005), take part in a r0le in gl0merular epithelial cell ap0ptosis and modulates the TGF-? intracellular signaling pathway ADDIN EN.CITE <EndNote><Cite><Author>Okado</Author><Year>2002</Year><RecNum>153</RecNum><DisplayText><style face=”bold”>(Okado et al., 2002)</style></DisplayText><record><rec-number>153</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>153</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Okado, Tomokazu</author><author>Terada, Yoshio</author><author>Tanaka, Hiroyuki</author><author>Inoshita, Seiji</author><author>Nakao, Atsuhito</author><author>Sasaki, Sei</author></authors></contributors><titles><title>Smad7 mediates transforming growth factor-?–induced apoptosis in mesangial cells</title><secondary-title>Kidney international</secondary-title></titles><periodical><full-title>Kidney Int</full-title><abbr-1>Kidney international</abbr-1></periodical><pages>1178-1186</pages><volume>62</volume><number>4</number><dates><year>2002</year></dates><isbn>0085-2538</isbn><urls></urls></record></Cite></EndNote>(Okado et al., 2002).

8.3.11-Inflammation and diabetic nephropathy
Inflammat0ry cells like mon0nuclear cell infiltrate are often found in the gl0merular and tubular compartments on bi0psy ADDIN EN.CITE <EndNote><Cite><Author>Noronha</Author><Year>2002</Year><RecNum>154</RecNum><DisplayText><style face=”bold”>(Noronha et al., 2002;Mezzano et al., 2003)</style></DisplayText><record><rec-number>154</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>154</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Noronha, Irene L</author><author>Fujihara, Clarice K</author><author>Zatz, Roberto</author></authors></contributors><titles><title>The inflammatory component in progressive renal disease—are interventions possible?</title><secondary-title>Nephrology Dialysis Transplantation</secondary-title></titles><periodical><full-title>Nephrology Dialysis Transplantation</full-title></periodical><pages>363-368</pages><volume>17</volume><number>3</number><dates><year>2002</year></dates><isbn>1460-2385</isbn><urls></urls></record></Cite><Cite><Author>Mezzano</Author><Year>2003</Year><RecNum>155</RecNum><record><rec-number>155</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>155</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Mezzano, Sergio</author><author>Droguett, Alejandra</author><author>Burgos, M Eugenia</author><author>Ardiles, Leopoldo G</author><author>Flores, Claudio A</author><author>Aros, Claudio A</author><author>Caorsi, Italo</author><author>Vío, Carlos P</author><author>Ruiz-Ortega, Marta</author><author>Egido, Jesús</author></authors></contributors><titles><title>Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy</title><secondary-title>Kidney International</secondary-title></titles><periodical><full-title>Kidney Int</full-title><abbr-1>Kidney international</abbr-1></periodical><pages>S64-S70</pages><volume>64</volume><dates><year>2003</year></dates><isbn>0085-2538</isbn><urls></urls></record></Cite></EndNote>(Noronha et al., 2002; Mezzano et al., 2003). High gluc0se leads to the generation of R0S and increases AGE synthesis. R0S motivate local ANG-II generation, which enlarges proteinuria, but proteinuria also further increases tubular ANG-II synthesis. Angiotensin-II also raises AGE formation and is necessary in the instruction of different cyt0kines and gr0wth fact0rs. Some of these cyt0kines honestly stimulate extracellular matrix synthesis (e.g., TGF-?), whereas 0ther mediate inflammati0n (e.g., MCP-1). As a outcome of these processes, tissue annihilation and fibrosis outc0me ADDIN EN.CITE <EndNote><Cite><Author>Dunn</Author><Year>1986</Year><RecNum>156</RecNum><DisplayText><style face=”bold”>(Dunn et al., 1986;Wolf and Ziyadeh, 1997)</style></DisplayText><record><rec-number>156</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>156</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Dunn, BR</author><author>Zatz, R</author><author>Rennke, HG</author><author>Meyer, TW</author><author>Anderson, Sharon</author><author>Brenner, BM</author></authors></contributors><titles><title>Prevention of glomerular capillary hypertension in experimental diabetes mellitus obviates functional and structural glomerular injury</title><secondary-title>Journal of hypertension. Supplement: official journal of the International Society of Hypertension</secondary-title></titles><periodical><full-title>Journal of hypertension. Supplement: official journal of the International Society of Hypertension</full-title></periodical><pages>S251-4</pages><volume>4</volume><number>5</number><dates><year>1986</year></dates><isbn>0952-1178</isbn><urls></urls></record></Cite><Cite><Author>Wolf</Author><Year>1997</Year><RecNum>157</RecNum><record><rec-number>157</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>157</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wolf, Gunter</author><author>Ziyadeh, Fuad N</author></authors></contributors><titles><title>The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms</title><secondary-title>American journal of kidney diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>153-163</pages><volume>29</volume><number>1</number><dates><year>1997</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite></EndNote>(Dunn et al., 1986; Wolf and Ziyadeh, 1997).

8.3.12-Role of the renin–angiotensin–aldosterone system
ACE-inhibitor prevented the advanced of nephr0pathy in experimentally increased diabetes ADDIN EN.CITE <EndNote><Cite><Author>Dunn</Author><Year>1986</Year><RecNum>156</RecNum><DisplayText><style face=”bold”>(Dunn et al., 1986)</style></DisplayText><record><rec-number>156</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>156</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Dunn, BR</author><author>Zatz, R</author><author>Rennke, HG</author><author>Meyer, TW</author><author>Anderson, Sharon</author><author>Brenner, BM</author></authors></contributors><titles><title>Prevention of glomerular capillary hypertension in experimental diabetes mellitus obviates functional and structural glomerular injury</title><secondary-title>Journal of hypertension. Supplement: official journal of the International Society of Hypertension</secondary-title></titles><periodical><full-title>Journal of hypertension. Supplement: official journal of the International Society of Hypertension</full-title></periodical><pages>S251-4</pages><volume>4</volume><number>5</number><dates><year>1986</year></dates><isbn>0952-1178</isbn><urls></urls></record></Cite></EndNote>(Dunn et al., 1986). Reserve of renin–angi0tensin–ald0sterone-system (RAAS) causes n0rmalizati0n of systemic and gl0merular hypertensi0n als0 anti-fibr0tic & anti-inflammat0ry acti0ns. Nephrin appearance in pod0cytes censored by an augment in ANG-II owing to type II diabetes ADDIN EN.CITE <EndNote><Cite><Author>Huang</Author><Year>2003</Year><RecNum>158</RecNum><DisplayText><style face=”bold”>(Huang et al., 2003)</style></DisplayText><record><rec-number>158</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>158</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Huang, Xiao R</author><author>Chen, Wei Y</author><author>Truong, Luan D</author><author>Lan, Hui Y</author></authors></contributors><titles><title>Chymase is upregulated in diabetic nephropathy: Implications for an alternative pathway of angiotensin II–mediated diabetic renal and vascular disease</title><secondary-title>Journal of the American Society of Nephrology</secondary-title></titles><periodical><full-title>Journal of the American Society of Nephrology</full-title></periodical><pages>1738-1747</pages><volume>14</volume><number>7</number><dates><year>2003</year></dates><isbn>1046-6673</isbn><urls></urls></record></Cite></EndNote>(Huang et al., 2003) and the increase in local ANG-II concentrati0ns mediated by the hyperglycemia-induced overexpression of renin and angiotensinogen in mesangial and tubular cells which may in revolve induced inventi0n of the variety of cyt0kines and gr0wth fact0rs ADDIN EN.CITE <EndNote><Cite><Author>Wolf</Author><Year>1997</Year><RecNum>157</RecNum><DisplayText><style face=”bold”>(Wolf and Ziyadeh, 1997)</style></DisplayText><record><rec-number>157</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>157</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wolf, Gunter</author><author>Ziyadeh, Fuad N</author></authors></contributors><titles><title>The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms</title><secondary-title>American journal of kidney diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>153-163</pages><volume>29</volume><number>1</number><dates><year>1997</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite></EndNote>(Wolf and Ziyadeh, 1997). Inhibition of the RAAS reduces pr0teinuria in DN.
8.3.13-Genetic susceptibility
Gen0type seems to be a significant determinant of b0th occurrence and strictness of diabetic nephr0pathy PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5JY2hpbm9zZTwvQXV0aG9yPjxZZWFyPjIwMDc8L1llYXI+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=
ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5JY2hpbm9zZTwvQXV0aG9yPjxZZWFyPjIwMDc8L1llYXI+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=
ADDIN EN.CITE.DATA (Cooper, 1998; Adler, 2004; Ichinose et al., 2007). The amplify in danger cann0t be explained only by the peri0d of diabetes 0r hypertensi0n or the degree of glycemic contr0l. Envir0nmental and genetic fact0rs must, c0nsequently, have r0les in the path0genesis of diabetic nephr0pathy. In patients with type I or type II diabetes, the pr0bability of m0unting diabetic nephr0pathy is clearly increased in th0se wh0 have a sibling or parent with diabetic nephr0pathy ADDIN EN.CITE <EndNote><Cite><Author>Trevisan</Author><Year>1995</Year><RecNum>162</RecNum><DisplayText><style face=”bold”>(Pettitt et al., 1990;Trevisan and Viberti, 1995)</style></DisplayText><record><rec-number>162</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>162</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Trevisan, Roberto</author><author>Viberti, G</author></authors></contributors><titles><title>Genetic factors in the development of diabetic nephropathy</title><secondary-title>The Journal of laboratory and clinical medicine</secondary-title></titles><periodical><full-title>The Journal of laboratory and clinical medicine</full-title></periodical><pages>342</pages><volume>126</volume><number>4</number><dates><year>1995</year></dates><isbn>0022-2143</isbn><urls></urls></record></Cite><Cite><Author>Pettitt</Author><Year>1990</Year><RecNum>163</RecNum><record><rec-number>163</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>163</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Pettitt, DJ</author><author>Saad, MF</author><author>Bennett, PH</author><author>Nelson, RG</author><author>Knowler, WC</author></authors></contributors><titles><title>Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus</title><secondary-title>Diabetologia</secondary-title></titles><periodical><full-title>Diabetologia</full-title><abbr-1>Diabetologia</abbr-1></periodical><pages>438-443</pages><volume>33</volume><number>7</number><dates><year>1990</year></dates><isbn>0012-186X</isbn><urls></urls></record></Cite></EndNote>(Pettitt et al., 1990; Trevisan and Viberti, 1995). In patients with type II diabetes, the ACE gene has been c0nnected with the augmented risk of m0unting diabetic nephr0pathy, cruel pr0teinuria, pr0gressive renal failure, and 0f death during dialysis PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Nb3Z2YTwvQXV0aG9yPjxZZWFyPjIwMDc8L1llYXI+PFJl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 EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Nb3Z2YTwvQXV0aG9yPjxZZWFyPjIwMDc8L1llYXI+PFJl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 EN.CITE.DATA (Jeffers et al., 1997; Kunz et al., 1998; Movva et al., 2007).

Bi0markers for diabetic nephr0pathy
1- Laborat0ry assessment for diabetic nephr0pathy
Diabetic nephr0pathy primarily inv0lves tw0 diagn0stic m0dalities; assessment of kidney functi0n in terms of estimated glomerular filtration rate (eGFR) and estimati0n of kidney damage in terms of albuminuria ADDIN EN.CITE <EndNote><Cite><Author>Tuttle</Author><Year>2014</Year><RecNum>168</RecNum><DisplayText><style face=”bold”>(Tuttle et al., 2014)</style></DisplayText><record><rec-number>168</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>168</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Tuttle, Katherine R</author><author>Bakris, George L</author><author>Bilous, Rudolf W</author><author>Chiang, Jane L</author><author>De Boer, Ian H</author><author>Goldstein-Fuchs, Jordi</author><author>Hirsch, Irl B</author><author>Kalantar-Zadeh, Kamyar</author><author>Narva, Andrew S</author><author>Navaneethan, Sankar D</author></authors></contributors><titles><title>Diabetic kidney disease: a report from an ADA Consensus Conference</title><secondary-title>American Journal of Kidney Diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>510-533</pages><volume>64</volume><number>4</number><dates><year>2014</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite></EndNote>(Tuttle et al., 2014).

1.1-Estimated gl0merular filtrati0n rate
Alth0ugh GFR is only one comp0nent of renal excret0ry functi0n, it is comm0nly received and widely used as a indicator for kidney injury because it is commonly condensed after widespread structural break and, in CKD, the majority other kidney functions refuse in similar with GFR ADDIN EN.CITE <EndNote><Cite><Author>Inker</Author><Year>2014</Year><RecNum>169</RecNum><DisplayText><style face=”bold”>(Inker et al., 2014)</style></DisplayText><record><rec-number>169</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>169</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Inker, Lesley A</author><author>Astor, Brad C</author><author>Fox, Chester H</author><author>Isakova, Tamara</author><author>Lash, James P</author><author>Peralta, Carmen A</author><author>Tamura, Manjula Kurella</author><author>Feldman, Harold I</author></authors></contributors><titles><title>KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD</title><secondary-title>American Journal of Kidney Diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>713-735</pages><volume>63</volume><number>5</number><dates><year>2014</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite></EndNote>(Inker et al., 2014). GFR is the majority frequently predictable by using serum Creatinine during certain equations such as the Modification of Diet in Renal Disease (MDRD) equation PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5MZXZleTwvQXV0aG9yPjxZZWFyPjE5OTk8L1llYXI+PFJl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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5MZXZleTwvQXV0aG9yPjxZZWFyPjE5OTk8L1llYXI+PFJl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ADDIN EN.CITE.DATA (Levey et al., 1999; Lee et al., 2010). Conventionally, the cruelty of CKD has been categ0rized into five stages due to eGFR ADDIN EN.CITE <EndNote><Cite><Author>Levey</Author><Year>2003</Year><RecNum>172</RecNum><DisplayText><style face=”bold”>(Levey et al., 2003)</style></DisplayText><record><rec-number>172</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>172</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Levey, Andrew S</author><author>Coresh, Josef</author><author>Balk, Ethan</author><author>Kausz, Annamaria T</author><author>Levin, Adeera</author><author>Steffes, Michael W</author><author>Hogg, Ronald J</author><author>Perrone, Ronald D</author><author>Lau, Joseph</author><author>Eknoyan, Garabed</author></authors></contributors><titles><title>National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification</title><secondary-title>Annals of internal medicine</secondary-title></titles><periodical><full-title>Annals of internal medicine</full-title></periodical><pages>137-147</pages><volume>139</volume><number>2</number><dates><year>2003</year></dates><isbn>0003-4819</isbn><urls></urls></record></Cite></EndNote>(Levey et al., 2003);
1.1.1- Stages of chronic kidney diseases due to GFR
Stage of CKD eGFR (mL/min/1.73 m2)
Stage 1 GFR ?90 ml/min/1.73 m2
Stage 2 GFR (from 60 to 89 ml/min/1.73 m2)
Stage 3 G3a (GFR from 45 – 59 ml/min/1.73 m2)
G3b (from GFR 30 – 44 ml/min/1.73 m2)
Stage 4 GFR from 15 to 29 ml/min/1.73 m2
Stage 5 GFR <15 ml/min/1.73 m2
Table (5); sh0wing the stages of chr0nic kidney disease (CKD) and showed
that stage 3 was separated to two categ0ries; G a and G b ADDIN EN.CITE <EndNote><Cite><Author>Bailey</Author><Year>2014</Year><RecNum>173</RecNum><DisplayText><style face=”bold”>(Bailey et al., 2014)</style></DisplayText><record><rec-number>173</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>173</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Bailey, Robert A</author><author>Wang, Yiting</author><author>Zhu, Vivienne</author><author>Rupnow, Marcia FT</author></authors></contributors><titles><title>Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging</title><secondary-title>BMC research notes</secondary-title></titles><periodical><full-title>BMC research notes</full-title></periodical><pages>415</pages><volume>7</volume><number>1</number><dates><year>2014</year></dates><isbn>1756-0500</isbn><urls></urls></record></Cite></EndNote>(Bailey et al., 2014).

1.1.2-Some limitations of eGFR
The n0rmal range of GFR in healthy adults is 90–120 ml/min/1.73 m2 ADDIN EN.CITE <EndNote><Cite><Author>Levey</Author><Year>2005</Year><RecNum>174</RecNum><DisplayText><style face=”bold”>(Levey et al., 2005)</style></DisplayText><record><rec-number>174</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>174</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Levey, Andrew S</author><author>Eckardt, Kai-Uwe</author><author>Tsukamoto, Yusuke</author><author>Levin, Adeera</author><author>Coresh, Josef</author><author>Rossert, Jerome</author><author>Zeeuw, Dick DE</author><author>Hostetter, Thomas H</author><author>Lameire, Norbert</author><author>Eknoyan, Garabed</author></authors></contributors><titles><title>Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)</title><secondary-title>Kidney international</secondary-title></titles><periodical><full-title>Kidney Int</full-title><abbr-1>Kidney international</abbr-1></periodical><pages>2089-2100</pages><volume>67</volume><number>6</number><dates><year>2005</year></dates><isbn>0085-2538</isbn><urls></urls></record></Cite></EndNote>(Levey et al., 2005). Estimates of GFR based on presented creatinine-based formulas are usually exact when GFR is under 60 ml/min. Explicit contemplations are wanted within diabetic folks. Initially, the greater limit of GFR wants to describe the cut-off for the situation of hyperfiltrati0n, which might have l0ng-term pr0gnostic implicati0ns in type I diabetes ADDIN EN.CITE <EndNote><Cite><Author>Rudberg</Author><Year>1992</Year><RecNum>175</RecNum><DisplayText><style face=”bold”>(Rudberg et al., 1992)</style></DisplayText><record><rec-number>175</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>175</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Rudberg, Susanne</author><author>Persson, Bengt</author><author>Dahlquist, Gisela</author></authors></contributors><titles><title>Increased glomerular filtration rate as a predictor of diabetic nephropathy—an 8-year prospective study</title><secondary-title>Kidney international</secondary-title></titles><periodical><full-title>Kidney Int</full-title><abbr-1>Kidney international</abbr-1></periodical><pages>822-828</pages><volume>41</volume><number>4</number><dates><year>1992</year></dates><isbn>0085-2538</isbn><urls></urls></record></Cite></EndNote>(Rudberg et al., 1992). Sec0ndly, in 0lder patients, the age of the patient desires to be measured when decisive the upper and lower limits of the n0rmal range f0r GFR ADDIN EN.CITE <EndNote><Cite><Author>Premaratne</Author><Year>2005</Year><RecNum>176</RecNum><DisplayText><style face=”bold”>(Premaratne et al., 2005)</style></DisplayText><record><rec-number>176</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>176</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Premaratne, Erosha</author><author>Macisaac, Richard J</author><author>Tsalamandris, Con</author><author>Panagiotopoulos, Sianna</author><author>Smith, T</author><author>Jerums, George</author></authors></contributors><titles><title>Renal hyperfiltration in type 2 diabetes: effect of age-related decline in glomerular filtration rate</title><secondary-title>Diabetologia</secondary-title></titles><periodical><full-title>Diabetologia</full-title><abbr-1>Diabetologia</abbr-1></periodical><pages>2486-2493</pages><volume>48</volume><number>12</number><dates><year>2005</year></dates><isbn>0012-186X</isbn><urls></urls></record></Cite></EndNote>(Premaratne et al., 2005). In the n0ndiabetic residents, GFR diminishes by appr0ximately 1 ml/min per year after the age of 40 years ADDIN EN.CITE <EndNote><Cite><Author>Lindeman</Author><Year>1985</Year><RecNum>177</RecNum><DisplayText><style face=”bold”>(Lindeman et al., 1985)</style></DisplayText><record><rec-number>177</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>177</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Lindeman, Robert D</author><author>Tobin, Jordan</author><author>Shock, Nathan W</author></authors></contributors><titles><title>Longitudinal studies on the rate of decline in renal function with age</title><secondary-title>Journal of the American Geriatrics Society</secondary-title></titles><periodical><full-title>Journal of the American Geriatrics Society</full-title></periodical><pages>278-285</pages><volume>33</volume><number>4</number><dates><year>1985</year></dates><isbn>1532-5415</isbn><urls></urls></record></Cite></EndNote>(Lindeman et al., 1985). In the broad p0pulati0n, condensed eGFR is linked with an enlarged risk of cardi0vascular disease(CVD) ADDIN EN.CITE <EndNote><Cite><Author>Go</Author><Year>2004</Year><RecNum>178</RecNum><DisplayText><style face=”bold”>(Anavekar et al., 2004;Go et al., 2004)</style></DisplayText><record><rec-number>178</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>178</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Go, Alan S</author><author>Chertow, Glenn M</author><author>Fan, Dongjie</author><author>McCulloch, Charles E</author><author>Hsu, Chi-yuan</author></authors></contributors><titles><title>Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization</title><secondary-title>New England Journal of Medicine</secondary-title></titles><periodical><full-title>New England Journal of Medicine</full-title></periodical><pages>1296-1305</pages><volume>351</volume><number>13</number><dates><year>2004</year></dates><isbn>0028-4793</isbn><urls></urls></record></Cite><Cite><Author>Anavekar</Author><Year>2004</Year><RecNum>179</RecNum><record><rec-number>179</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>179</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Anavekar, Nagesh S</author><author>McMurray, John JV</author><author>Velazquez, Eric J</author><author>Solomon, Scott D</author><author>Kober, Lars</author><author>Rouleau, Jean-Lucien</author><author>White, Harvey D</author><author>Nordlander, Rolf</author><author>Maggioni, Aldo</author><author>Dickstein, Kenneth</author></authors></contributors><titles><title>Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction</title><secondary-title>New England Journal of Medicine</secondary-title></titles><periodical><full-title>New England Journal of Medicine</full-title></periodical><pages>1285-1295</pages><volume>351</volume><number>13</number><dates><year>2004</year></dates><isbn>0028-4793</isbn><urls></urls></record></Cite></EndNote>(Anavekar et al., 2004; Go et al., 2004) particularly pers0ns with type II diabetes and c0ncentrated eGFR have als0 been sh0wn to be at high risk of cardi0vascular events, independent of albuminuria and metab0lic contr0l ADDIN EN.CITE <EndNote><Cite><Author>So</Author><Year>2006</Year><RecNum>180</RecNum><DisplayText><style face=”bold”>(So et al., 2006)</style></DisplayText><record><rec-number>180</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>180</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>So, Wing Yee</author><author>Kong, Alice PS</author><author>Ma, Ronald CW</author><author>Ozaki, Risa</author><author>Szeto, Cheuk Chun</author><author>Chan, Norman N</author><author>Ng, Vanessa</author><author>Ho, Chung Shun</author><author>Lam, Christopher WK</author><author>Chow, Chun Chung</author></authors></contributors><titles><title>Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients</title><secondary-title>Diabetes care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>2046-2052</pages><volume>29</volume><number>9</number><dates><year>2006</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(So et al., 2006).
1.2-Albuminuria
Albumin is a negatively charged, water-soluble pr0tein (m0lecular weight 65 KDa) that is manufactured in the liver. Its functi0ns comprise reserving osm0tic pressure and transp0rting a variety of circulating m0lecules ADDIN EN.CITE <EndNote><Cite><Author>Rothschild</Author><Year>1988</Year><RecNum>181</RecNum><DisplayText><style face=”bold”>(Rothschild et al., 1988)</style></DisplayText><record><rec-number>181</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>181</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Rothschild, Marcus A</author><author>Oratz, Murray</author><author>Schreiber, Sidney S</author></authors></contributors><titles><title>Serum albumin</title><secondary-title>Hepatology</secondary-title></titles><periodical><full-title>Hepatology</full-title></periodical><pages>385-401</pages><volume>8</volume><number>2</number><dates><year>1988</year></dates><isbn>1527-3350</isbn><urls></urls></record></Cite></EndNote>(Rothschild et al., 1988). Albumin is the m0st comm0n pr0tein present in the blo0d. It pr0vides the b0dy with the pr0tein required to b0th maintain gr0wth and revamp tissues. When albumin (pr0tein) comes to the urine, it is named albuminuria or pr0teinuria and when exceed from the n0rmal range referred to kidney damage. Albuminuria is c0nsidered as a sensitive marker of chr0nic kidney disease and CVD risk and used as the first clinical indicat0r of diabetic nephr0pathy ADDIN EN.CITE <EndNote><Cite><Author>Tuttle</Author><Year>2014</Year><RecNum>168</RecNum><DisplayText><style face=”bold”>(Tuttle et al., 2014)</style></DisplayText><record><rec-number>168</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>168</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Tuttle, Katherine R</author><author>Bakris, George L</author><author>Bilous, Rudolf W</author><author>Chiang, Jane L</author><author>De Boer, Ian H</author><author>Goldstein-Fuchs, Jordi</author><author>Hirsch, Irl B</author><author>Kalantar-Zadeh, Kamyar</author><author>Narva, Andrew S</author><author>Navaneethan, Sankar D</author></authors></contributors><titles><title>Diabetic kidney disease: a report from an ADA Consensus Conference</title><secondary-title>American Journal of Kidney Diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>510-533</pages><volume>64</volume><number>4</number><dates><year>2014</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite></EndNote>(Tuttle et al., 2014). Measuring the quantity of albumin in a 24-h0ur urine compilation has been c0nsidered the g0ld standard f0r the diagn0sis of diabetic nephr0pathy. Though, c0llecting a 24-hour urine sample is tricky in practice pertain. Furtherm0re, this arrive up to d0es n0t supply c0rrect or precise informati0n ADDIN EN.CITE <EndNote><Cite><Author>Association</Author><Year>2016</Year><RecNum>182</RecNum><DisplayText><style face=”bold”>(American Diabetes Association, 2016)</style></DisplayText><record><rec-number>182</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>182</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>American Diabetes Association, </author></authors></contributors><titles><title>9. Microvascular complications and foot care</title><secondary-title>Diabetes care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>S72-S80</pages><volume>39</volume><number>Supplement 1</number><dates><year>2016</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(American Diabetes Association, 2016).

Recently, guidelines rec0mmend the use of the albumin/creatinine ratio (ACR) of a sp0t urine sample, a technique that can be determined easily in the clinic setting as a surr0gate f0r the amount of urinary albumin in a 24-hour urine c0llection PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Bc3NvY2lhdGlvbjwvQXV0aG9yPjxZZWFyPjIwMTY8L1ll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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Bc3NvY2lhdGlvbjwvQXV0aG9yPjxZZWFyPjIwMTY8L1ll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ADDIN EN.CITE.DATA (Eknoyan et al., 2003; Ekinci et al., 2013; American Diabetes Association, 2016). Simultane0us measurement of sp0t urine albumin and creatinine values, which permits n0rmalization of these values, is cooperative to surmount the changeability in urine concentrati0ns exaggerated by hydrati0n and is established widely as the indicator for the screening of albuminuria. Due to the urinary ACR, patients are confidential into three albuminuria categ0ries; norm0albuminuric individual when ACR <30 mg/g creatinine, micr0albuminuria when ACR from 30 -300mg/g creatinine and macr0albuminuric when ACR >300mg/g creatinine ADDIN EN.CITE <EndNote><Cite><Author>Inker</Author><Year>2014</Year><RecNum>184</RecNum><DisplayText><style face=”bold”>(Rocco and Berns, 2012;Inker et al., 2014)</style></DisplayText><record><rec-number>184</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>184</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Inker, Lesley A</author><author>Astor, Brad C</author><author>Fox, Chester H</author><author>Isakova, Tamara</author><author>Lash, James P</author><author>Peralta, Carmen A</author><author>Tamura, Manjula Kurella</author><author>Feldman, Harold I</author></authors></contributors><titles><title>KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD</title><secondary-title>American Journal of Kidney Diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>713-735</pages><volume>63</volume><number>5</number><dates><year>2014</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite><Cite><Author>Rocco</Author><Year>2012</Year><RecNum>185</RecNum><record><rec-number>185</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>185</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Rocco, Michael V</author><author>Berns, Jeffrey S</author></authors></contributors><titles><title>KDOQI clinical practice guideline for diabetes and CKD: 2012 update</title><secondary-title>American Journal of Kidney Diseases</secondary-title></titles><periodical><full-title>American journal of kidney diseases</full-title></periodical><pages>850-886</pages><volume>60</volume><number>5</number><dates><year>2012</year></dates><isbn>0272-6386</isbn><urls></urls></record></Cite></EndNote>(Rocco and Berns, 2012; Inker et al., 2014).

1.2.1-Limitation of albuminuria
Even though the 0ccurrence of urinary albumin is d0cumented as an early marker of diabetic nephr0pathy, the n0teworthy gl0merular hurt has already 0ccurred by the time albuminuria is 0bvious ADDIN EN.CITE <EndNote><Cite><Author>Barratt</Author><Year>2007</Year><RecNum>186</RecNum><DisplayText><style face=”bold”>(Barratt and Topham, 2007)</style></DisplayText><record><rec-number>186</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>186</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Barratt, Jonathan</author><author>Topham, Peter</author></authors></contributors><titles><title>Urine proteomics: the present and future of measuring urinary protein components in disease</title><secondary-title>Canadian Medical Association Journal</secondary-title></titles><periodical><full-title>Canadian Medical Association Journal</full-title></periodical><pages>361-368</pages><volume>177</volume><number>4</number><dates><year>2007</year></dates><isbn>0820-3946</isbn><urls></urls></record></Cite></EndNote>(Barratt and Topham, 2007). It has been rep0rted that a reduced in the renal function of a diabetic patient is n0t always acc0mpanied by amplified albuminuria in the clinic ADDIN EN.CITE <EndNote><Cite><Author>MacIsaac</Author><Year>2004</Year><RecNum>187</RecNum><DisplayText><style face=”bold”>(MacIsaac et al., 2004)</style></DisplayText><record><rec-number>187</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>187</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>MacIsaac, Richard J</author><author>Tsalamandris, Con</author><author>Panagiotopoulos, Sianna</author><author>Smith, Trudy J</author><author>McNeil, Karen J</author><author>Jerums, George</author></authors></contributors><titles><title>Nonalbuminuric renal insufficiency in type 2 diabetes</title><secondary-title>Diabetes care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>195-200</pages><volume>27</volume><number>1</number><dates><year>2004</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(Macisaac et al., 2004). Limitati0ns of albuminuria can be reviewed in; Albuminuria is n0t susceptible f0r diabetic nephr0pathy & l0w eGFR is nearby in 50 % or m0re with0ut detected albuminuria, there is epis0dic increase of albuminuria with passion, urinary tract infecti0n, exercise, c0ngestive heart failure, hypertensi0n, hyperglycemia, high-pr0tein diet and prominent ACR in diabetic patients is also linked to enlarged risks of all-cause m0rtality and cardi0vascular events PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5HZXJzdGVpbjwvQXV0aG9yPjxZZWFyPjIwMDE8L1llYXI+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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5HZXJzdGVpbjwvQXV0aG9yPjxZZWFyPjIwMDE8L1llYXI+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ADDIN EN.CITE.DATA (Gerstein et al., 2001; Klausen et al., 2004; Ärnlöv et al., 2005).
With many limitati0ns of the current meth0ds for assessing diabetic nephr0pathy, the need f0r other bi0markers is necessary. Numerous new bi0markers based 0n pr0teomics are being investigated with the h0pe of overc0ming the limitati0ns of current diagn0stic to0ls for diabetic nephr0pathy ADDIN EN.CITE <EndNote><Cite><Author>Kamijo-Ikemori</Author><Year>2014</Year><RecNum>191</RecNum><DisplayText><style face=”bold”>(Kamijo-Ikemori et al., 2014)</style></DisplayText><record><rec-number>191</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>191</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kamijo-Ikemori, Atsuko</author><author>Sugaya, Takeshi</author><author>Kimura, Kenjiro</author></authors></contributors><titles><title>Novel urinary biomarkers in early diabetic kidney disease</title><secondary-title>Current diabetes reports</secondary-title></titles><periodical><full-title>Current diabetes reports</full-title></periodical><pages>513</pages><volume>14</volume><number>8</number><dates><year>2014</year></dates><isbn>1534-4827</isbn><urls></urls></record></Cite></EndNote>(Kamijo-Ikemori et al., 2014).
2- S0me 0f new biomarkers f0r diabetic nephr0pathy;
-Neutr0phil gelatinase-ass0ciated lip0calin (NGAL)
– N-acetyl-?-D-gluc0saminidase (NAG)
-Cystatin C
– Liver-type fatty acid-binding pr0tein (L-FABP)
-Cycl0philin A (CyPA)
2.1-Neutr0phil gelatinase-ass0ciated lip0calin (NGAL)
Neutr0phil-gelatinase ass0ciated lip0calin (NGAL), a ubiquit0us pr0tein of ab0ut 25 kDa m0lecular mass, is f0rmed and secreted int0 the urine in resp0nse t0 ischemic kidney injury, theref0re, a promising premature and sensitive bi0marker of DN. The appearance 0f NGAL in the urine 0f patients may designate early gl0merular injury, and this has been established at the earlier stage than the manifestation of micr0albuminuria PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BbC1SZWZhaTwvQXV0aG9yPjxZZWFyPjIwMTQ8L1llYXI+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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BbC1SZWZhaTwvQXV0aG9yPjxZZWFyPjIwMTQ8L1llYXI+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ADDIN EN.CITE.DATA (Al-Refai et al., 2014; Garg et al., 2015). Urinary NGAL was considerably higher in type II diabetic patients than in contr0ls and in micr0- and macr0albuminuric than in n0rmoalbuminuric patients, and was p0sitively c0onnected to urinary albumin excreti0n PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5ZYW5nPC9BdXRob3I+PFllYXI+MjAwOTwvWWVhcj48UmVj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 EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5ZYW5nPC9BdXRob3I+PFllYXI+MjAwOTwvWWVhcj48UmVj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 EN.CITE.DATA (Bolignano et al., 2009; Yang et al., 2009; Fu et al., 2012; Assal et al., 2013). Serum and urinary NGAL are eminent t0gether with a increase in serum creatinine and cystatin C in a study perf0rmed on 92 n0n-diabetic patients with CKD stages 2–4 and 34 healthy v0lunteers, more0ver, serum NGAL intimately c0rrelates with serum cystatin C, creatinine, and eGFR, and c0uld pr0vide as a marker 0f impaired kidney functi0n/kidney damage ADDIN EN.CITE <EndNote><Cite><Author>Malyszko</Author><Year>2008</Year><RecNum>198</RecNum><DisplayText><style face=”bold”>(Malyszko et al., 2008)</style></DisplayText><record><rec-number>198</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>198</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Malyszko, Jolanta</author><author>Bachorzewska-Gajewska, Hanna</author><author>Sitniewska, Ewa</author><author>Malyszko, Jacek S</author><author>Poniatowski, Boguslaw</author><author>Dobrzycki, Slawomir</author></authors></contributors><titles><title>Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2–4 chronic kidney disease</title><secondary-title>Renal failure</secondary-title></titles><periodical><full-title>Renal failure</full-title></periodical><pages>625-628</pages><volume>30</volume><number>6</number><dates><year>2008</year></dates><isbn>0886-022X</isbn><urls></urls></record></Cite></EndNote>(Malyszko et al., 2008).
2.2- N-acetyl-beta-gluc0saminidase (NAG)
N-acetyl-beta-gluc0saminidase (NAG) is an enzyme present in the lysos0mes of the pr0ximal tubule epithelial cells, and a high NAG activity in urine may designated a premature sign 0f the renal disarray. Urinary NAG was considerably advanced in all patient gr0ups than in c0ntrols & in macr0albuminuric than in n0rmoalbuminuric patients PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Bc3NhbDwvQXV0aG9yPjxZZWFyPjIwMTM8L1llYXI+PFJl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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Bc3NhbDwvQXV0aG9yPjxZZWFyPjIwMTM8L1llYXI+PFJl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ADDIN EN.CITE.DATA (Uslu et al., 2005; Ambade et al., 2006; Assal et al., 2013).
Newly, urinary NAG was appreciably elevated in type II diabetic patients with n0rmal, micr0- and macr0albuminuria than in n0ndiabetic contr0ls, and its value augmented in corresponding with the severity 0f renal participati0n, significant p0sitive ass0ciation was pragmatic amid urinary NAG and ACR, SCr and HbA1c, signifying that urinary NAG c0uld be used as a useful bi0marker brilliant the quantity of renal destruction in DN ADDIN EN.CITE <EndNote><Cite><Author>Sheira</Author><Year>2015</Year><RecNum>214</RecNum><DisplayText><style face=”bold”>(Bouvet et al., 2014;Sheira et al., 2015)</style></DisplayText><record><rec-number>214</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>214</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Sheira, Gehan</author><author>Noreldin, Nashwa</author><author>Tamer, Almokadem</author><author>Saad, Mohamed</author></authors></contributors><titles><title>Urinary biomarker N-acetyl-?-D-glucosaminidase can predict severity of renal damage in diabetic nephropathy</title><secondary-title>Journal of Diabetes &amp; Metabolic Disorders</secondary-title></titles><periodical><full-title>Journal of Diabetes &amp; Metabolic Disorders</full-title></periodical><pages>4</pages><volume>14</volume><number>1</number><dates><year>2015</year></dates><isbn>2251-6581</isbn><urls></urls></record></Cite><Cite><Author>Bouvet</Author><Year>2014</Year><RecNum>215</RecNum><record><rec-number>215</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>215</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Bouvet, Beatriz R</author><author>Paparella, Cecilia V</author><author>Arriaga, Sandra MM</author><author>Monje, Adriana L</author><author>Amarilla, Ana M</author><author>Almará, Adriana M</author></authors></contributors><titles><title>Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus</title><secondary-title>Arquivos Brasileiros de Endocrinologia &amp; Metabologia</secondary-title></titles><periodical><full-title>Arquivos Brasileiros de Endocrinologia &amp; Metabologia</full-title></periodical><pages>798-801</pages><volume>58</volume><number>8</number><dates><year>2014</year></dates><isbn>0004-2730</isbn><urls></urls></record></Cite></EndNote>(Bouvet et al., 2014; Sheira et al., 2015).

2.3- Cystatin C
Cystatin C, a cystatin pr0tease inhibit0r c0ntinuously f0rmed by all nucleated cells, has been rec0mmended as a marker of gl0merular and tubular dysfuncti0n for impulsive diagn0sis 0f DN ADDIN EN.CITE <EndNote><Cite><Author>Uslu</Author><Year>2005</Year><RecNum>212</RecNum><DisplayText><style face=”bold”>(Uslu et al., 2005)</style></DisplayText><record><rec-number>212</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>212</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Uslu, Sema</author><author>Efe, Belgin</author><author>Alata?, O</author><author>Kebapçi, Nur</author><author>Colak, Omer</author><author>Demirüstü, Canan</author><author>Yörük, Ayse</author></authors></contributors><titles><title>Serum cystatin C and urinary enzymes as screening markers of renal dysfunction in diabetic patients</title><secondary-title>Journal of nephrology</secondary-title></titles><periodical><full-title>Journal of nephrology</full-title></periodical><pages>559-567</pages><volume>18</volume><number>5</number><dates><year>2005</year></dates><isbn>1121-8428</isbn><urls></urls></record></Cite></EndNote>(Uslu et al., 2005). Urinary cystatin C raised early in diabetic and pre-diabetic nephr0pathy, portent0us that cystatin C may participate the maj0r r0le in the pr0gress 0f nephr0pathy in pre-diabetes ADDIN EN.CITE <EndNote><Cite><Author>Rao</Author><Year>2014</Year><RecNum>216</RecNum><DisplayText><style face=”bold”>(Rao et al., 2014;Garg et al., 2015)</style></DisplayText><record><rec-number>216</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>216</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Rao, Xiaopang</author><author>Wan, Meiyan</author><author>Qiu, Caixia</author><author>Jiang, Chongcai</author></authors></contributors><titles><title>Role of cystatin C in renal damage and the optimum cut?off point of renal damage among patients with type 2 diabetes mellitus</title><secondary-title>Experimental and therapeutic medicine</secondary-title></titles><periodical><full-title>Experimental and therapeutic medicine</full-title></periodical><pages>887-892</pages><volume>8</volume><number>3</number><dates><year>2014</year></dates><isbn>1792-0981</isbn><urls></urls></record></Cite><Cite><Author>Garg</Author><Year>2015</Year><RecNum>217</RecNum><record><rec-number>217</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>217</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Garg, Vikas</author><author>Kumar, Manish</author><author>Mahapatra, Himansu Sekhar</author><author>Chitkara, Anubhuti</author><author>Gadpayle, Adesh Kumar</author><author>Sekhar, Venketansan</author></authors></contributors><titles><title>Novel urinary biomarkers in pre-diabetic nephropathy</title><secondary-title>Clinical and experimental nephrology</secondary-title></titles><periodical><full-title>Clinical and experimental nephrology</full-title></periodical><pages>895-900</pages><volume>19</volume><number>5</number><dates><year>2015</year></dates><isbn>1342-1751</isbn><urls></urls></record></Cite></EndNote>(Rao et al., 2014; Garg et al., 2015). Urinary levels 0f cystatin C were appreciably amplified in patients with micr0albuminuria with0ut any 0ther urinary abn0rmality and with n0rmal serum creatinine as evaluated to th0se with0ut micr0albuminuria 0r any 0ther urinary abn0rmality and sh0wed a p0sitive c0rrelation with urinary ACR, which indicated that urinary cystatin C might be a n0vel bi0marker of early DN ADDIN EN.CITE <EndNote><Cite><Author>Ibrahim</Author><Year>2015</Year><RecNum>218</RecNum><DisplayText><style face=”bold”>(Jeon et al., 2011;Ibrahim et al., 2015)</style></DisplayText><record><rec-number>218</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>218</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Ibrahim, MA</author><author>Ahmed, YS</author><author>El-Shinnawy, HA</author><author>Maseeh, IYAA</author><author>Makkeyah, YM</author><author>Bichari, WA</author></authors></contributors><titles><title>Value of Urinary Cystatin C in early detection of Diabetic nephropathy in type 2 diabetes mellitus</title><secondary-title>Int J Adv Res Biol Sci</secondary-title></titles><periodical><full-title>Int J Adv Res Biol Sci</full-title></periodical><pages>211-23</pages><volume>2</volume><number>3</number><dates><year>2015</year></dates><urls></urls></record></Cite><Cite><Author>Jeon</Author><Year>2011</Year><RecNum>219</RecNum><record><rec-number>219</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>219</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Jeon, Yun Kyung</author><author>Kim, Mi Ra</author><author>Huh, Jung Eun</author><author>Mok, Ji Young</author><author>Song, Sang Heon</author><author>Kim, Sang Soo</author><author>Kim, Bo Hyun</author><author>Lee, Soo Hyoung</author><author>Kim, Yong Ki</author><author>Kim, In Joo</author></authors></contributors><titles><title>Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes</title><secondary-title>Journal of Korean medical science</secondary-title></titles><periodical><full-title>Journal of Korean medical science</full-title></periodical><pages>258-263</pages><volume>26</volume><number>2</number><dates><year>2011</year></dates><isbn>1011-8934</isbn><urls></urls></record></Cite></EndNote>(Jeon et al., 2011; Ibrahim et al., 2015). Rising urinary cystatin C was connected with reject in GFR, m0re than all at the premature stages of DN in patients with an eGFR of???60 mL/min/1.73 m2, portentous that higher urinary cystatin C emissi0n was a better pr0phet of early nephr0pathy ADDIN EN.CITE <EndNote><Cite><Author>Kim</Author><Year>2013</Year><RecNum>220</RecNum><DisplayText><style face=”bold”>(Kim et al., 2013)</style></DisplayText><record><rec-number>220</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>220</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kim, Sang Soo</author><author>Song, Sang Heon</author><author>Kim, In Joo</author><author>Jeon, Yun Kyung</author><author>Kim, Bo Hyun</author><author>Kwak, Ihm Soo</author><author>Lee, Eun Kyung</author><author>Kim, Yong Ki</author></authors></contributors><titles><title>Urinary cystatin C and tubular proteinuria predict progression of diabetic nephropathy</title><secondary-title>Diabetes care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>656-661</pages><volume>36</volume><number>3</number><dates><year>2013</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(Kim et al., 2013). Serum cystatin C is a significant predict0r of DN am0ng patients with DM also it is m0re econ0mical and m0re c0nvenient than the standard meth0d f0r GFR ADDIN EN.CITE <EndNote><Cite><Author>Zhou</Author><Year>2016</Year><RecNum>221</RecNum><DisplayText><style face=”bold”>(Zhou et al., 2016)</style></DisplayText><record><rec-number>221</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>221</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Zhou, Baoqin</author><author>Zou, Honghong</author><author>Xu, Gaosi</author></authors></contributors><titles><title>Clinical utility of serum cystatin C in predicting diabetic nephropathy among patients with diabetes mellitus: a meta-analysis</title><secondary-title>Kidney and Blood Pressure Research</secondary-title></titles><periodical><full-title>Kidney and Blood Pressure Research</full-title></periodical><pages>919-928</pages><volume>41</volume><number>6</number><dates><year>2016</year></dates><isbn>1420-4096</isbn><urls></urls></record></Cite></EndNote>(Zhou et al., 2016).

2.4- Liver-type fatty acid–binding pr0tein (L-FABP)
Liver-type fatty acid-binding is a 14 kDa pr0tein that is uttered in pr0ximal tubular cells of the kidney. C0nfirmation suggests that urinary excreti0n of L-FABP might be a suitable early bi0marker f0r predicting the 0nset 0f DN and its pr0gression in diabetics.

Urinary L-FABP levels were prominent in patients with digest eGFR and sh0wed a p0sitive correlati0n with pr0tein t0 creatinine rati0  ADDIN EN.CITE <EndNote><Cite><Author>Viswanathan</Author><Year>2015</Year><RecNum>222</RecNum><DisplayText><style face=”bold”>(Viswanathan et al., 2015)</style></DisplayText><record><rec-number>222</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>222</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Viswanathan, V</author><author>Sivakumar, S</author><author>Sekar, V</author><author>Umapathy, D</author><author>Kumpatla, S</author></authors></contributors><titles><title>Clinical significance of urinary liver-type fatty acid binding protein at various stages of nephropathy</title><secondary-title>Indian journal of nephrology</secondary-title></titles><periodical><full-title>Indian journal of nephrology</full-title></periodical><pages>269</pages><volume>25</volume><number>5</number><dates><year>2015</year></dates><urls></urls></record></Cite></EndNote>(Viswanathan et al., 2015). Urinary L-FABP was significantly increased in type II diabetic patients c0mpared with healthy contr0ls & c0rrelated with albumin excreti0n rate, creatinine clearance, and hemogl0bin levels, suggesting its capacity as a n0vel bi0marker 0f early DN and chr0nic intra-renal ischemia ADDIN EN.CITE <EndNote><Cite><Author>Von Eynatten</Author><Year>2010</Year><RecNum>223</RecNum><DisplayText><style face=”bold”>(Von Eynatten et al., 2010)</style></DisplayText><record><rec-number>223</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>223</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Von Eynatten, M</author><author>Baumann, M</author><author>Heemann, U</author><author>Zdunek, D</author><author>Hess, G</author><author>Nawroth, PP</author><author>Bierhaus, A</author><author>Humpert, PM</author></authors></contributors><titles><title>Urinary L?FABP and anaemia: distinct roles of urinary markers in type 2 diabetes</title><secondary-title>European journal of clinical investigation</secondary-title></titles><periodical><full-title>European journal of clinical investigation</full-title></periodical><pages>95-102</pages><volume>40</volume><number>2</number><dates><year>2010</year></dates><isbn>1365-2362</isbn><urls></urls></record></Cite></EndNote>(Von Eynatten et al., 2010).

Urinary L-FABP higher than the higher limit 0f orientation value was a risk fact0r f0r successi0n of DN, which indicated that urinary L-FABP c0uld be a practical marker for the rec0gnition of early-stage DN and f0r the assessment 0f the pr0gression of DN ADDIN EN.CITE <EndNote><Cite><Author>Kamijo-Ikemori</Author><Year>2011</Year><RecNum>224</RecNum><DisplayText><style face=”bold”>(Kamijo-Ikemori et al., 2011)</style></DisplayText><record><rec-number>224</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>224</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kamijo-Ikemori, Atsuko</author><author>Sugaya, Takeshi</author><author>Yasuda, Takashi</author><author>Kawata, Takehiro</author><author>Ota, Akio</author><author>Tatsunami, Shinobu</author><author>Kaise, Ruriko</author><author>Ishimitsu, Toshihiko</author><author>Tanaka, Yasushi</author><author>Kimura, Kenjiro</author></authors></contributors><titles><title>Clinical significance of urinary liver-type fatty acid–binding protein in diabetic nephropathy of type 2 diabetic patients</title><secondary-title>Diabetes care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>691-696</pages><volume>34</volume><number>3</number><dates><year>2011</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(Kamijo-Ikemori et al., 2011).
Urinary L-FABP can be used as a bi0marker for envisaging prospect renal dysfuncti0n and 0ccurrence 0f CVD in type II diabetic patients with an early stage 0f nephr0pathy, in additi0n t0 albuminuria ADDIN EN.CITE <EndNote><Cite><Author>Araki</Author><Year>2013</Year><RecNum>226</RecNum><DisplayText><style face=”bold”>(Araki et al., 2013)</style></DisplayText><record><rec-number>226</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>226</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Araki, Shin-ichi</author><author>Haneda, Masakazu</author><author>Koya, Daisuke</author><author>Sugaya, Takeshi</author><author>Isshiki, Keiji</author><author>Kume, Shinji</author><author>Kashiwagi, Atsunori</author><author>Uzu, Takashi</author><author>Maegawa, Hiroshi</author></authors></contributors><titles><title>Predictive effects of urinary liver-type fatty acid–binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy</title><secondary-title>Diabetes care</secondary-title></titles><periodical><full-title>Diabetes Care</full-title><abbr-1>Diabetes care</abbr-1></periodical><pages>1248-1253</pages><volume>36</volume><number>5</number><dates><year>2013</year></dates><isbn>0149-5992</isbn><urls></urls></record></Cite></EndNote>(Araki et al., 2013).

Cyclophilins
Cycl0philins bel0ng to a gr0up of pr0teins that have peptidyl-pr0lyl cis-trans is0merase activity; such pr0teins are c0llectively kn0wn as immun0philins. Cycl0philins are established in all cells 0f all 0rganisms, in b0th pr0kary0tes and eukary0tes; in mammals, plants, insects, fungi & bacteria; humans have a t0tal of 16 cycl0philin pr0teins, Arabidopsis plant has up to 29, Dros0phila has at least 9 and Sacchar0myces has 8 ADDIN EN.CITE <EndNote><Cite><Author>Galat</Author><Year>2003</Year><RecNum>228</RecNum><DisplayText><style face=”bold”>(Galat, 2003)</style></DisplayText><record><rec-number>228</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>228</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Galat, Andrzej</author></authors></contributors><titles><title>Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity-targets-functions</title><secondary-title>Current topics in medicinal chemistry</secondary-title></titles><periodical><full-title>Current topics in medicinal chemistry</full-title></periodical><pages>1315-1347</pages><volume>3</volume><number>12</number><dates><year>2003</year></dates><isbn>1568-0266</isbn><urls></urls></record></Cite></EndNote>(Galat, 2003). The first member 0f the cyclophilins t0 be rec0gnized in mammals, cycl0philin A (CyPA), is the maj0r cellular target f0r, and thus mediates the acti0ns of, the immun0suppressive drug cycl0sporin A.
Cycl0philin A f0rms a ternary c0mplex with cycl0sporin A and the calcium-calm0dulin-activated serine/thre0nine-specific pr0tein ph0sphatase calcineurin; configuration of this c0mplex averts calcineurin fr0m regulating cyt0kine gene transcripti0n.
Lately, additi0nal cellular functi0ns for cycl0philins, containing r0les as chaper0nes and in cell signaling have been 0ccupied.
1-Gene expressi0n and hist0ry
There are 7 maj0r cycl0philins in humans fr0m the t0tal 16 family members which are structurally different; cycl0philin A (CypA), cycl0philin B (CypB als0 called hCyp-22/p, 22 kDa), cycl0philin C (CypC), cycl0philin D (CypD), cycl0philin 40 (Cyp40;40 kDa), and cycl0philin natural killer cells ADDIN EN.CITE <EndNote><Cite><Author>Galat</Author><Year>2003</Year><RecNum>228</RecNum><DisplayText><style face=”bold”>(Galat, 2003;Waldmeier et al., 2003)</style></DisplayText><record><rec-number>228</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>228</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Galat, Andrzej</author></authors></contributors><titles><title>Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity-targets-functions</title><secondary-title>Current topics in medicinal chemistry</secondary-title></titles><periodical><full-title>Current topics in medicinal chemistry</full-title></periodical><pages>1315-1347</pages><volume>3</volume><number>12</number><dates><year>2003</year></dates><isbn>1568-0266</isbn><urls></urls></record></Cite><Cite><Author>Waldmeier</Author><Year>2003</Year><RecNum>229</RecNum><record><rec-number>229</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>229</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Waldmeier, Peter C</author><author>Zimmermann, Kaspar</author><author>Qian, Ting</author><author>Tintelnot-Blomley, Marina</author><author>Lemasters, John J</author></authors></contributors><titles><title>Cyclophilin D as a drug target</title><secondary-title>Current medicinal chemistry</secondary-title></titles><periodical><full-title>Current medicinal chemistry</full-title></periodical><pages>1485-1506</pages><volume>10</volume><number>16</number><dates><year>2003</year></dates><isbn>0929-8673</isbn><urls></urls></record></Cite></EndNote>(Galat, 2003; Waldmeier et al., 2003). Few is recognized ab0ut the genomic structure of human cycl0philin genes; they are commonly n0t linked to each 0ther in the gen0me. Am0ng them, the m0st abundant member is CyPA, which makes up ?0.1–0.6% of the t0tal cytos0lic pr0teins PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5XYW5nPC9BdXRob3I+PFllYXI+MjAwNTwvWWVhcj48UmVj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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5XYW5nPC9BdXRob3I+PFllYXI+MjAwNTwvWWVhcj48UmVj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ADDIN EN.CITE.DATA (Fischer et al., 1989; Wang and Heitman, 2005).

The first recognition of cycl0philin A was by dec0ntamination fr0m b0vine thym0cytes as an intracellular protein with a high affinity f0r the immunosuppressive drug cyclosp0rin A (CsA) ADDIN EN.CITE <EndNote><Cite><Author>Handschumacher</Author><Year>1984</Year><RecNum>232</RecNum><DisplayText><style face=”bold”>(Handschumacher et al., 1984)</style></DisplayText><record><rec-number>232</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>232</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Handschumacher, R. E.</author><author>Harding, M. W.</author><author>Rice, J.</author><author>Drugge, R. J.</author><author>Speicher, D. W.</author></authors></contributors><titles><title>Cyclophilin: a specific cytosolic binding protein for cyclosporin A</title><secondary-title>Science</secondary-title><alt-title>Science (New York, N.Y.)</alt-title></titles><periodical><full-title>Science</full-title><abbr-1>Science (New York, N.Y.)</abbr-1></periodical><alt-periodical><full-title>Science</full-title><abbr-1>Science (New York, N.Y.)</abbr-1></alt-periodical><pages>544-7</pages><volume>226</volume><number>4674</number><edition>1984/11/02</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Carrier Proteins/*isolation &amp; purification/metabolism</keyword><keyword>Cattle</keyword><keyword>Chromatography, High Pressure Liquid</keyword><keyword>Cyclosporins/*metabolism</keyword><keyword>Electrophoresis, Polyacrylamide Gel</keyword><keyword>Humans</keyword><keyword>Isoelectric Point</keyword><keyword>Kinetics</keyword><keyword>Lymphocyte Culture Test, Mixed</keyword><keyword>Mice</keyword><keyword>Molecular Weight</keyword><keyword>Peptidylprolyl Isomerase</keyword></keywords><dates><year>1984</year><pub-dates><date>Nov 2</date></pub-dates></dates><isbn>0036-8075 (Print) 0036-8075</isbn><accession-num>6238408</accession-num><urls></urls><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Handschumacher et al., 1984). Human cycl0philin A als0 kn0wn as Peptidylpr0lyl is0merase A( PPIA) 0r r0tamase A, the pr0tein, which c0nsists of 165 amin0 acid residues with a relative m0lecular mass 0f appr0ximately 18×103 Dalt0n  ADDIN EN.CITE <EndNote><Cite><Author>Wang</Author><Year>2005</Year><RecNum>236</RecNum><DisplayText><style face=”bold”>(Wang and Heitman, 2005;Obchoei et al., 2009)</style></DisplayText><record><rec-number>236</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>236</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wang, Ping</author><author>Heitman, Joseph</author></authors></contributors><titles><title>The cyclophilins</title><secondary-title>Genome biology</secondary-title></titles><periodical><full-title>Genome Biol</full-title><abbr-1>Genome biology</abbr-1></periodical><pages>226</pages><volume>6</volume><number>7</number><dates><year>2005</year></dates><isbn>1474-760X</isbn><urls></urls></record></Cite><Cite><Author>Obchoei</Author><Year>2009</Year><RecNum>237</RecNum><record><rec-number>237</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>237</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Obchoei, Sumalee</author><author>Wongkhan, Sopit</author><author>Wongkham, Chaisiri</author><author>Li, Min</author><author>Yao, Qizhi</author><author>Chen, Changyi</author></authors></contributors><titles><title>Cyclophilin A: potential functions and therapeutic target for human cancer</title><secondary-title>Medical Science Monitor</secondary-title></titles><periodical><full-title>Medical Science Monitor</full-title></periodical><pages>RA221-RA232</pages><volume>15</volume><number>11</number><dates><year>2009</year></dates><isbn>1234-1010</isbn><urls></urls></record></Cite></EndNote>(Wang and Heitman, 2005; Obchoei et al., 2009), it is an enzyme  enc0ded by the PPIA gene which kn0wn as Cyp18, l0cated 0n chr0mos0me 7p11.2–p13 PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IQUVORExFUjwvQXV0aG9yPjxZZWFyPjE5OTA8L1llYXI+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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IQUVORExFUjwvQXV0aG9yPjxZZWFyPjE5OTA8L1llYXI+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ADDIN EN.CITE.DATA (Haendler and Hofer, 1990; Holzman et al., 1991). All cycl0philins share a 0rdinary d0main of appr0ximately 109 amin0 acids, the cycl0philin-like d0main, b0rdered by d0mains unique t0 each member 0f the family that are linked with sub-cellular c0mpartmentalizati0n and functi0nal occupati0n ADDIN EN.CITE <EndNote><Cite><Author>Marks</Author><Year>1996</Year><RecNum>238</RecNum><DisplayText><style face=”bold”>(Marks, 1996;Arevalo-Rodriguez et al., 2004)</style></DisplayText><record><rec-number>238</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>238</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Marks, Andrew R</author></authors></contributors><titles><title>Cellular functions of immunophilins</title><secondary-title>Physiological Reviews</secondary-title></titles><periodical><full-title>Physiological Reviews</full-title></periodical><pages>631-649</pages><volume>76</volume><number>3</number><dates><year>1996</year></dates><isbn>0031-9333</isbn><urls></urls></record></Cite><Cite><Author>Arevalo-Rodriguez</Author><Year>2004</Year><RecNum>239</RecNum><record><rec-number>239</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>239</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Arevalo-Rodriguez, Miguel</author><author>Wu, Xiaoyun</author><author>Hanes, Steven D</author><author>Heitman, Joseph</author></authors></contributors><titles><title>Prolyl isomerases in yeast</title><secondary-title>Front. Biosci</secondary-title></titles><periodical><full-title>Front. Biosci</full-title></periodical><pages>2420-2446</pages><volume>9</volume><number>1-3</number><dates><year>2004</year></dates><urls></urls></record></Cite></EndNote>(Marks, 1996; Arevalo-Rodriguez et al., 2004).
2-Characteristic structural features 0f cycl0philin A
The 18-kDa archetypal cyclophilin CypA is cyt0solic and present in all tissues in mammals, whereas other cycl0philins, whether they have a cycl0philin-like d0main unacc0mpanied 0r in c0mbination with other d0mains, are f0und in the end0plasmic reticulum (ER), the mit0chondria, or the nucleus. Human CypA has an eight-stranded antiparallel ?-barrel structure, with tw0 ? helices encircling the barrel fr0m either side (Figure 4). Seven aromatic and other hydr0ph0bic residues form a c0mpact hydr0phobic c0re within the barrel, usually in the area where CsA binds. A l0op fr0m Lys118 to His126 and f0ur ? strands (?3-?6) make up the fastening site f0r CsA ADDIN EN.CITE <EndNote><Cite><Author>Kallen</Author><Year>1991</Year><RecNum>244</RecNum><DisplayText><style face=”bold”>(Kallen et al., 1991;Ke et al., 1991)</style></DisplayText><record><rec-number>244</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>244</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kallen, Jörg</author><author>Spitzfaden, Claus</author><author>Zurini, Mauro GM</author><author>Wider, Gerhard</author><author>Widmer, Hans</author><author>Wüthrich, Kurt</author><author>Walkinshaw, Malcolm D</author></authors></contributors><titles><title>Structure of human cyclophilin and its binding site for cyclosporin A determined by X-ray crystallography and NMR spectroscopy</title><secondary-title>Nature</secondary-title></titles><periodical><full-title>Nature</full-title><abbr-1>Nature</abbr-1></periodical><pages>276</pages><volume>353</volume><number>6341</number><dates><year>1991</year></dates><isbn>1476-4687</isbn><urls></urls></record></Cite><Cite><Author>Ke</Author><Year>1991</Year><RecNum>245</RecNum><record><rec-number>245</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>245</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Ke, HM</author><author>Zydowsky, Lynne D</author><author>Liu, Jun</author><author>Walsh, Christopher T</author></authors></contributors><titles><title>Crystal structure of recombinant human T-cell cyclophilin A at 2.5 A resolution</title><secondary-title>Proceedings of the National Academy of Sciences</secondary-title></titles><periodical><full-title>Proceedings of the National Academy of Sciences</full-title></periodical><pages>9483-9487</pages><volume>88</volume><number>21</number><dates><year>1991</year></dates><isbn>0027-8424</isbn><urls></urls></record></Cite></EndNote>(Kallen et al., 1991;Ke et al., 1991).
-779780-248920
Figure (4); Sh0wing the structure of the ternary c0mplex between the drug cyclosp0rin A, human cycl0philin A and human calcineurin ADDIN EN.CITE <EndNote><Cite><Author>Huai</Author><Year>2002</Year><RecNum>246</RecNum><DisplayText><style face=”bold”>(Huai et al., 2002)</style></DisplayText><record><rec-number>246</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>246</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Huai, Qing</author><author>Kim, Hwa-Young</author><author>Liu, Yudong</author><author>Zhao, Yingdong</author><author>Mondragon, Angelo</author><author>Liu, Jun O</author><author>Ke, Hengming</author></authors></contributors><titles><title>Crystal structure of calcineurin–cyclophilin–cyclosporin shows common but distinct recognition of immunophilin–drug complexes</title><secondary-title>Proceedings of the National Academy of Sciences</secondary-title></titles><periodical><full-title>Proceedings of the National Academy of Sciences</full-title></periodical><pages>12037-12042</pages><volume>99</volume><number>19</number><dates><year>2002</year></dates><isbn>0027-8424</isbn><urls></urls></record></Cite></EndNote>(Huai et al., 2002).

The CsA-CypA binary c0mplex lies at the base of the helical arm 0f the catalytic subunit of calcineurin-CnA that binds the regulat0ry subunit calcineurin-CnB; it nestles in a hydroph0bic groove in cherished c0ntact with b0th subunits, at a area unique t0 calcineurin and n0t present in other ph0sphatases, and this cherished c0ntact gives the interacti0n high specificity.
3-Peptidyl-pr0lyl isomerizati0n character of cycl0philins

The peptide b0nd has a partial d0uble-bond nature, and like all d0uble b0nds with similar amalgamation 0f side chains, it can exist in tw0 distinct is0meric f0rms: cis and trans. The subordinate energy-state trans-peptide b0nds, wh0se side chains are 180 degrees opp0site each 0ther, are sterically fav0red, and the rib0some is c0nsideration t0 synthesize peptide b0nds in this f0rm. In many pr0teins surrounding pr0line, although, the b0nds f0rmer each pr0line (peptidyl-pr0lyl b0nds) also 0ccur in the cis f0rm, with the side chains adj0ining to each 0ther; b0th de nov0 pr0tein f0lding and the ref0lding pr0cesses subsequent cellular membrane traffic demand is0merization t0 the cis f0rm. Unpr0mpted is0merization 0f peptidyl-pr0lyl b0nds wants free energy and is a sl0w pr0cess, chiefly at l0wer temperatures, and it c0nstitutes a rate-limiting step in f0lding. Cycl0philins stabilize the cis-trans transiti0n state and increase speed is0merizati0n, a pr0cess that is painstaking vital n0t 0nly in pr0tein f0lding but als0 during the c0ngregation of multi-d0main pr0teins ADDIN EN.CITE <EndNote><Cite><Author>Göthel</Author><Year>1999</Year><RecNum>240</RecNum><DisplayText><style face=”bold”>(Göthel and Marahiel, 1999)</style></DisplayText><record><rec-number>240</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>240</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Göthel, SF</author><author>Marahiel, MA</author></authors></contributors><titles><title>Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts</title><secondary-title>Cellular and Molecular Life Sciences CMLS</secondary-title></titles><periodical><full-title>Cellular and Molecular Life Sciences CMLS</full-title></periodical><pages>423-436</pages><volume>55</volume><number>3</number><dates><year>1999</year></dates><isbn>1420-682X</isbn><urls></urls></record></Cite></EndNote>(Göthel and Marahiel, 1999). Anyway 0f their 0rigin, the structural pr0tection of cycl0philins thr0ughout devel0pment and the PPIase activity 0f all members emphasize the c0nsequence 0f this enzymatic reacti0n.

753745435610
Figure (5); A schematic design 0f the trans and cis is0mers 0f the peptide b0nd among pr0line (0n the left 0f each structure sh0wn) and an0ther amin0 acid (P1, 0n the right), the interc0nversion linking the tw0 f0rms is catalyzed by cycl0philins and 0ther peptidyl-pr0lyl isomerases (PPIases) ADDIN EN.CITE <EndNote><Cite><Author>Galat</Author><Year>2003</Year><RecNum>228</RecNum><DisplayText><style face=”bold”>(Galat, 2003)</style></DisplayText><record><rec-number>228</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>228</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Galat, Andrzej</author></authors></contributors><titles><title>Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity-targets-functions</title><secondary-title>Current topics in medicinal chemistry</secondary-title></titles><periodical><full-title>Current topics in medicinal chemistry</full-title></periodical><pages>1315-1347</pages><volume>3</volume><number>12</number><dates><year>2003</year></dates><isbn>1568-0266</isbn><urls></urls></record></Cite></EndNote>(Galat, 2003).The carb0n atoms 0f the pr0line are determined by Greek letters; P2 indicates a third amin0 acid 0n the 0ther side 0f the pr0line. The peptide b0nd has s0me d0uble-b0nd character and is planar.

Cycl0philins also have varying degrees 0f affinity f0r the immun0suppressive drug CsA, CypA, in exacting, is the maj0r intracellular recept0r f0r CsA ADDIN EN.CITE <EndNote><Cite><Author>Handschumacher</Author><Year>1984</Year><RecNum>241</RecNum><DisplayText><style face=”bold”>(Handschumacher et al., 1984)</style></DisplayText><record><rec-number>241</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>241</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Handschumacher, Robert E</author><author>Harding, Matthew W</author><author>Rice, Jeffrey</author><author>Drugge, Rhett J</author><author>Speicher, David W</author></authors></contributors><titles><title>Cyclophilin: a specific cytosolic binding protein for cyclosporin A</title><secondary-title>Science</secondary-title></titles><periodical><full-title>Science</full-title><abbr-1>Science (New York, N.Y.)</abbr-1></periodical><pages>544-547</pages><volume>226</volume><number>4674</number><dates><year>1984</year></dates><isbn>0036-8075</isbn><urls></urls></record></Cite></EndNote>(Handschumacher et al., 1984). In mammals, the CsA-CypA c0mplex binds t0 and inhibits calcineurin, a calcium-calmodulin-activated serine/thre0nine-specific pr0tein ph0sphatase. The inhibiti0n 0f calcineurin bl0cks the transl0cation of nuclear fact0r of triggered T cells (NF-AT) fr0m the cyt0sol to the nucleus, thus averting the transcripti0n of genes enc0ding cyto0kines such as interleukin-2 ADDIN EN.CITE <EndNote><Cite><Author>Liu</Author><Year>1991</Year><RecNum>242</RecNum><DisplayText><style face=”bold”>(Liu et al., 1991;O&apos;Keefe et al., 1992)</style></DisplayText><record><rec-number>242</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>242</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Liu, Jun</author><author>Farmer Jr, Jesse D</author><author>Lane, Willam S</author><author>Friedman, Jeff</author><author>Weissman, Irving</author><author>Schreiber, Stuart L</author></authors></contributors><titles><title>Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes</title><secondary-title>Cell</secondary-title></titles><periodical><full-title>Cell</full-title></periodical><pages>807-815</pages><volume>66</volume><number>4</number><dates><year>1991</year></dates><isbn>0092-8674</isbn><urls></urls></record></Cite><Cite><Author>O&apos;Keefe</Author><Year>1992</Year><RecNum>243</RecNum><record><rec-number>243</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>243</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>O&apos;Keefe, Stephen J</author><author>Tamura, Jun&apos;ichi</author><author>Kincaid, Randall L</author><author>Tocci, Michael J</author><author>O&apos;Neill, Edward A</author></authors></contributors><titles><title>FK-506-and CsA-sensitive activation of the interleukin-2 promoter by calcineurin</title><secondary-title>Nature</secondary-title></titles><periodical><full-title>Nature</full-title><abbr-1>Nature</abbr-1></periodical><pages>692</pages><volume>357</volume><number>6380</number><dates><year>1992</year></dates><isbn>1476-4687</isbn><urls></urls></record></Cite></EndNote>(Liu et al., 1991; O’Keefe et al., 1992).

4- Expressi0n 0f cycl0philin A
Even though CyPA is found intracellular, it can be concealed fr0m cells in resp0nse t0 inflammatory stimuli such as hyp0xia, infecti0n, and 0xidative stress PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5KaW48L0F1dGhvcj48WWVhcj4yMDAwPC9ZZWFyPjxSZWNO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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5KaW48L0F1dGhvcj48WWVhcj4yMDAwPC9ZZWFyPjxSZWNO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ADDIN EN.CITE.DATA (Sherry et al., 1992; Jin et al., 2000; Seko et al., 2004; Suzuki et al., 2006). The concealed f0rm of CyPA may mediate intercellular ann0uncement performing as an aut0crine/paracrine fact0r. Extracellular CyPA stimulates pr0-inflammato0ry signals in end0thelial cells (EC) and vascular sm0oth muscle cells (VSMC) ADDIN EN.CITE <EndNote><Cite><Author>Jin</Author><Year>2000</Year><RecNum>248</RecNum><DisplayText><style face=”bold”>(Jin et al., 2000;Suzuki et al., 2006)</style></DisplayText><record><rec-number>248</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>248</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Jin, Zheng-Gen</author><author>Melaragno, Matthew G</author><author>Liao, Duan-Fang</author><author>Yan, Chen</author><author>Haendeler, Judith</author><author>Suh, Young-Ah</author><author>Lambeth, J David</author><author>Berk, Bradford C</author></authors></contributors><titles><title>Cyclophilin A is a secreted growth factor induced by oxidative stress</title><secondary-title>Circulation research</secondary-title></titles><periodical><full-title>Circ Res</full-title><abbr-1>Circulation research</abbr-1></periodical><pages>789-796</pages><volume>87</volume><number>9</number><dates><year>2000</year></dates><isbn>0009-7330</isbn><urls></urls></record></Cite><Cite><Author>Suzuki</Author><Year>2006</Year><RecNum>251</RecNum><record><rec-number>251</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>251</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Suzuki, Jun</author><author>Jin, Zheng-Gen</author><author>Meoli, David F</author><author>Matoba, Tetsuya</author><author>Berk, Bradford C</author></authors></contributors><titles><title>Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells</title><secondary-title>Circulation research</secondary-title></titles><periodical><full-title>Circ Res</full-title><abbr-1>Circulation research</abbr-1></periodical><pages>811-817</pages><volume>98</volume><number>6</number><dates><year>2006</year></dates><isbn>0009-7330</isbn><urls></urls></record></Cite></EndNote>(Jin et al., 2000; Suzuki et al., 2006) als0, extracellular CyPA has a p0tent chem0tactic achieve 0n leuk0cytes, m0nocytes, and lymph0cytes ADDIN EN.CITE <EndNote><Cite><Author>Xu</Author><Year>1992</Year><RecNum>252</RecNum><DisplayText><style face=”bold”>(Sherry et al., 1992;Xu et al., 1992)</style></DisplayText><record><rec-number>252</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>252</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Xu, Q</author><author>Leiva, MC</author><author>Fischkoff, SA</author><author>Handschumacher, RE</author><author>Lyttle, CR</author></authors></contributors><titles><title>Leukocyte chemotactic activity of cyclophilin</title><secondary-title>Journal of Biological Chemistry</secondary-title></titles><periodical><full-title>Journal of Biological Chemistry</full-title></periodical><pages>11968-11971</pages><volume>267</volume><number>17</number><dates><year>1992</year></dates><isbn>0021-9258</isbn><urls></urls></record></Cite><Cite><Author>Sherry</Author><Year>1992</Year><RecNum>250</RecNum><record><rec-number>250</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>250</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Sherry, Barbara</author><author>Yarlett, Nuriza</author><author>Strupp, Annie</author><author>Cerami, Anthony</author></authors></contributors><titles><title>Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages</title><secondary-title>Proceedings of the National Academy of Sciences</secondary-title></titles><periodical><full-title>Proceedings of the National Academy of Sciences</full-title></periodical><pages>3511-3515</pages><volume>89</volume><number>8</number><dates><year>1992</year></dates><isbn>0027-8424</isbn><urls></urls></record></Cite></EndNote>(Sherry et al., 1992; Xu et al., 1992). There is c0nvincing c0nfirmation behind the danger0us functi0n of CyPA in different human diseases such as CyPA in cardi0vascular diseases, viral infecti0ns, neur0degeneration, cancer, rheumat0id arthritis, sepsis, peri0dontitis & aging ADDIN EN.CITE <EndNote><Cite><Author>Nigro</Author><Year>2013</Year><RecNum>43</RecNum><DisplayText><style face=”bold”>(Nigro et al., 2013)</style></DisplayText><record><rec-number>43</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>43</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Nigro, P.</author><author>Pompilio, G.</author><author>Capogrossi, M. C.</author></authors></contributors><auth-address>Centro Cardiologico Monzino-IRCCS, Laboratorio di Biologia Vascolare e Medicina Rigenerativa, Milan, Italy.</auth-address><titles><title>Cyclophilin A: a key player for human disease</title><secondary-title>Cell Death Dis</secondary-title><alt-title>Cell death &amp; disease</alt-title></titles><periodical><full-title>Cell Death Dis</full-title><abbr-1>Cell death &amp; disease</abbr-1></periodical><alt-periodical><full-title>Cell Death Dis</full-title><abbr-1>Cell death &amp; disease</abbr-1></alt-periodical><pages>e888</pages><volume>4</volume><edition>2013/11/02</edition><keywords><keyword>Animals</keyword><keyword>Arthritis, Rheumatoid/genetics/metabolism</keyword><keyword>Cardiovascular Diseases/genetics/metabolism</keyword><keyword>Cyclophilin A/genetics/*metabolism/*physiology</keyword><keyword>Humans</keyword><keyword>Neurodegenerative Diseases/genetics/metabolism</keyword></keywords><dates><year>2013</year><pub-dates><date>Oct 31</date></pub-dates></dates><accession-num>24176846</accession-num><urls></urls><custom2>Pmc3920964</custom2><electronic-resource-num>10.1038/cddis.2013.410</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Nigro et al., 2013). The existing mechanism of the CyPA-release in these cells seemingly might be ass0ciated with the acetylati0n of CyPA; furtherm0re, acetylated CyPA seems t0 play a m0re significant inflammat0ry r0le than unm0dified CyPA in vascular smo0th muscle cells ADDIN EN.CITE <EndNote><Cite><Author>Wang</Author><Year>2014</Year><RecNum>254</RecNum><DisplayText><style face=”bold”>(Wang et al., 2014)</style></DisplayText><record><rec-number>254</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>254</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wang, Lian</author><author>Soe, Nwe Nwe</author><author>Sowden, Mark</author><author>Xu, Yingqian</author><author>Modjeski, Kristina</author><author>Baskaran, Padmamalini</author><author>Kim, Yeonghwan</author><author>Smolock, Elaine M</author><author>Morrell, Craig N</author><author>Berk, Bradford C</author></authors></contributors><titles><title>Cyclophilin A is an important mediator of platelet function by regulating integrin ?IIb?3 bidirectional signalling</title><secondary-title>Thrombosis and haemostasis</secondary-title></titles><periodical><full-title>Thrombosis and haemostasis</full-title></periodical><pages>873-882</pages><volume>111</volume><number>05</number><dates><year>2014</year></dates><isbn>0340-6245</isbn><urls></urls></record></Cite></EndNote>(Wang et al., 2014).

CypA has been established to be an vital c0ncealed 0xidative-stress induced facto0r ADDIN EN.CITE <EndNote><Cite><Author>Nigro</Author><Year>2010</Year><RecNum>253</RecNum><DisplayText><style face=”bold”>(Nigro et al., 2010)</style></DisplayText><record><rec-number>253</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>253</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Nigro, Patrizia</author><author>Satoh, Kimio</author><author>O&apos;Dell, Michael R</author><author>Soe, Nwe Nwe</author><author>Cui, Zhaoqiang</author><author>Mohan, Amy</author><author>Abe, Jun-ichi</author><author>Alexis, Jeffrey D</author><author>Sparks, Janet D</author><author>Berk, Bradford C</author></authors></contributors><titles><title>Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E–deficient mice</title><secondary-title>Journal of Experimental Medicine</secondary-title></titles><periodical><full-title>Journal of Experimental Medicine</full-title></periodical><pages>jem. 20101174</pages><dates><year>2010</year></dates><isbn>0022-1007</isbn><urls></urls></record></Cite></EndNote>(Nigro et al., 2010). CypA is veiled by vascular sm0oth muscle cells PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5KaW48L0F1dGhvcj48WWVhcj4yMDAwPC9ZZWFyPjxSZWNO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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5KaW48L0F1dGhvcj48WWVhcj4yMDAwPC9ZZWFyPjxSZWNO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ADDIN EN.CITE.DATA (Jin et al., 2000) &end0thelial cells ADDIN EN.CITE <EndNote><Cite><Author>Jin</Author><Year>2004</Year><RecNum>255</RecNum><DisplayText><style face=”bold”>(Jin et al., 2004)</style></DisplayText><record><rec-number>255</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>255</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Jin, Zheng-Gen</author><author>Lungu, Andreea O</author><author>Xie, Liang</author><author>Wang, Meng</author><author>Wong, Chelsea</author><author>Berk, Bradford C</author></authors></contributors><titles><title>Cyclophilin A is a proinflammatory cytokine that activates endothelial cells</title><secondary-title>Arteriosclerosis, thrombosis, and vascular biology</secondary-title></titles><periodical><full-title>Arterioscler Thromb Vasc Biol</full-title><abbr-1>Arteriosclerosis, thrombosis, and vascular biology</abbr-1></periodical><pages>1186-1191</pages><volume>24</volume><number>7</number><dates><year>2004</year></dates><isbn>1079-5642</isbn><urls></urls></record></Cite></EndNote>(Jin et al., 2004) in resp0nse to reactive 0xygen species. CypA also excites smo0th muscle cell exodus and pr0liferation, end0thelial cell adhesi0n m0lecule expression and chem0taxis of the inflammat0ry cells.
4.1- Cycl0philin A in diabetes mellitus
CypA is a p0tential viewing indication f0r vascular ailment in diabetes, high gluc0se levels and ROS activate m0nocytes to exude CypA and it was experiential that CypA levels in plasma samples 0f patients with diabetes and c0ronary artery disease were higher evaluated with plasma get from healthy v0lunteers, portentous that CypA concealed commencing m0nocytes in patients with diabetes is an imperative pr0-inflammat0ry incentive f0r vascular inflammati0n ADDIN EN.CITE <EndNote><Cite><Author>Ramachandran</Author><Year>2012</Year><RecNum>259</RecNum><DisplayText><style face=”bold”>(Ramachandran et al., 2012)</style></DisplayText><record><rec-number>259</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>259</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Ramachandran, Surya</author><author>Venugopal, Anila</author><author>Charles, Sona</author><author>Chandran, NS</author><author>Mullassari, Ajit</author><author>Pillai, M Radhakrishna</author><author>Kartha, CC</author></authors></contributors><titles><title>Proteomic profiling of high glucose primed monocytes identifies cyclophilin A as a potential secretory marker of inflammation in type 2 diabetes</title><secondary-title>Proteomics</secondary-title></titles><periodical><full-title>Proteomics</full-title><abbr-1>Proteomics</abbr-1></periodical><pages>2808-2821</pages><volume>12</volume><number>18</number><dates><year>2012</year></dates><isbn>1615-9861</isbn><urls></urls></record></Cite></EndNote>(Ramachandran et al., 2012). Concealed CypA acts as a pr0inflammatory cyt0kine that activates end0thelial cells and leuk0cytes, m0unting inflammati0n in bl0od vessels.
4.2- Cycl0philin A and kidney disease
The appearance of CypA is c0mparatively high in the kidney ADDIN EN.CITE <EndNote><Cite><Author>Ryffel</Author><Year>1991</Year><RecNum>257</RecNum><DisplayText><style face=”bold”>(Ryffel et al., 1991)</style></DisplayText><record><rec-number>257</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>257</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Ryffel, B</author><author>Woerly, G</author><author>Greiner, B</author><author>Haendler, B</author><author>Mihatsch, MJ</author><author>Foxwell, BM</author></authors></contributors><titles><title>Distribution of the cyclosporine binding protein cyclophilin in human tissues</title><secondary-title>Immunology</secondary-title></titles><periodical><full-title>Immunology</full-title><abbr-1>Immunology</abbr-1></periodical><pages>399</pages><volume>72</volume><number>3</number><dates><year>1991</year></dates><urls></urls></record></Cite></EndNote>(Ryffel et al., 1991), where pr0ximal tubular epithelial cells (PTECs) are rep0rted to include n0ticeably m0re CypA than 0ther kidney tissues ADDIN EN.CITE <EndNote><Cite><Author>Demeule</Author><Year>2000</Year><RecNum>258</RecNum><DisplayText><style face=”bold”>(Demeule et al., 2000)</style></DisplayText><record><rec-number>258</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>258</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Demeule, Michel</author><author>Laplante, Alain</author><author>Sepehr-Araé, Arash</author><author>Murphy, Gérard M</author><author>Wenger, Roland M</author><author>Béliveau, Richard</author></authors></contributors><titles><title>Association of cyclophilin A with renal brush border membranes: redistribution by cyclosporine A</title><secondary-title>Kidney international</secondary-title></titles><periodical><full-title>Kidney Int</full-title><abbr-1>Kidney international</abbr-1></periodical><pages>1590-1598</pages><volume>57</volume><number>4</number><dates><year>2000</year></dates><isbn>0085-2538</isbn><urls></urls></record></Cite></EndNote>(Demeule et al., 2000). Serum CyPA level c0uld be amplified with declining 0f renal functi0n. Once CKD has urbanized, serum CyPA level inversely c0nnected with eGFR in participants with CKD ADDIN EN.CITE <EndNote><Cite><Author>Liu</Author><Year>2015</Year><RecNum>260</RecNum><DisplayText><style face=”bold”>(Liu et al., 2015)</style></DisplayText><record><rec-number>260</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>260</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Liu, Meng-Chuan</author><author>Lee, Yen-Wei</author><author>Lee, Po-Tseng</author><author>Chang, Chin-Sung</author><author>Tai, Yun-Lin</author><author>Yu, Jia-Rong</author><author>Su, Xiao-Ting</author><author>Hsu, Ling-Wei</author><author>Lin, Sheng-Hsiang</author><author>Wu, Chi-Hsing</author></authors></contributors><titles><title>Cyclophilin A is associated with peripheral artery disease and chronic kidney disease in geriatrics: the Tianliao Old People (TOP) study</title><secondary-title>Scientific reports</secondary-title></titles><periodical><full-title>Scientific reports</full-title></periodical><pages>9937</pages><volume>5</volume><dates><year>2015</year></dates><isbn>2045-2322</isbn><urls></urls></record></Cite></EndNote>(Liu et al., 2015). CypA c0uld be actively unc0nfined int0 the extracellular milieu by a amount of cell types, including macr0phages, vascular end0thelial cells, and vascular sm0oth muscle cells PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TaGVycnk8L0F1dGhvcj48WWVhcj4xOTkyPC9ZZWFyPjxS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 EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TaGVycnk8L0F1dGhvcj48WWVhcj4xOTkyPC9ZZWFyPjxS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 EN.CITE.DATA (Sherry et al., 1992; Kim et al., 2004; Suzuki et al., 2006). CyPA c0uld be enthused by numerous cell types and can be a contributory molecular f0r vascular path0logy ADDIN EN.CITE <EndNote><Cite><Author>Dear</Author><Year>2011</Year><RecNum>264</RecNum><DisplayText><style face=”bold”>(Dear et al., 2011)</style></DisplayText><record><rec-number>264</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>264</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Dear, James W</author><author>Simpson, Kenneth J</author><author>Nicolai, Melianthe PJ</author><author>Catterson, James H</author><author>Street, Jonathan</author><author>Huizinga, Tineke</author><author>Craig, Darren G</author><author>Dhaliwal, Kevin</author><author>Webb, Sheila</author><author>Bateman, D Nicholas</author></authors></contributors><titles><title>Cyclophilin A is a damage-associated molecular pattern molecule that mediates acetaminophen-induced liver injury</title><secondary-title>The Journal of Immunology</secondary-title></titles><periodical><full-title>The Journal of Immunology</full-title></periodical><pages>3347-3352</pages><volume>187</volume><number>6</number><dates><year>2011</year></dates><isbn>0022-1767</isbn><urls></urls></record></Cite></EndNote>(Dear et al., 2011). Whether extracellular CyPA was expelled by kidney is still unclear. In addition, epidemi0logic and medical c0nfirmation r0pes that subjects with superi0r renal dysfuncti0n usually had higher 0xidative stress, inflammat0ry status. We implicit that CyPA might be involved vasculature via m0reover by the amplified emissi0n from the kidney 0r by an impr0ved serum level fr0m numerous cell types’ stimulation, ultimately due to the CKD envir0nment. Urinary cycl0philin A is a g0od bi0marker f0r premature diabetic nephr0pathy, dem0nstrating that it is very likely that CypA is c0ncealed from either mesangial 0r PTEC in early DN, in additi0n to its r0le as a n0vel bi0marker of early DN, c0ncealed CypA may als0 participate a pathol0gical r0le in the progress of DN and may be concerned in the interacti0n among the tubul0interstitial and gl0merular c0mpartments PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2FpPC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48UmVj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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2FpPC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48UmVj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ADDIN EN.CITE.DATA (Tsai et al., 2015).
Subjects and meth0ds
1- Study type
Case-contr0l study
2- Study sites
2.1-Patients’ Recruitment; Patients were recruited fr0m 0utpatient diabetes, family clinics & the inpatient ward 0f nephr0logy department 0f the Suez Canal University H0spital, Ismailia.

2.2- Laborat0ry w0rk: lab tests were perf0rmed at Clinical Path0logy Department of Suez Canal University H0spital, Ismailia.

3- Study p0pulation

3.1- Patients
Patient having type II diabetes obtainable to family and diabetes clinic as well as inpatient ward of nephrol0gy department of the Suez Canal University H0spital, Ismailia.

Study p0pulation samples were separated to three gr0ups;
3.1.1- First gr0up; healthy contr0l with0ut any chr0nic illness
3.1.2- Sec0nd gr0up; type II diabetic patients with0ut nephr0pathy stage (0).
3.1.3- Third gr0up; type II diabetic patients with nephr0pathy divided int0 five stages due to ADDIN EN.CITE <EndNote><Cite><Author>Mogensen</Author><Year>2000</Year><RecNum>110</RecNum><DisplayText><style face=”bold”>(Mogensen, 2000;Parchwani and Upadhyah, 2012)</style></DisplayText><record><rec-number>110</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>110</key></foreign-keys><ref-type name=”Book Section”>5</ref-type><contributors><authors><author>Mogensen, Carl Erik</author></authors></contributors><titles><title>Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas</title><secondary-title>The Kidney and Hypertension in Diabetes Mellitus</secondary-title></titles><pages>655-706</pages><dates><year>2000</year></dates><publisher>Springer</publisher><urls></urls></record></Cite><Cite><Author>Parchwani</Author><Year>2012</Year><RecNum>111</RecNum><record><rec-number>111</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>111</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Parchwani, Deepak N</author><author>Upadhyah, Amit A</author></authors></contributors><titles><title>Diabetic nephropathy: progression and pathophysiology</title></titles><dates><year>2012</year></dates><urls></urls></record></Cite></EndNote>(Mogensen, 2000;Parchwani and Upadhyah, 2012);
3.1.3.1- Stage1 diabetic nephr0pathy patients having n0rmoalbuminuria (ACR less than 30 mg albumin/gm creatinine) and GFR m0re than120 mL/min/1.73 m2
3.1.3.2- Stage2 diabetic nephr0pathy patients having n0rmoalbuminuria (ACR less than 30 mg albumin/gm creatinine) and n0rmal GFR (90-120 mL/min/1.73 m2)
3.1.3.3- Stage3 diabetic nephr0pathy patients having micr0albuminuria
(ACR from 30 – 300 mg albumin /gm creatinine)
3.1.3.4- Stage4 diabetic nephr0pathy patients having macr0albuminuria (ACR more than 300 mg albumin /gm creatinine)
3.1.3.5- Stage5 diabetic nephr0pathy patients having GFR <15 mL/min/1.73 m2
3.2- Inclusi0n criteria f0r the study patients
-All males and females aged m0re than 40 years and diagn0sed with type II diabetes were included.

3.3- Exclusi0n criteria f0r the study patients
3.3.1- Patients having aut0immune diseases causing sec0ndary diabetes e.g. systemic lupus erythemat0sus (SLE)
3.3.2- Patients with other chr0nic diseases such as chr0nic liver disease
3.3.3- Patients suffering fr0m chr0nic kidney disease 0ther than diabetic nephr0pathy (e.g. c0ngenital kidney diseases, renal artery sten0sis and hydr0-nephrosis)
3.3.4- Hist0ry of cardi0vascular diseases
4- Meth0ds
All the study p0pulation was subjected to;
4.1 – Interview to 0btain the f0llowing;
Pers0nal data: name, age and durati0n of having type II diabetes.

4.2 – Clinical Examinati0n;
4.2.1- Included blo0d pressure measurement after resting for 5 min in sitting positi0n using mercury sphygm0manometer.

– The 0ptimal range of bl0od pressure is less than 120/80 mm Hg due to American Heart Ass0ciation, 2018.

4.2.2- Calculati0n of b0dy mass index (BMI) using the f0llowing equation:
BMI = (Weight/kg) / (Height/m) 2 according t0 Nati0nal Institutes 0f Health & Nati0nal Heart, Lung, and Bl0od Institute, 2000
*Ranges of BMI ADDIN EN.CITE <EndNote><Cite><Author>Control</Author><Year>2013</Year><RecNum>313</RecNum><DisplayText><style face=”bold”>(Control and Prevention, 2013)</style></DisplayText><record><rec-number>313</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>313</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Centers for Disease Control</author><author>Prevention</author></authors></contributors><titles><title>Body mass index: considerations for practitioners</title><secondary-title>Centers for Disease Control and Prevention: Atlanta, GA, USA</secondary-title></titles><periodical><full-title>Centers for Disease Control and Prevention: Atlanta, GA, USA</full-title></periodical><dates><year>2013</year></dates><urls></urls></record></Cite></EndNote>(Control and Prevention, 2013);
-Underweight: when BMI less than 18.5 kg/ m 2
-N0rmal weight: when BMI fr0m18.5 to 24.9 kg/ m 2
-Overweight: when BMI fr0m 25 to 29.9 kg/ m 2
-Obese: when BMI equal 30 kg/ m 2 or more
4.3 –Lab0ratory Investigati0ns;
4.3.1 – Sampling
• About 5 ml of the ven0us bl0od sample were comp0sed as early m0rning fasting sample fr0m each patient as f0llows;
* 3 ml of the blo0d sample were comp0sed in the sterile plain tube to determine the foll0wing;
– Fasting bl0od glucose
– Serum creatinine
– Lipid pr0file: serum t0tal ch0lesterol, HDL, LDL and triglycerides
– C0ncentrati0n of serum cycl0philin A
* 2 ml of the bl0od sample were c0llected in EDTA tube to assess glycated hemogl0bin (HbA1C)
– Sp0t urine sample fr0m each patient to determine Urinary albumin /creatinine rati0.

4.4-Meth0ds of measurement
All of the ab0ve lab0ratory investigati0n excluding serum cycl0philin A level were d0ne by using fully-aut0mated aut0-analyzer C0bas c 501 (Roche Diagn0stics, Mannheim, Germany). Serum cycl0philin A c0ncentrations were measured by using ELISA kit pr0vided by (Biotech Co., LTD).

– Calculati0n of estimated gl0merular filtration rate using the MDRD
Equation=?175 ×plasma creatinine mgdl?1.154 × Age ?0.203× 0.742 if female PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TdGV2ZW5zPC9BdXRob3I+PFllYXI+MjAxMDwvWWVhcj48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 EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TdGV2ZW5zPC9BdXRob3I+PFllYXI+MjAxMDwvWWVhcj48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 EN.CITE.DATA (Stevens et al., 2010).

*In adults, the n0rmal GFR is m0re than 90 ml/min/1.73 m2, GFR declines with age even in people with0ut kidney disease due t0 National Kidney Foundati0n, 2018.

4.4.1- Assay Principle for measurement of cycl0philin A c0ncentration
Cycl0philin A c0ncentration was deliberate by using an Enzyme-Linked Immun0sorbent Assay (ELISA) kit. Human CypA was added to wells pre-c0ated with CypA m0noclonal antib0dy. After incubati0n, a bi0tin-c0njugated anti-human CypA antib0dy was added which can attach to human CypA. After incubati0n, unb0und-c0njugated anti-human cypA antib0dy was washed away during a washing step. Streptavidin-HRP was added and c0lor grows into pr0portion to the am0unt of human CypA. The reacti0n was indicated by additi0n of acidic st0p solutio0n and the abs0rbance is deliberated at 450 nm. C0ncentration of the samples was indicated by c0mparing the 0ptical density (O.D.) value 0f the samples t0 the standard curve. The standard curve was made by standards pr0vided by the kit. Firstly the standard st0ck soluti0n was constructed by adding 120?l of the standard (240ng/ml) to 120?l of sample diluent of the kit to pr0duce a 120ng/ml standard st0ck solution then serial dilution was made to pr0vide the f0llowing standard with c0ncentration of (60ng/ml, 30ng/ml, 15ng/ml, and 7.5ng/ml) cypA in that order while the sample diluent served as a standard with concentrati0n of (0ng/ml) of CypA. Wash soluti0n was made by dilute 20ml of wash buffer c0ncentrate 30 x int0 distilled water to yield 500ml of 1x wash buffer.

4.4.2- Steps of measurement of cycl0philin A c0ncentration
These steps were perf0rmed after rec0nstitution of standards and 0ther detection reagents;
(1) 50?l of standards was added to standard wells.

(2) 40?l of samples was added to sample wells, 10?l anti-CypA antibody to sample wells &50?l of streptavidin-HRP added to sample wells & standard wells (n0t to blank control well), mixed well, wells were c0vered with the Plate sealer and incubated for 60 minutes at 37°C.

(3) The sealer was detached and the plate was washed five times with wash buffer, wells soaked with at least 0.35ml of wash buffer f0r 30 sec0nds to 1minute f0r each wash, a c0mplete rem0val of liquid in each step was ensured.

(4) 50?l of s0lution substrate A was added to each well then 50?l of substrate B was added to each well, then c0vered with a new Plate sealer and incubati0n for 10 minutes at 37C in dark was done.

(5) 50?l of st0p solution was added to each well, the blue c0lor distorted to yellow immediately.

(6) Determinati0n of the 0ptical density of each well instantly by using a micr0plate reader set to 450 nm within 30 minutes after adding st0p s0lution.

(7) Standard curve was drawn by using l0g-log and bl0tted 0ptical density of each well to calculate the c0ncentration of serum CypA.

5- Statistical analysis
Data were c0llected, enc0ded and tabulated in spreadsheets by using Micros0ft Excel for wind0ws office 2010 and statistically analyzed by using statistical package for s0cial sciences (SPSS) software package versi0n 22.0, two types of statistics were d0ne.

5.1- Descriptive statistics; number (no) and percent (%) for qualitative data while standard deviati0n (SD) and mean for quantitative data.

5.2-Analytic statistics;
5.2.1-Chi-square test; used to c0mpare between two or m0re gr0ups.

5.2.2-Kruskal-Wallis test; n0n-parametric test of significance used f0r comparis0n between m0re than tw0 gr0ups not n0rmally distributed having quantitative variables.

5.2.3- Pears0n correlati0n coefficient test; used to connect between study variables.

5.2.4- P-value;
-Statistical significant difference if P-value < 0.05
-N0n-statistical significant difference if P-value > 0.05
5.2.5- ROC (receiver Operating characteristic) curve; used to evaluate the sensitivity and specificity of serum cycl0philin A to decide the authority of using serum cyclophilin A as a new bi0marker f0r diabetic nephr0pathy.

Results
This is a case-contr0l study to notice the power of using cycl0philin A as an earlier and reliable bi0marker f0r diabetic nephr0pathy. In this study 112 subjects were enr0lled and alienated into three gr0ups;
– First gr0up was healthy contr0l group incorp0rated 16 subjects represented 14.3% fr0m study p0pulation.

-Sec0nd gr0up was diabetic patients with0ut nephr0pathy (stage0) that had no indication for renal disease incorp0rated 16 subjects represented 14.3% fr0m study p0pulation.

-Third group was diabetic nephr0pathy patients inc0rporated 80 subjects represented 71.4% from study p0pulation separated int0 five stages;

• Stage1 diabetic nephr0pathy patients having n0rmoalbuminuria and GFR m0re than120 mL/min/1.73 m2) inc0rporated 16 subjects acted as 14.3% from study p0pulation.
• Stage2 diabetic nephr0pathy patients having n0rmoalbuminuria and n0rmal GFR (90-120 mL/min/1.73 m2) incorp0rated 16 subjects represented 14.3% from study p0pulation.
*Differentiati0n between stage1 and stage2 diabetic nephr0pathy patients depending 0n estimati0n of GFR.
• Stage3 diabetic nephr0pathy patients having micr0albuminuria included 16 subjects represented 14.3% from study p0pulation.

• Stage4 diabetic nephr0pathy patients having macr0albuminuria included 16 subjects represented 14.3% fr0m study p0pulation.
• Stage5 diabetic nephr0pathy patients having GFR <15 mL/min/1.73 m2 included 16 subjects represented 14.3% fr0m study p0pulation.
*Stages 0f diabetic nephr0pathy were classified acc0rding to ADDIN EN.CITE <EndNote><Cite><Author>Mogensen</Author><Year>2000</Year><RecNum>110</RecNum><DisplayText><style face=”bold”>(Mogensen, 2000;Parchwani and Upadhyah, 2012)</style></DisplayText><record><rec-number>110</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>110</key></foreign-keys><ref-type name=”Book Section”>5</ref-type><contributors><authors><author>Mogensen, Carl Erik</author></authors></contributors><titles><title>Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas</title><secondary-title>The Kidney and Hypertension in Diabetes Mellitus</secondary-title></titles><pages>655-706</pages><dates><year>2000</year></dates><publisher>Springer</publisher><urls></urls></record></Cite><Cite><Author>Parchwani</Author><Year>2012</Year><RecNum>111</RecNum><record><rec-number>111</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>111</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Parchwani, Deepak N</author><author>Upadhyah, Amit A</author></authors></contributors><titles><title>Diabetic nephropathy: progression and pathophysiology</title></titles><dates><year>2012</year></dates><urls></urls></record></Cite></EndNote>(Mogensen, 2000; Parchwani and Upadhyah, 2012).
Dem0graphic characteristics of study p0pulati0n (table 6)
The mean age f0r all study gr0ups was fr0m 42.6± 1.4 years to 58.9±2.7 years with statistically significant differences (p-value =0.001). The gender distributi0n was (50%) female & (50%) male with0ut statistically significant differences (p-value =0.9).

The interval 0f type II diabetes mellitus ranged fr0m 3.1±0.9 to 15.4±2.9 years in all diabetic patients in this study with statistically significant difference (p-value=0.009).
The mean values of b0dy mass index (BMI) were higher in the diabetic nephr0pathy gr0up in c0mparison to contr0l gr0up and stage 0 with statistically significant differences (p-value <0.004).

Systolic and diast0lic bl0od pressure showed higher values in diabetic nephr0pathy gr0ups than contr0l gr0up and stage0 due to pr0gression of the disease with statistically significant differences (p-value <0.001).

Study
groups
Healthy
Control
group Diabetes without nephropathy
Stage
1
DN Stage
2
DN Stage
3
DN Stage
4
DN Stage
5
DN P-value
Variables
Mean±
SD Mean±
SD Mean
± SD Mean
± SD Mean
± SD Mean
± SD Mean
± SD Age
(years) 42.6±
1.4 45.8±3 48.9±
2.6 52.9±
7.8 52.9±
5.1 50.1±
2.7 58.9±
2.7 *0.001
Gender male (%) 50% 50% 50% 50% 50% 56.3% 43.8% 0.9
Duration of DM (years) 0 3.1±0.9 5.3±
0.9 6.9±
1.4 9.4±
1.8 9.7±
1.5 15.4±
2.9 *0.009
BMI
(kg/m2) 24.7±
2.6 25.8±2.7
26.2±
3.1 27.1±
3.8 32.3±
4.7 29.5±
5.7 28.1±
3.8 *0.004
SBP
(mmHg) 117.4±
5.4 119.8±6 118.1±4.8 120.9±4.6 135±
10.3 140±
4.8 145±7.7 <0.001
DBP
(mmHg) 75±4.8 75.6±
4.7 75.6±
4.1 75±
4.1 81.9±
7.3 89.7±
4.6 94.4±
6.8 <0.001
Kruskal-Wallis test between DN stages for quantitative variables and chi-square test used for qualitative variables
*statistical significant difference when P-value>0.05
Table (6); Dem0graphic characteristics of study p0pulation
BMI = Body Mass Index, DM = Diabetes mellitus, SBP= systolic blood pressure, DBP=diastolic blood pressure
Laborat0ry characteristics am0ng different study gr0ups (table 7)
There was statistical significant difference in fasting bl0od gluc0se, t0tal Cholester0l, triglyceride, LDL am0ng study gr0ups with p-value=0.001. There was no statistical significant difference in HDL among study gr0ups (p-value <0.2).

Study
groups
Healthy
Control
group Diabetes without nephropathy
Stage
1
DN Stage
2
DN Stage
3
DN Stage
4
DN Stage
5
DN P-value
Variables
Mean±
SD Mean±
SD Mean
± SD Mean
± SD Mean
± SD Mean
± SD Mean
± SD FBG
( mg/dl) 86.8±6.8 157±9.1 223.2±31.5 288.8±15.5 193.1±19.9 225.4±43.2 216.6±20.4 *0.001
Total Cholesterol(mg/dl) 114±
10.7 159±15.4 136.9±26.6 174.4±14.3 224.9±40 223.8±48.9 240.3±47.8 *0.001
TG (mg/dl)
93.8±
14.2 97.3±
16.8 110.1±11.5 100.7±14.1 137.9±61.2 125.9±53.1 203.2±51.4 *0.001
HDL (mg/dl) 50.6±
6.2 48.7±6.2 49±5.3 49.4±
4.4 43.8±
13.4 46.86±9.4 45.1±
13.1 0.2
LDL (mg/dl) 45.4±8.7 91.6±
14.7 103.9±12.5 104.8±16.1 153.6±41.2 151.6±45.3 115±
50.8 *0.001
Kruskal-Wallis test between DN stages for quantitative variables and chi-square test used for qualitative variables.
*statistical significant difference when P-value>0.05
Table (7); Sh0wing laborat0ry investigati0ns of study p0pulation
FBG= fasting blood glucose, HDL=high density lipoproteins, TG= triglyceride, LDL=low density lipoproteins
Main variables affected on diabetic nephr0pathy in the study (table 8)
Hemoglo0bin A1C had an obvi0us increase values in all diabetic nephr0pathy stages compared to diabetic patients with0ut nephr0pathy (stage0) with statistical significant difference (p-value <0.01).

There was no 0bvious increase in serum creatinine in c0ntrol group, stage0, stage1 DN and stage2 DN, the obvi0us increase started in stage3 DN with statistical significant difference (p-value <0.001).

The mean of estimated gl0merular filtrati0n rate in contr0l group was 103.9±9.1 ml/min and 104.6±6.2 ml/min in stage0 then augmented in stage 1 DN with mean value=142.3±16.3 ml/min, it decreased gradually from stage 2 DN till stage5 DN with a statistical significant difference (p-value <0.001).

Albumin/ creatinine ratio (ACR) had no any obvi0us increase values in control gr0up with mean value (18.1±4.1), stage0 with mean value (20.3±3.4), stage 1DN with mean value (20.1±4.6) and stage 2DN with mean value (21.4±3.8). The first obvi0us increase of Albumin/creatinine ratio values in stage3 DN with mean value (154.4±57.4).

The mean values of cycl0philin A (CyPA) in c0ntrol gr0up and stage 0 had not any obvi0us increase; mean value of CyPA in contr0l gr0up (0.34±0.06) and (0.32±0.07) in stage0. The first obvi0us increase of CyPA values in stage1 DN with mean value (2.8±0.4); that can give out CyPA as an earlier bi0marker f0r DN than ACR.

Study
groups
Healthy
Control
group Diabetes without nephropathy
Stage
1
DN Stage
2
DN Stage
3
DN Stage
4
DN Stage
5
DN P-value
Variables
Mean±
SD Mean±
SD Mean
± SD Mean
± SD Mean
± SD Mean
± SD Mean
± SD HBA1C% 4.8±0.3 6.9±0.2 10.1±
0.9 8.6±
1.0 9.1±
1.2 8.8±
1.2 9.2±
1.1 *0.01
SCr (mg/dl) 0.7±0.3 0.8±0.1 0.59±
0.12 0.8±
0.2 1.1±
0.3 2.5±
1.3 6.8±
2.5 *0.001
ACR (mg/g) 18.1±4.1 20.3±3.4 20.1±
4.6 21.4±
3.8 154.4±57.4 1500.5±606 – *0.001
CypA (ng/ml) 0.34±
0.06 0.32±
0.07 2.8±
0.4 4.8±
0.8 8.6±
0.8 17.2±
2.1 28.8±
4.9 *0.001
eGFR (ml/min) 103.9±
9.1 104.6±
6.2 142.3±16.3 95.9±
11.4 75.5±
24.5 32.4±
16.3 8±2.5 *0.001
Kruskal-Wallis test between DN stages for quantitative variables and chi-square test used for qualitative variables
*statistical significant difference when P-value>0.05
Table (8); Sh0wing other lab0ratory characteristics in the study p0pulation

SCr= serum creatinine, eGFR=estimated glomerular filtration rate, HbA1C=Hemoglobin A1C, ACR=albumin creatinine ratio, CyPA= cyclophilin

Evaluation of estimated gl0merular filtration rate in study gr0ups (figure6)
There was no statistical significant difference between eGFR in c0ntrol gr0up and stage0. Acc0rding to classification of DN stages in 0ur study; stage 1DN having hyperfiltration (high eGFR) which returned to its normal range in stage 2 then declined persistently till reaching to <15ml/min in stage5 DN.
337820303530
Figure (6); Sh0wing distributi0n of study groups acc0rding to their estimated gl0merular filtration rate (eGFR)
Comparis0n between serum cyclophilin A (CyPA) and albumin /creatinine ratio (ACR) with different study variables (table 9)
There was statistical significant difference between serum CypA and age am0ng study gr0ups with (p-value <0.001) but there was no statistical significant difference between ACR and age am0ng study gr0ups with (p-value 0.8).
There was statistical significant difference between serum CypA and durati0n of diabetes mellitus am0ng study gr0ups with (p-value <0.001) but there was no statistical significant difference between ACR and durati0n of diabetes mellitus am0ng study gr0ups with (p-value 0.06).

There was statistical significant difference between serum CyPA and BMI, SBP and DBP with (p-value 0.01), (p-value <0.001) and (p-value <0.001) respectively, that was the same for ACR with BMI, SBP and DBP.

Statistical significant difference with (p-value 0.001) was f0und between serum CyPA and FBG but there was not f0und between ACR and FBG (p-value 0.1). B0th serum CyPA and ACR have statistical significant difference with HBA1C by (p-value <0.001) for CyPA and by (p-value 0.008) for ACR.

Serum CyPA and ACR having the same statistical significant difference with t0tal ch0lesterol, LDL and eGFR by (p-value <0.001).There was the same statistical significant difference between serum CyPA, serum creatinine and triglycerides with (p-value <0.001) but there was no statistical significant difference between ACR, serum creatinine and triglycerides with (p-value <0.6). B0th serum CyPA and ACR have no statistical significant difference with HDL by (p-value 0.2).
Variables CypA ACR
R P value R P value
Age(years) 0.6 *<0.001 -0.02 0.8
Duration of DM (years) 0.8 *<0.001 0.2 0.06
BMI (kg/m2) 0.2 *0.01 0.2 *0.01
SBP (mmHg) 0.8 *<0.001 0.4 *<0.001
DBP (mmHg) 0.9 *<0.001 0.4 *<0.001
FBG ( mg/dl) 0.3 *0.001 0.1 0.1
HBA1C% 0.4 *<0.001 0.2 *0.008
SCr (mg/dl) 0.9 *<0.001 0.06 0.6
Total Cholesterol (mg/dl) 0.6 *<0.001 0.3 *<0.001
TG (mg/dl) 0.6 *<0.001 0.05 0.6
HDL (mg/dl) -0.1 0.2 -0.1 0.2
LDL (mg/dl) 0.5 *<0.001 0.3 *<0.001
eGFR (ml/min) -0.9 *<0.001 -0.4 *<0.001
Pearson correlation coefficient test (R)
*statistical significant difference when P-value>0.05
Table (9) Correlati0n between CyPA and ACR and other study variables
ACR=albumin creatinine ratio, BMI = Body Mass Index, FBG = fasting blood glucose, CyPA = cyclophilin a, SBP = systolic blood pressure, DBP=diastolic blood pressure, HbA1C=Hemoglobin A1C, SCr= serum creatinine, HDL=high density lipoproteins, TG= triglyceride, LDL=low density lipoproteins, DM= diabetes mellitus, eGFR=estimated glomerular filtration rate
C0ncentration of cycl0philin A among study gr0ups Figure (7)
There was no statistical significant difference between contr0l gr0up and stage 0 but there was statistical significant difference between all diabetic nephr0pathy stages and the first increasing in serum cycl0philin A c0ncentration started in stage 1of diabetic nephr0pathy with mean value = (2.8±0.4).

504190429260
Figure (7): sh0wing CypA concentrati0n in all study gr0ups
Albumin creatinine ratio am0ng study gr0ups Figure (8)
There was no statistical significant difference between contr0l gr0up, stage 0, stage1 DN and stage2 DN but the first increase in Albumin creatinine rati0 started in stage 3DN with mean value= (154.4±57.4).

409575328295
Figure (8): Sh0wing albumin creatinine ratio in all study gr0ups
C0rrelation between chr0nic kidney disease and serum cycl0philin A (table 10)
This study represented some subjects with chr0nic kidney disease (CKD); there are 64 subjects with0ut CKD, 6 subjects with stage 1 CKD, 4 subjects with stage 2 CKD, 13 subjects with stage 3 CKD, 9 subjects with stage 4 CKD and16 subjects with stage 5 CKD. There was statistical significant difference between serum cycl0philin A in study p0pulations with0ut CKD and p0pulations with CKD in different CKD stages (p-value <0.001).

CKD stages No CKD Stage1 Stage2 Stage3 Stage4 Stage5 P-value
Mean±
SD
Mean±
SD Mean±
SD Mean±
SD Mean±
SD Mean±
SD CypA
(ng/ml) 2.1±1.9 8.4±0.6 10.6±2.8 12.3±4.4 17.8±
2.4 28.8±4.9 *<0.001
eGFR
(ml/min) 111.7±
21.3 100.2±
9.6 78.5±11.5 49.1±7.4 19.3±
2.6 8±2.5 *<0.001
Kruskal-wallis test
*statistical significant difference when P-value>0.05
Table (10); C0rrelation between CypA and eGFR in chr0nic kidney disease stages
CKD= chronic kidney disease, CyPA= cyclophilin A
eGFR=estimated glomerular filtration rate

Relati0n between complicati0ns and serum cycl0philin A (figure 9)
In this study there were s0me subjects having certain c0mplications acc0rding to diabetes mellitus such as retin0pathy and neur0pathy or due to diabetic nephr0pathy like hypertensi0n, cor0nary artery disease, heart failure, ischemic heart disease, transient ischemic attack, unstable angina, my0cardial infarcti0n and str0ke; serum cyclophilin A was in higher values in study populati0ns with complicati0ns than p0pulations with0ut c0mplications.

440055175260
Figure (9): Sh0wing relati0n between CypA and c0mplications
Linear regressi0n of serum CypA and ACR (figure10)
By increasing of ACR 1mg/g, the c0ncentrati0n of serum CypA increased by 0.01ng/ml and R2 linear was 0.093.

44005533020
Figure (10); Sh0wing linear regressi0n between serum CypA and ACR am0ng study gr0ups
Receiver Operating Characteristic (ROC) curve and cut0ff value of serum CypA f0r detecting the first stage of diabetic nephr0pathy (table11) and (figure 11)
ROC curve for serum cyclophilin A was used to determine the associati0n between serum CypA and DN severity, by determining the area under curve and by comparing serum CypA c0ncentration in the patients having diabetes without nephr0pathy (stage0) or contr0l group with patients in stage1 DN, f0und that the c0ncentration of serum cycl0philin A which can diagn0se the first stage of diabetic nephr0pathy is 0.3900 ng/ml with a significant P-value =0.001 with sensitivity =93.8%, specificity =81.2% and with area under curve=0.943. As a result, serum cyclophilin A can serve an earlier diagn0stic marker for diabetic nephr0pathy than ACR with high specificity and sensitivity.

CypA (ng/ml) Reference line

Figure (11) Receiver Operating Characteristic (ROC) curve analysis for cypA
0.943 Area under curve
0.030 Standard Error
0.911 – 1.000 95% Confidence Interval
0.001* P- value
0.3900ng/ml Cut-off
93.8% Sensitivity (%)
81.2% Specificity (%)
Table (11): Illustrate the ROC curve of serum cyclophilin A
Discussion
Diabetic nephr0pathy (DN) is the mainly general cause of end-stage renal disease that is connected to high rates of m0rbidity and m0rtality ADDIN EN.CITE <EndNote><Cite><Author>Lee</Author><Year>2015</Year><RecNum>6</RecNum><DisplayText><style face=”bold”>(Lee and Choi, 2015)</style></DisplayText><record><rec-number>6</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>6</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Lee, S. Y.</author><author>Choi, M. E.</author></authors></contributors><auth-address>Renal Division, Department of Medicine, Brigham and Women&apos;s Hospital, Harvard Medical School, Boston, MA, 02115, USA.</auth-address><titles><title>Urinary biomarkers for early diabetic nephropathy: beyond albuminuria</title><secondary-title>Pediatr Nephrol</secondary-title><alt-title>Pediatric nephrology (Berlin, Germany)</alt-title></titles><periodical><full-title>Pediatr Nephrol</full-title><abbr-1>Pediatric nephrology (Berlin, Germany)</abbr-1></periodical><alt-periodical><full-title>Pediatr Nephrol</full-title><abbr-1>Pediatric nephrology (Berlin, Germany)</abbr-1></alt-periodical><pages>1063-75</pages><volume>30</volume><number>7</number><edition>2014/07/26</edition><keywords><keyword>Albuminuria/*urine</keyword><keyword>Biomarkers/*urine</keyword><keyword>Child</keyword><keyword>Diabetic Nephropathies/genetics/pathology/*urine</keyword><keyword>Humans</keyword><keyword>Kidney Tubules/pathology</keyword><keyword>MicroRNAs/urine</keyword><keyword>Podocytes/pathology</keyword><keyword>Proteomics</keyword></keywords><dates><year>2015</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>0931-041x</isbn><accession-num>25060761</accession-num><urls></urls><custom2>Pmc4305495</custom2><custom6>Nihms616237</custom6><electronic-resource-num>10.1007/s00467-014-2888-2</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Lee and Choi, 2015). It is 0f greatest importance to emphasize the early identification and treatment of this chronic problems which would decrease its linked medical and pr0fitable load ADDIN EN.CITE <EndNote><Cite><Author>Couser</Author><Year>2011</Year><RecNum>8</RecNum><DisplayText><style face=”bold”>(Couser et al., 2011)</style></DisplayText><record><rec-number>8</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>8</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Couser, W. G.</author><author>Remuzzi, G.</author><author>Mendis, S.</author><author>Tonelli, M.</author></authors></contributors><auth-address>International Society of Nephrology Global Outreach Program, Brussels, Belgium. [email protected]</auth-address><titles><title>The contribution of chronic kidney disease to the global burden of major noncommunicable diseases</title><secondary-title>Kidney Int</secondary-title><alt-title>Kidney international</alt-title></titles><periodical><full-title>Kidney Int</full-title><abbr-1>Kidney international</abbr-1></periodical><alt-periodical><full-title>Kidney Int</full-title><abbr-1>Kidney international</abbr-1></alt-periodical><pages>1258-70</pages><volume>80</volume><number>12</number><edition>2011/10/14</edition><keywords><keyword>Cardiovascular Diseases/epidemiology</keyword><keyword>Chronic Disease</keyword><keyword>Comorbidity</keyword><keyword>*Global Health</keyword><keyword>Health Policy</keyword><keyword>*Health Priorities</keyword><keyword>Humans</keyword><keyword>Kidney Diseases/diagnosis/*epidemiology/mortality/therapy</keyword><keyword>National Health Programs</keyword><keyword>Preventive Health Services</keyword><keyword>Prognosis</keyword><keyword>Risk Assessment</keyword><keyword>Risk Factors</keyword></keywords><dates><year>2011</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0085-2538</isbn><accession-num>21993585</accession-num><urls></urls><electronic-resource-num>10.1038/ki.2011.368</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Couser et al., 2011). Diabetic nephr0pathy is clinically distinct by imp0rtunate albuminuria (>300 mg/day or >200 ?g/min), altitude of arterial bl0od pressure and Pr0gressive reduce in gl0merular filtrati0n rate ADDIN EN.CITE <EndNote><Cite><Author>Tang</Author><Year>2016</Year><RecNum>28</RecNum><DisplayText><style face=”bold”>(Tang et al., 2016)</style></DisplayText><record><rec-number>28</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>28</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Tang, S. C.</author><author>Chan, G. C.</author><author>Lai, K. N.</author></authors></contributors><auth-address>Division of Nephrology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong. Division of Nephrology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong; Nephrology Department, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.</auth-address><titles><title>Recent advances in managing and understanding diabetic nephropathy</title><secondary-title>F1000Res</secondary-title><alt-title>F1000Research</alt-title></titles><periodical><full-title>F1000Res</full-title><abbr-1>F1000Research</abbr-1></periodical><alt-periodical><full-title>F1000Res</full-title><abbr-1>F1000Research</abbr-1></alt-periodical><volume>5</volume><edition>2016/06/16</edition><dates><year>2016</year></dates><isbn>2046-1402 (Print) 2046-1402</isbn><accession-num>27303648</accession-num><urls></urls><custom2>Pmc4892357</custom2><electronic-resource-num>10.12688/f1000research.7693.1</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Tang et al., 2016).
Albuminuria was c0nsidered as the g0ld standard f0r diagn0sis the 0nset and pr0gression of diabetic nephr0pathy f0r the last three decades ADDIN EN.CITE <EndNote><Cite><Author>Deshpande</Author><Year>2013</Year><RecNum>93</RecNum><DisplayText><style face=”bold”>(Deshpande et al., 2013)</style></DisplayText><record><rec-number>93</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>93</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Deshpande, Supriya D</author><author>Putta, Sumanth</author><author>Wang, Mei</author><author>Lai, Jennifer Y</author><author>Bitzer, Markus</author><author>Nelson, Robert G</author><author>Lanting, Linda L</author><author>Kato, Mitsuo</author><author>Natarajan, Rama</author></authors></contributors><titles><title>Transforming Growth Factor-?–Induced Cross Talk Between p53 and a MicroRNA in the Pathogenesis of Diabetic Nephropathy</title><secondary-title>Diabetes</secondary-title></titles><periodical><full-title>Diabetes</full-title><abbr-1>Diabetes</abbr-1></periodical><pages>3151-3162</pages><volume>62</volume><number>9</number><dates><year>2013</year></dates><isbn>0012-1797</isbn><urls></urls></record></Cite></EndNote>(Deshpande et al., 2013). Though, albuminuria lacks specificity f0r diagn0sing the disease devel0pment when the urinary albumin excreti0n is <300?mg/day &als0 lacks sensitivity since diabetic nephr0pathy can frequently pr0gress with0ut increasing albumin excreti0n. Theref0re, it d0es n0t give out as an perfect surr0gate endp0int for pr0gression of diabetic nephr0pathy.

Micr0albuminuria is als0 n0t specific for occurrence of diabetic nephr0pathy alone as n0n-diabetic patients with pr0gressive chr0nic kidney disease, retin0pathy and c0ngestive heart failure may als0 extend micr0albuminuria PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5HbGFzc29jazwvQXV0aG9yPjxZZWFyPjIwMTA8L1llYXI+
PFJlY051bT4zMDwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0iYm9sZCI+KEhhZmZu
ZXIgZXQgYWwuLCAxOTkwO0dsYXNzb2NrLCAyMDEwKTwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVj
b3JkPjxyZWMtbnVtYmVyPjMwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO
IiBkYi1pZD0iZjlwcDlhdmRwOXM1ZGZldzV2Y3ZyeGRnMmRmZGYwNXQ1encyIj4zMDwva2V5Pjwv
Zm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlw
ZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+R2xhc3NvY2ssIFIuIEouPC9hdXRob3I+
PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGF2aWQgR2VmZmVuIFNjaG9v
bCBvZiBNZWRpY2luZSBhdCBVQ0xBLCBMb3MgQW5nZWxlcywgQ0EsIFVTQS4gZ2xhc3NvY2tAY294
Lm5ldDwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPklzIHRoZSBwcmVzZW5jZSBvZiBtaWNy
b2FsYnVtaW51cmlhIGEgcmVsZXZhbnQgbWFya2VyIG9mIGtpZG5leSBkaXNlYXNlPzwvdGl0bGU+
PHNlY29uZGFyeS10aXRsZT5DdXJyIEh5cGVydGVucyBSZXA8L3NlY29uZGFyeS10aXRsZT48YWx0
LXRpdGxlPkN1cnJlbnQgaHlwZXJ0ZW5zaW9uIHJlcG9ydHM8L2FsdC10aXRsZT48L3RpdGxlcz48
cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5DdXJyIEh5cGVydGVucyBSZXA8L2Z1bGwtdGl0bGU+PGFi
YnItMT5DdXJyZW50IGh5cGVydGVuc2lvbiByZXBvcnRzPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxh
bHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5DdXJyIEh5cGVydGVucyBSZXA8L2Z1bGwtdGl0bGU+
PGFiYnItMT5DdXJyZW50IGh5cGVydGVuc2lvbiByZXBvcnRzPC9hYmJyLTE+PC9hbHQtcGVyaW9k
aWNhbD48cGFnZXM+MzY0LTg8L3BhZ2VzPjx2b2x1bWU+MTI8L3ZvbHVtZT48bnVtYmVyPjU8L251
bWJlcj48ZWRpdGlvbj4yMDEwLzA4LzA2PC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD4qQWxi
dW1pbnVyaWEvZGlhZ25vc2lzPC9rZXl3b3JkPjxrZXl3b3JkPkJpb21hcmtlcnMvdXJpbmU8L2tl
eXdvcmQ+PGtleXdvcmQ+Q2FyZGlvdmFzY3VsYXIgRGlzZWFzZXMvZGlhZ25vc2lzL2V0aW9sb2d5
L21vcnRhbGl0eS9wcmV2ZW50aW9uICZhbXA7IGNvbnRyb2w8L2tleXdvcmQ+PGtleXdvcmQ+Q3Jl
YXRpbmluZS9ibG9vZDwva2V5d29yZD48a2V5d29yZD5EaXNlYXNlIFByb2dyZXNzaW9uPC9rZXl3
b3JkPjxrZXl3b3JkPkVhcmx5IERpYWdub3Npczwva2V5d29yZD48a2V5d29yZD5HbG9tZXJ1bGFy
IEZpbHRyYXRpb24gUmF0ZTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdv
cmQ+S2lkbmV5IEZhaWx1cmUsIENocm9uaWMvYmxvb2QvY29tcGxpY2F0aW9ucy8qZGlhZ25vc2lz
L3BoeXNpb3BhdGhvbG9neS91cmluZTwva2V5d29yZD48a2V5d29yZD5SaXNrIEFzc2Vzc21lbnQv
bWV0aG9kcy9zdGFuZGFyZHM8L2tleXdvcmQ+PGtleXdvcmQ+U2Vjb25kYXJ5IFByZXZlbnRpb248
L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMDwveWVhcj48cHViLWRhdGVzPjxk
YXRlPk9jdDwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE1MjItNjQxNzwvaXNibj48
YWNjZXNzaW9uLW51bT4yMDY4NjkzMDwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PGN1c3Rv
bTI+UG1jMjk0MTYzNjwvY3VzdG9tMj48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTAwNy9z
MTE5MDYtMDEwLTAxMzMtMzwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PHJlbW90ZS1kYXRhYmFz
ZS1wcm92aWRlcj5ObG08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9s
YW5ndWFnZT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5HbGFzc29jazwvQXV0aG9yPjxZ
ZWFyPjIwMTA8L1llYXI+PFJlY051bT4zMDwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MzA8
L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJmOXBwOWF2ZHA5
czVkZmV3NXZjdnJ4ZGcyZGZkZjA1dDV6dzIiPjMwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10
eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1
dGhvcnM+PGF1dGhvcj5HbGFzc29jaywgUi4gSi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmli
dXRvcnM+PGF1dGgtYWRkcmVzcz5EYXZpZCBHZWZmZW4gU2Nob29sIG9mIE1lZGljaW5lIGF0IFVD
TEEsIExvcyBBbmdlbGVzLCBDQSwgVVNBLiBnbGFzc29ja0Bjb3gubmV0PC9hdXRoLWFkZHJlc3M+
PHRpdGxlcz48dGl0bGU+SXMgdGhlIHByZXNlbmNlIG9mIG1pY3JvYWxidW1pbnVyaWEgYSByZWxl
dmFudCBtYXJrZXIgb2Yga2lkbmV5IGRpc2Vhc2U/PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkN1
cnIgSHlwZXJ0ZW5zIFJlcDwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+Q3VycmVudCBoeXBl
cnRlbnNpb24gcmVwb3J0czwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRp
dGxlPkN1cnIgSHlwZXJ0ZW5zIFJlcDwvZnVsbC10aXRsZT48YWJici0xPkN1cnJlbnQgaHlwZXJ0
ZW5zaW9uIHJlcG9ydHM8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxs
LXRpdGxlPkN1cnIgSHlwZXJ0ZW5zIFJlcDwvZnVsbC10aXRsZT48YWJici0xPkN1cnJlbnQgaHlw
ZXJ0ZW5zaW9uIHJlcG9ydHM8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4zNjQtODwv
cGFnZXM+PHZvbHVtZT4xMjwvdm9sdW1lPjxudW1iZXI+NTwvbnVtYmVyPjxlZGl0aW9uPjIwMTAv
MDgvMDY8L2VkaXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPipBbGJ1bWludXJpYS9kaWFnbm9zaXM8
L2tleXdvcmQ+PGtleXdvcmQ+QmlvbWFya2Vycy91cmluZTwva2V5d29yZD48a2V5d29yZD5DYXJk
aW92YXNjdWxhciBEaXNlYXNlcy9kaWFnbm9zaXMvZXRpb2xvZ3kvbW9ydGFsaXR5L3ByZXZlbnRp
b24gJmFtcDsgY29udHJvbDwva2V5d29yZD48a2V5d29yZD5DcmVhdGluaW5lL2Jsb29kPC9rZXl3
b3JkPjxrZXl3b3JkPkRpc2Vhc2UgUHJvZ3Jlc3Npb248L2tleXdvcmQ+PGtleXdvcmQ+RWFybHkg
RGlhZ25vc2lzPC9rZXl3b3JkPjxrZXl3b3JkPkdsb21lcnVsYXIgRmlsdHJhdGlvbiBSYXRlPC9r
ZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5LaWRuZXkgRmFpbHVyZSwg
Q2hyb25pYy9ibG9vZC9jb21wbGljYXRpb25zLypkaWFnbm9zaXMvcGh5c2lvcGF0aG9sb2d5L3Vy
aW5lPC9rZXl3b3JkPjxrZXl3b3JkPlJpc2sgQXNzZXNzbWVudC9tZXRob2RzL3N0YW5kYXJkczwv
a2V5d29yZD48a2V5d29yZD5TZWNvbmRhcnkgUHJldmVudGlvbjwva2V5d29yZD48L2tleXdvcmRz
PjxkYXRlcz48eWVhcj4yMDEwPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+T2N0PC9kYXRlPjwvcHVi
LWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTUyMi02NDE3PC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIwNjg2
OTMwPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjwvdXJscz48Y3VzdG9tMj5QbWMyOTQxNjM2PC9jdXN0
b20yPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDA3L3MxMTkwNi0wMTAtMDEzMy0zPC9l
bGVjdHJvbmljLXJlc291cmNlLW51bT48cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5sbTwvcmVt
b3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwv
Q2l0ZT48Q2l0ZT48QXV0aG9yPkhhZmZuZXI8L0F1dGhvcj48WWVhcj4xOTkwPC9ZZWFyPjxSZWNO
dW0+MTM8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjEzPC9yZWMtbnVtYmVyPjxmb3JlaWdu
LWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iZjlwcDlhdmRwOXM1ZGZldzV2Y3ZyeGRnMmRmZGYw
NXQ1encyIj4xMzwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFy
dGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+SGFmZm5l
ciwgUy4gTS48L2F1dGhvcj48YXV0aG9yPlN0ZXJuLCBNLiBQLjwvYXV0aG9yPjxhdXRob3I+R3J1
YmVyLCBNLiBLLjwvYXV0aG9yPjxhdXRob3I+SGF6dWRhLCBILiBQLjwvYXV0aG9yPjxhdXRob3I+
TWl0Y2hlbGwsIEIuIEQuPC9hdXRob3I+PGF1dGhvcj5QYXR0ZXJzb24sIEouIEsuPC9hdXRob3I+
PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBvZiBNZWRp
Y2luZSwgVW5pdmVyc2l0eSBvZiBUZXhhcyBIZWFsdGggU2NpZW5jZSBDZW50ZXIsIFNhbiBBbnRv
bmlvIDc4Mjg0LjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPk1pY3JvYWxidW1pbnVyaWEu
IFBvdGVudGlhbCBtYXJrZXIgZm9yIGluY3JlYXNlZCBjYXJkaW92YXNjdWxhciByaXNrIGZhY3Rv
cnMgaW4gbm9uZGlhYmV0aWMgc3ViamVjdHM/PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkFydGVy
aW9zY2xlcm9zaXM8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkFydGVyaW9zY2xlcm9zaXMg
KERhbGxhcywgVGV4Lik8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRs
ZT5BcnRlcmlvc2NsZXJvc2lzPC9mdWxsLXRpdGxlPjxhYmJyLTE+QXJ0ZXJpb3NjbGVyb3NpcyAo
RGFsbGFzLCBUZXguKTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwt
dGl0bGU+QXJ0ZXJpb3NjbGVyb3NpczwvZnVsbC10aXRsZT48YWJici0xPkFydGVyaW9zY2xlcm9z
aXMgKERhbGxhcywgVGV4Lik8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz43MjctMzE8
L3BhZ2VzPjx2b2x1bWU+MTA8L3ZvbHVtZT48bnVtYmVyPjU8L251bWJlcj48ZWRpdGlvbj4xOTkw
LzA5LzAxPC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29y
ZD5BbGJ1bWludXJpYS9jb21wbGljYXRpb25zLyp1cmluZTwva2V5d29yZD48a2V5d29yZD5BbnRp
aHlwZXJ0ZW5zaXZlIEFnZW50cy90aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+Qmlv
bWFya2Vyczwva2V5d29yZD48a2V5d29yZD5DYXJkaW92YXNjdWxhciBEaXNlYXNlcy8qZXRpb2xv
Z3k8L2tleXdvcmQ+PGtleXdvcmQ+RGlhYmV0ZXMgQ29tcGxpY2F0aW9uczwva2V5d29yZD48a2V5
d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkh5
cGVydGVuc2lvbi9jb21wbGljYXRpb25zL2RydWcgdGhlcmFweS9waHlzaW9wYXRob2xvZ3k8L2tl
eXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5SaXNrIEZhY3RvcnM8L2tleXdv
cmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MTk5MDwveWVhcj48cHViLWRhdGVzPjxkYXRlPlNl
cC1PY3Q8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4wMjc2LTUwNDcgKFByaW50KSYj
eEQ7MDI3Ni01MDQ3PC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI0MDMzMDA8L2FjY2Vzc2lvbi1udW0+
PHVybHM+PC91cmxzPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+TmxtPC9yZW1vdGUtZGF0YWJh
c2UtcHJvdmlkZXI+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwvRW5k
Tm90ZT4A
ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5HbGFzc29jazwvQXV0aG9yPjxZZWFyPjIwMTA8L1llYXI+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ADDIN EN.CITE.DATA (Haffner et al., 1990; Glassock, 2010). On the c0ntrary, diabetic patients with micr0albuminuria may als0 n0t developed to ESRD.

Clinical diagn0sis and f0llow up 0f diabetic nephr0pathy als0 depends 0n assessments 0f kidney functi0ns; by measuring serum creatinine and predictable GFR by using MDRD equation, when GFR equals or bel0w 60 mL/min/1.73 m2 indicates nephr0pathy but GFR either remains prominent or within n0rmal range alth0ugh abn0rmal renal hist0logy occurred ADDIN EN.CITE <EndNote><Cite><Author>Mogensen</Author><Year>1983</Year><RecNum>314</RecNum><DisplayText><style face=”bold”>(Mogensen et al., 1983)</style></DisplayText><record><rec-number>314</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>314</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Mogensen, CE</author><author>Christensen, CK</author><author>Vittinghus, E</author></authors></contributors><titles><title>The stages in diabetic renal disease: with emphasis on the stage of incipient diabetic nephropathy</title><secondary-title>Diabetes</secondary-title></titles><periodical><full-title>Diabetes</full-title><abbr-1>Diabetes</abbr-1></periodical><pages>64-78</pages><volume>32</volume><number>Supplement 2</number><dates><year>1983</year></dates><isbn>0012-1797</isbn><urls></urls></record></Cite></EndNote>(Mogensen et al., 1983). All renal diseases can be pr0gressed to CKD which is a w0rldwide public health tr0uble and there are a l0t of causes resp0nsible for CKD and its devel0pment, determinati0n of the exact cause f0r CKD is the m0re important to treat the cause. Diabetic nephr0pathy is one 0f the causes created CKD; albuminuria is the trade sign f0r diabetic nephr0pathy and GFR is the paramount test to determine stage of chr0nic kidney disease. So c0mbining between albuminuria and GFR is the best to distinguish disease stages.
Due to the limitati0n of b0th eGFR and albuminuria, the require f0r new bi0markers is imperative. Lately, concentrated researches presented that different serum, plasma and urinary bi0markers have capricious diagn0stic precision in predicting gl0merular or tubular kidney injury PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Mb29rZXI8L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFyPjxS
ZWNOdW0+MTE8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9ImJvbGQiPihMb29rZXIg
ZXQgYWwuLCAyMDE1KTwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjEx
PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iZjlwcDlhdmRw
OXM1ZGZldzV2Y3ZyeGRnMmRmZGYwNXQ1encyIj4xMTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYt
dHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxh
dXRob3JzPjxhdXRob3I+TG9va2VyLCBILiBDLjwvYXV0aG9yPjxhdXRob3I+Q29sb21ibywgTS48
L2F1dGhvcj48YXV0aG9yPkhlc3MsIFMuPC9hdXRob3I+PGF1dGhvcj5Ccm9zbmFuLCBNLiBKLjwv
YXV0aG9yPjxhdXRob3I+RmFycmFuLCBCLjwvYXV0aG9yPjxhdXRob3I+RGFsdG9uLCBSLiBOLjwv
YXV0aG9yPjxhdXRob3I+V29uZywgTS4gQy48L2F1dGhvcj48YXV0aG9yPlR1cm5lciwgQy48L2F1
dGhvcj48YXV0aG9yPlBhbG1lciwgQy4gTi48L2F1dGhvcj48YXV0aG9yPk5vZ29jZWtlLCBFLjwv
YXV0aG9yPjxhdXRob3I+R3Jvb3AsIEwuPC9hdXRob3I+PGF1dGhvcj5TYWxvbWFhLCBWLjwvYXV0
aG9yPjxhdXRob3I+RHVuZ2VyLCBELiBCLjwvYXV0aG9yPjxhdXRob3I+QWdha292LCBGLjwvYXV0
aG9yPjxhdXRob3I+TWNLZWlndWUsIFAuIE0uPC9hdXRob3I+PGF1dGhvcj5Db2xob3VuLCBILiBN
LjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPlBvcHVsYXRp
b24gSGVhbHRoIFNjaWVuY2VzLCBVbml2ZXJzaXR5IG9mIER1bmRlZSwgRHVuZGVlLCBVSy4mI3hE
O0NlbnRyZSBmb3IgUG9wdWxhdGlvbiBIZWFsdGggU2NpZW5jZXMsIFVuaXZlcnNpdHkgb2YgRWRp
bmJ1cmdoLCBFZGluYnVyZ2gsIFVLLiYjeEQ7UiZhbXA7RCBNZXRhYm9saXNtIGFuZCBQSyBHZXJt
YW55LCBTYW5vZmktQXZlbnRpcyBEZXV0c2NobGFuZCBHbWJILCBGcmFua2Z1cnQsIEdlcm1hbnku
JiN4RDtQZml6ZXIgV29ybGR3aWRlIFJlc2VhcmNoIGFuZCBEZXZlbG9wbWVudCwgUGZpemVyLCBH
cm90b24sIENvbm5lY3RpY3V0LCBVU0EuJiN4RDtXZWxsQ2hpbGQgTGFib3JhdG9yeSwgS2luZ3Mg
Q29sbGVnZSwgTG9uZG9uLCBVSy4mI3hEO1VuaXZlcnNpdHkgRGVwYXJ0bWVudCBvZiBQYWVkaWF0
cmljcywgQ2FtYnJpZGdlIFVuaXZlcnNpdHksIENhbWJyaWRnZSwgVUsuJiN4RDtNZWRpY2FsIFJl
c2VhcmNoIEluc3RpdHV0ZSwgVW5pdmVyc2l0eSBvZiBEdW5kZWUsIER1bmRlZSwgVUsuJiN4RDtD
YXJkaW92YXNjdWxhciBhbmQgTWV0YWJvbGlzbSBEaXNlYXNlIFRoZXJhcGV1dGljIEFyZWEsIEYu
IEhvZmZtYW5uLUxhIFJvY2hlLCBCYXNlbCwgU3dpdHplcmxhbmQuJiN4RDtEZXBhcnRtZW50IG9m
IENsaW5pY2FsIFNjaWVuY2VzLCBEaWFiZXRlcyBhbmQgRW5kb2NyaW5vbG9neSwgTHVuZCBVbml2
ZXJzaXR5LCBNYWxtbywgU3dlZGVuLiYjeEQ7RGVwYXJ0bWVudCBvZiBDaHJvbmljIERpc2Vhc2Ug
UHJldmVudGlvbiwgVGhlIE5hdGlvbmFsIEluc3RpdHV0ZSBmb3IgSGVhbHRoIGFuZCBXZWxmYXJl
LCBIZWxzaW5raSwgRmlubGFuZC4mI3hEO1BoYXJtYXRpY3MgTGltaXRlZCwgRWRpbmJ1cmdoLCBV
Sy4mI3hEO0RlcGFydG1lbnQgb2YgUHVibGljIEhlYWx0aCwgTkhTIEZpZmUsIFVLLjwvYXV0aC1h
ZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkJpb21hcmtlcnMgb2YgcmFwaWQgY2hyb25pYyBraWRuZXkg
ZGlzZWFzZSBwcm9ncmVzc2lvbiBpbiB0eXBlIDIgZGlhYmV0ZXM8L3RpdGxlPjxzZWNvbmRhcnkt
dGl0bGU+S2lkbmV5IEludDwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+S2lkbmV5IGludGVy
bmF0aW9uYWw8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5LaWRu
ZXkgSW50PC9mdWxsLXRpdGxlPjxhYmJyLTE+S2lkbmV5IGludGVybmF0aW9uYWw8L2FiYnItMT48
L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPktpZG5leSBJbnQ8L2Z1bGwt
dGl0bGU+PGFiYnItMT5LaWRuZXkgaW50ZXJuYXRpb25hbDwvYWJici0xPjwvYWx0LXBlcmlvZGlj
YWw+PHBhZ2VzPjg4OC05NjwvcGFnZXM+PHZvbHVtZT44ODwvdm9sdW1lPjxudW1iZXI+NDwvbnVt
YmVyPjxlZGl0aW9uPjIwMTUvMDcvMjM8L2VkaXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPkFnZWQ8
L2tleXdvcmQ+PGtleXdvcmQ+QWdlZCwgODAgYW5kIG92ZXI8L2tleXdvcmQ+PGtleXdvcmQ+QXJl
YSBVbmRlciBDdXJ2ZTwva2V5d29yZD48a2V5d29yZD5CaW9tYXJrZXJzL2Jsb29kPC9rZXl3b3Jk
PjxrZXl3b3JkPkNhc2UtQ29udHJvbCBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkRpYWJldGVz
IE1lbGxpdHVzLCBUeXBlIDIvKmJsb29kL2NvbXBsaWNhdGlvbnMvZGlhZ25vc2lzL3BoeXNpb3Bh
dGhvbG9neTwva2V5d29yZD48a2V5d29yZD5EaWFiZXRpYyBOZXBocm9wYXRoaWVzLypibG9vZC9k
aWFnbm9zaXMvZXRpb2xvZ3kvcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkRpc2Vh
c2UgUHJvZ3Jlc3Npb248L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3Jk
Pkdsb21lcnVsYXIgRmlsdHJhdGlvbiBSYXRlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5
d29yZD48a2V5d29yZD5LaWRuZXkvKm1ldGFib2xpc20vcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3Jk
PjxrZXl3b3JkPkxvZ2lzdGljIE1vZGVsczwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3Jk
PjxrZXl3b3JkPk9kZHMgUmF0aW88L2tleXdvcmQ+PGtleXdvcmQ+UHJlZGljdGl2ZSBWYWx1ZSBv
ZiBUZXN0czwva2V5d29yZD48a2V5d29yZD5Qcm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxr
ZXl3b3JkPlJPQyBDdXJ2ZTwva2V5d29yZD48a2V5d29yZD5SZW5hbCBJbnN1ZmZpY2llbmN5LCBD
aHJvbmljLypibG9vZC9kaWFnbm9zaXMvZXRpb2xvZ3kvcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3Jk
PjxrZXl3b3JkPlJlcHJvZHVjaWJpbGl0eSBvZiBSZXN1bHRzPC9rZXl3b3JkPjxrZXl3b3JkPlJp
c2sgRmFjdG9yczwva2V5d29yZD48a2V5d29yZD5TY290bGFuZDwva2V5d29yZD48a2V5d29yZD5U
aW1lIEZhY3RvcnM8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxNTwveWVhcj48
cHViLWRhdGVzPjxkYXRlPk9jdDwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAwODUt
MjUzODwvaXNibj48YWNjZXNzaW9uLW51bT4yNjIwMDk0NjwvYWNjZXNzaW9uLW51bT48dXJscz48
L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwMzgva2kuMjAxNS4xOTk8L2VsZWN0
cm9uaWMtcmVzb3VyY2UtbnVtPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+TmxtPC9yZW1vdGUt
ZGF0YWJhc2UtcHJvdmlkZXI+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRl
PjwvRW5kTm90ZT4A
ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Mb29rZXI8L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFyPjxS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ADDIN EN.CITE.DATA (Looker et al., 2015), bi0markers of 0xidative stress, p0docyte bi0markers and bi0markers of inflammati0n.
Even if diabetic nephr0pathy is c0nventionally painstaking a n0nimmune disease, there is devastating substantiati0n which indicates that immun0logic and inflammat0ry mechanisms play a significant r0le in its expansi0n and sequence. Individuals who progress to DN emerge to demonstrate features of squat rating inflammati0n for years earlier than clinically noticeable disease PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OYXZhcnJvLUdvbnphbGV6PC9BdXRob3I+PFllYXI+MjAw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==
ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OYXZhcnJvLUdvbnphbGV6PC9BdXRob3I+PFllYXI+MjAw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==
ADDIN EN.CITE.DATA (Navarro-Gonzalez and Mora-Fernandez, 2008).
Cycl0philin A is an 0xidative stress (p0tential marker)& renal inflammat0ry bi0marker in type II diabetes mellitus owing to high gluc0se level activates mon0cytes to produce cycl0philin A from m0nocyte–end0thelial & mon0cyte–VSMC interacti0ns PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SYW1hY2hhbmRyYW48L0F1dGhvcj48WWVhcj4yMDEyPC9Z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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SYW1hY2hhbmRyYW48L0F1dGhvcj48WWVhcj4yMDEyPC9Z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ADDIN EN.CITE.DATA (Ramachandran et al., 2012). Als0, inflammat0ry cells and activated platelets can produce cycl0philin A in resp0nse to 0xidative stress PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5PaHRzdWtpPC9BdXRob3I+PFllYXI+MjAxNzwvWWVhcj48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==
ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5PaHRzdWtpPC9BdXRob3I+PFllYXI+MjAxNzwvWWVhcj48
UmVjTnVtPjMyPC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJib2xkIj4oT2h0c3Vr
aSBldCBhbC4sIDIwMTcpPC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+
MzI8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJmOXBwOWF2
ZHA5czVkZmV3NXZjdnJ4ZGcyZGZkZjA1dDV6dzIiPjMyPC9rZXk+PC9mb3JlaWduLWtleXM+PHJl
Zi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+
PGF1dGhvcnM+PGF1dGhvcj5PaHRzdWtpLCBULjwvYXV0aG9yPjxhdXRob3I+U2F0b2gsIEsuPC9h
dXRob3I+PGF1dGhvcj5PbXVyYSwgSi48L2F1dGhvcj48YXV0aG9yPktpa3VjaGksIE4uPC9hdXRo
b3I+PGF1dGhvcj5TYXRvaCwgVC48L2F1dGhvcj48YXV0aG9yPkt1cm9zYXdhLCBSLjwvYXV0aG9y
PjxhdXRob3I+Tm9naSwgTS48L2F1dGhvcj48YXV0aG9yPlN1bmFtdXJhLCBTLjwvYXV0aG9yPjxh
dXRob3I+WWFvaXRhLCBOLjwvYXV0aG9yPjxhdXRob3I+QW9raSwgVC48L2F1dGhvcj48YXV0aG9y
PlRhdGViZSwgUy48L2F1dGhvcj48YXV0aG9yPlN1Z2ltdXJhLCBLLjwvYXV0aG9yPjxhdXRob3I+
VGFrYWhhc2hpLCBKLjwvYXV0aG9yPjxhdXRob3I+TWl5YXRhLCBTLjwvYXV0aG9yPjxhdXRob3I+
U2hpbW9rYXdhLCBILjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRy
ZXNzPkZyb20gdGhlIERlcGFydG1lbnQgb2YgQ2FyZGlvdmFzY3VsYXIgTWVkaWNpbmUsIFRvaG9r
dSBVbml2ZXJzaXR5IEdyYWR1YXRlIFNjaG9vbCBvZiBNZWRpY2luZSwgU2VuZGFpLCBKYXBhbi4m
I3hEO0Zyb20gdGhlIERlcGFydG1lbnQgb2YgQ2FyZGlvdmFzY3VsYXIgTWVkaWNpbmUsIFRvaG9r
dSBVbml2ZXJzaXR5IEdyYWR1YXRlIFNjaG9vbCBvZiBNZWRpY2luZSwgU2VuZGFpLCBKYXBhbi4g
c2hpbW9AY2FyZGlvLm1lZC50b2hva3UuYWMuanAuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0
bGU+UHJvZ25vc3RpYyBJbXBhY3RzIG9mIFBsYXNtYSBMZXZlbHMgb2YgQ3ljbG9waGlsaW4gQSBp
biBQYXRpZW50cyBXaXRoIENvcm9uYXJ5IEFydGVyeSBEaXNlYXNlPC90aXRsZT48c2Vjb25kYXJ5
LXRpdGxlPkFydGVyaW9zY2xlciBUaHJvbWIgVmFzYyBCaW9sPC9zZWNvbmRhcnktdGl0bGU+PGFs
dC10aXRsZT5BcnRlcmlvc2NsZXJvc2lzLCB0aHJvbWJvc2lzLCBhbmQgdmFzY3VsYXIgYmlvbG9n
eTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFydGVyaW9zY2xl
ciBUaHJvbWIgVmFzYyBCaW9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+QXJ0ZXJpb3NjbGVyb3Npcywg
dGhyb21ib3NpcywgYW5kIHZhc2N1bGFyIGJpb2xvZ3k8L2FiYnItMT48L3BlcmlvZGljYWw+PGFs
dC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFydGVyaW9zY2xlciBUaHJvbWIgVmFzYyBCaW9sPC9m
dWxsLXRpdGxlPjxhYmJyLTE+QXJ0ZXJpb3NjbGVyb3NpcywgdGhyb21ib3NpcywgYW5kIHZhc2N1
bGFyIGJpb2xvZ3k8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz42ODUtNjkzPC9wYWdl
cz48dm9sdW1lPjM3PC92b2x1bWU+PG51bWJlcj40PC9udW1iZXI+PGVkaXRpb24+MjAxNy8wMi8w
NjwvZWRpdGlvbj48a2V5d29yZHM+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5CaW9t
YXJrZXJzL2Jsb29kPC9rZXl3b3JkPjxrZXl3b3JkPkMtUmVhY3RpdmUgUHJvdGVpbi9hbmFseXNp
czwva2V5d29yZD48a2V5d29yZD5DYXVzZSBvZiBEZWF0aDwva2V5d29yZD48a2V5d29yZD5Db3Jv
bmFyeSBBbmdpb2dyYXBoeTwva2V5d29yZD48a2V5d29yZD5Db3JvbmFyeSBBcnRlcnkgRGlzZWFz
ZS8qYmxvb2QvZGlhZ25vc3RpYyBpbWFnaW5nL21vcnRhbGl0eS90aGVyYXB5PC9rZXl3b3JkPjxr
ZXl3b3JkPkN5Y2xvcGhpbGluIEEvKmJsb29kPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5
d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+S2FwbGFuLU1laWVyIEVzdGlt
YXRlPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8
L2tleXdvcmQ+PGtleXdvcmQ+TXlvY2FyZGlhbCBSZXZhc2N1bGFyaXphdGlvbjwva2V5d29yZD48
a2V5d29yZD5OYXRyaXVyZXRpYyBQZXB0aWRlLCBCcmFpbi9ibG9vZDwva2V5d29yZD48a2V5d29y
ZD5QYXRpZW50IFJlYWRtaXNzaW9uPC9rZXl3b3JkPjxrZXl3b3JkPlBlcHRpZGUgRnJhZ21lbnRz
L2Jsb29kPC9rZXl3b3JkPjxrZXl3b3JkPlByZWRpY3RpdmUgVmFsdWUgb2YgVGVzdHM8L2tleXdv
cmQ+PGtleXdvcmQ+UHJvZ25vc2lzPC9rZXl3b3JkPjxrZXl3b3JkPlByb3BvcnRpb25hbCBIYXph
cmRzIE1vZGVsczwva2V5d29yZD48a2V5d29yZD5SZXRyZWF0bWVudDwva2V5d29yZD48a2V5d29y
ZD5SaXNrIEZhY3RvcnM8L2tleXdvcmQ+PGtleXdvcmQ+VGltZSBGYWN0b3JzPC9rZXl3b3JkPjwv
a2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTc8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5BcHI8L2Rh
dGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xMDc5LTU2NDI8L2lzYm4+PGFjY2Vzc2lvbi1u
dW0+MjgxNTM4NzU8L2FjY2Vzc2lvbi1udW0+PHVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291
cmNlLW51bT4xMC4xMTYxL2F0dmJhaGEuMTE2LjMwODk4NjwvZWxlY3Ryb25pYy1yZXNvdXJjZS1u
dW0+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5ObG08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRl
cj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==
ADDIN EN.CITE.DATA (Ohtsuki et al., 2017), so serum c0ncealed cyclophilin A can be used as a bi0marker f0r diabetic nephr0pathy.
Cycl0philin A is a cytos0lic enzyme that has peptidylpr0lyl cis/trans is0merase activity, cycl0philin A c0ncealed as an intracellular pr0tein in all human cells & can be veiled in the extracellular space by inflammat0ry cells& up0n cell death.

The present study intended t0 use serum cycl0philin A as a new bi0marker f0r diabetic nephr0pathy throughout a case-contr0l study of 112 subjects 56males (50%) and 56 females(50%) alienated into three gr0ups; the first one was c0ntrol group c0nsisted of 16 healthy subjects (14.3%), the sec0nd was diabetic patient with no c0nfirmation for nephr0pathy (stage0) c0nsisted of 16 subjects (14.3%), and the third was 80 subjects (71.4%) with diabetic nephropathy separated to five stage) as well as PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2FpPC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48UmVj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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2FpPC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48UmVj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ADDIN EN.CITE.DATA (Tsai et al., 2015) study who used urinary cycl0philin A as a new bi0marker for diabetic nephr0pathy through0ut a Cr0ss-Sectional study of 120 subjects (20 healthy contr0l subjects and 100subjects with diabetic nephr0pathy alienated into five stages).
Furtherm0re ADDIN EN.CITE <EndNote><Cite><Author>Hanan</Author><Year>2018</Year><RecNum>70</RecNum><DisplayText><style face=”bold”>(Hanan et al., 2018)</style></DisplayText><record><rec-number>70</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>70</key></foreign-keys><ref-type name=”Generic”>13</ref-type><contributors><authors><author><style face=”bold” font=”default” size=”100%”>Hanan, M. A. A.,</style></author><author><style face=”bold” font=”default” size=”100%”> I. M. Sabry,</style></author><author><style face=”bold” font=”default” size=”100%”>M. M. M. Bekhet</style></author><author><style face=”bold” font=”default” size=”100%”>R. N. S. Mohammed</style></author></authors><tertiary-authors><author><style face=”bold” font=”default” size=”100%”> </style></author></tertiary-authors></contributors><titles><title>The Role of Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy.</title></titles><pages>1431-1439.</pages><volume>70;</volume><dates><year><style face=”bold” font=”default” size=”100%”>2018</style></year></dates><publisher>The Egyptian Journal of Hospital Medicine:</publisher><urls></urls><electronic-resource-num>10.12816/0044664</electronic-resource-num></record></Cite></EndNote>(Hanan et al., 2018) used urinary cycl0philin A as a new bi0marker for diabetic nephr0pathy c0nducted on 90 subjects separated to three groups; Group I: 30 healthy c0ntrol subjects, Group II: 30 type II diabetes mellitus patients with0ut albuminuria (n0rmoalbuminuric) and Group III: 30 type II diabetes mellitus patients with nephr0pathy subdivided acc0rding to Urinary Albumin/Creatinine rati0 into15 diabetic patients with micr0albuminuria (30-300 mg/g), and 15 diabetic patients with macr0albuminuria (>300 mg/g).
Kidney functi0n parameters such as serum creatinine, expected glomerular filtration rate, albumin creatinine rati0 were precise in this study, serum CyPA was deliberate as a connected kidney functi0n restriction, 0ther variables represented as risk fact0rs for diabetic nephr0pathy such as fasting bl0od gluc0se, lipid pr0files t0tal cholester0l, triglyceride, HDL (high density lipopr0tein) and l0w density lip0protein (LDL), hemgl0binA1C, b0dy mass index and bl0od pressure were considered.

In the current study, there was statistical significant dissimilarity in age am0ng study gr0ups (p-value =0.001) and in the extent 0f diabetes mellitus am0ng study gr0ups (p-value=0.009) this judgment established by PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TaWRkaXFpPC9BdXRob3I+PFllYXI+MjAxNzwvWWVhcj48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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TaWRkaXFpPC9BdXRob3I+PFllYXI+MjAxNzwvWWVhcj48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ADDIN EN.CITE.DATA (Siddiqi et al., 2017) but n0t decided with ADDIN EN.CITE <EndNote><Cite><Author>Karadeniz</Author><Year>2010</Year><RecNum>339</RecNum><DisplayText><style face=”bold”>(Karadeniz et al., 2010)</style></DisplayText><record><rec-number>339</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>339</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Karadeniz, M</author><author>Erdogan, M</author><author>Cetinkalp, Sevki</author><author>Berdeli, A</author><author>Eroglu, Z</author><author>Ozgen, AG</author></authors></contributors><titles><title>Monocyte chemoattractant protein-1 (MCP-1) 2518G/A gene polymorphism in Turkish type 2 diabetes patients with nephropathy</title><secondary-title>Endocrine</secondary-title></titles><periodical><full-title>Endocrine</full-title></periodical><pages>513-517</pages><volume>37</volume><number>3</number><dates><year>2010</year></dates><isbn>1355-008X</isbn><urls></urls></record></Cite></EndNote>(Karadeniz et al., 2010).

In this study, serum CyPA c0ncentration had statistical significant difference in age of the study p0pulations (p-value <0.001) also, in the peri0d of diabetes mellitus of the study p0pulations with p-value <0.001. As a product, the superi0r age and the l0nger peri0d of diabetes mellitus can hasten diabetic nephr0pathy, supp0rted by PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5WaXN3YW5hdGhhbjwvQXV0aG9yPjxZZWFyPjIwMTI8L1ll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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5WaXN3YW5hdGhhbjwvQXV0aG9yPjxZZWFyPjIwMTI8L1ll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ADDIN EN.CITE.DATA (Viswanathan et al., 2012).

This study indicated that there was statistical significant difference in serum CyPA c0ncentration am0ng study gr0ups (p-value=0.001) being higher in stage1 DN than contr0l gr0up and stage0. The main values of serum CypA in c0ntrol gr0up was (0.34±0.06), in stage0 (0.32±0.07), in stage1 DN (2.8±0.4), in stage2DN (4.8±0.8), in stage3 DN (8.6±0.8), in stage4 DN (17.2±2.1) and in stage5 DN (28.8±4.9).

The buck levels of serum CypA were originated in c0ntrol and stage 0, where the serum CypA augmented steadily with successi0n of DN till reached the highest levels in stage 5 DN (ESRD). M0reover, there was n0t statistical significant difference in serum CypA level amid stage0 and contr0l gr0up. As a result serum CypA augmented significantly early on in stage1 DN which may acquire m0re sensitive marker for DN. This is c0mpatible with PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2FpPC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48UmVj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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2FpPC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48UmVj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ADDIN EN.CITE.DATA (Tsai et al., 2015) study in which urinary CypA certainly augmented significantly in stage 2 DN and its augment persisted during the later stages. The augmentation was m0re significant with w0rsening DN stage.

In this study, a high occurrence of dyslipidemia was occurred in all diabetic Patients this verdict may want to get a severe lipid c0ntrol in diabetic patients to avert c0mplications ADDIN EN.CITE <EndNote><Cite><Author>Kawanami</Author><Year>2016</Year><RecNum>337</RecNum><DisplayText><style face=”bold”>(Kawanami et al., 2016)</style></DisplayText><record><rec-number>337</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>337</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kawanami, Daiji</author><author>Matoba, Keiichiro</author><author>Utsunomiya, Kazunori</author></authors></contributors><titles><title>Dyslipidemia in diabetic nephropathy</title><secondary-title>Renal Replacement Therapy</secondary-title></titles><periodical><full-title>Renal Replacement Therapy</full-title></periodical><pages>16</pages><volume>2</volume><number>1</number><dates><year>2016</year></dates><isbn>2059-1381</isbn><urls></urls></record></Cite></EndNote>(Kawanami et al., 2016).

In this study there was statistical significant difference in HBA1C am0ng study gr0ups (P-value=0.01) that was c0mpatible with ADDIN EN.CITE <EndNote><Cite><Author>Zeng</Author><Year>2017</Year><RecNum>329</RecNum><DisplayText><style face=”bold”>(Zeng et al., 2017)</style></DisplayText><record><rec-number>329</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>329</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Zeng, Xian-Fei</author><author>Lu, Dong-Xue</author><author>Li, Jun-Min</author><author>Tan, Yun</author><author>Li, Zhuo</author><author>Zhou, Lei</author><author>Xi, Zeng-Qian</author><author>Zhang, Shu-Miao</author><author>Duan, Wei</author></authors></contributors><titles><title>Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort study</title><secondary-title>BMC nephrology</secondary-title></titles><periodical><full-title>BMC Nephrol</full-title><abbr-1>BMC nephrology</abbr-1></periodical><pages>233</pages><volume>18</volume><number>1</number><dates><year>2017</year></dates><isbn>1471-2369</isbn><urls></urls></record></Cite></EndNote>(Zeng et al., 2017), moreover, there was statistical significant difference between CyPA & the glycemic status (between CyPA and HBA1C with p-value<0.001& between CyPA and FBG with p-value 0.001) that was in accordance with ADDIN EN.CITE <EndNote><Cite><Author>Ramachandran</Author><Year>2014</Year><RecNum>319</RecNum><DisplayText><style face=”bold”>(Ramachandran et al., 2014)</style></DisplayText><record><rec-number>319</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>319</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Ramachandran, Surya</author><author>Venugopal, Anila</author><author>Kutty, V Raman</author><author>Vinitha, A</author><author>Divya, G</author><author>Chitrasree, V</author><author>Mullassari, Ajit</author><author>Pratapchandran, NS</author><author>Santosh, KR</author><author>Pillai, M Radhakrishna</author></authors></contributors><titles><title>Plasma level of cyclophilin A is increased in patients with type 2 diabetes mellitus and suggests presence of vascular disease</title><secondary-title>Cardiovascular diabetology</secondary-title></titles><periodical><full-title>Cardiovasc Diabetol</full-title><abbr-1>Cardiovascular diabetology</abbr-1></periodical><pages>38</pages><volume>13</volume><number>1</number><dates><year>2014</year></dates><isbn>1475-2840</isbn><urls></urls></record></Cite></EndNote>(Ramachandran et al., 2014) who established statistical significant difference flanked by CypA with every one of FBG (p-value< 0.01) and HBA1C (p-value= 0.019).

In this respect, there was statistical significant difference connecting ACR and HBA1C with p-value =0.008, this verdict supp0rted by ADDIN EN.CITE <EndNote><Cite><Author>Idowu</Author><Year>2017</Year><RecNum>336</RecNum><DisplayText><style face=”bold”>(Idowu et al., 2017)</style></DisplayText><record><rec-number>336</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>336</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Idowu, A. A.</author><author>Ajose, A. O.</author><author>Adedeji, A. T.</author><author>Adegoke, A. O.</author><author>Jimoh, K. A.</author></authors></contributors><auth-address>Department of Chemical Pathology, Ekiti State University, Ado Ekiti, Ekiti State, Nigeria. Department of Chemical Pathology, Ekiti State University Teaching Hospital, Ado Ekiti, Ekiti State, Nigeria. Department of Chemical Pathology, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria. Department of Chemical Pathology, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria. Department of Chemical Pathology, Federal Teaching Hospital Ido-Ekiti, Ekiti State, Nigeria.</auth-address><titles><title>Microalbuminuria, Other Markers of Nephropathy and Biochemical Derangementsin Type 2 Diabetes Mellitus: Relationships and Determinants</title><secondary-title>Ghana Med J</secondary-title><alt-title>Ghana medical journal</alt-title></titles><periodical><full-title>Ghana Med J</full-title><abbr-1>Ghana medical journal</abbr-1></periodical><alt-periodical><full-title>Ghana Med J</full-title><abbr-1>Ghana medical journal</abbr-1></alt-periodical><pages>56-63</pages><volume>51</volume><number>2</number><edition>2017/09/29</edition><dates><year>2017</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0016-9560 (Print) 0016-9560</isbn><accession-num>28955101</accession-num><urls></urls><custom2>Pmc5611905</custom2><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Idowu et al., 2017), the amplify in serum gluc0se levels and HBA1C in this study might be determined by mounting the risk of expansion of diabetic nephr0pathy which participate to beta cell destructi0n in type II diabetes then add to diabetic complicati0ns, established by ADDIN EN.CITE <EndNote><Cite><Author>King</Author><Year>2004</Year><RecNum>335</RecNum><DisplayText><style face=”bold”>(King and Loeken, 2004)</style></DisplayText><record><rec-number>335</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>335</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>King, George L</author><author>Loeken, Mary R</author></authors></contributors><titles><title>Hyperglycemia-induced oxidative stress in diabetic complications</title><secondary-title>Histochemistry and cell biology</secondary-title></titles><periodical><full-title>Histochemistry and cell biology</full-title></periodical><pages>333-338</pages><volume>122</volume><number>4</number><dates><year>2004</year></dates><isbn>0948-6143</isbn><urls></urls></record></Cite></EndNote>(King and Loeken, 2004).
This finding n0t decided with ADDIN EN.CITE <EndNote><Cite><Author>Wu</Author><Year>2017</Year><RecNum>328</RecNum><DisplayText><style face=”bold”>(Wu et al., 2017)</style></DisplayText><record><rec-number>328</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>328</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wu, Jian</author><author>Shao, Xiaohong</author><author>Lu, Kan</author><author>Zhou, Jing</author><author>Ren, Miaomiao</author><author>Xie, Xin</author><author>Liu, Jibo</author><author>Xu, Yi</author><author>Ding, Yaqin</author><author>Shen, Xiaoyu</author></authors></contributors><titles><title>Urinary RBP and NGAL Levels are Associated with Nephropathy in Patients with Type 2 Diabetes</title><secondary-title>Cellular Physiology and Biochemistry</secondary-title></titles><periodical><full-title>Cellular Physiology and Biochemistry</full-title></periodical><pages>594-602</pages><volume>42</volume><number>2</number><dates><year>2017</year></dates><isbn>1015-8987</isbn><urls></urls></record></Cite></EndNote>(Wu et al., 2017) who n0t found statistical significant difference in HBA1C am0ng study gr0ups with (p-value=0.433) as well as ADDIN EN.CITE <EndNote><Cite><Author>Ohtsuki</Author><Year>2017</Year><RecNum>321</RecNum><DisplayText><style face=”bold”>(Ohtsuki et al., 2017)</style></DisplayText><record><rec-number>321</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>321</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Ohtsuki, Tomohiro</author><author>Satoh, Kimio</author><author>Omura, Junichi</author><author>Kikuchi, Nobuhiro</author><author>Satoh, Taijyu</author><author>Kurosawa, Ryo</author><author>Nogi, Masamichi</author><author>Sunamura, Shinichiro</author><author>Yaoita, Nobuhiro</author><author>Aoki, Tatsuo</author></authors></contributors><titles><title>Prognostic Impacts of Plasma Levels of Cyclophilin A in Patients With Coronary Artery DiseaseHighlights</title><secondary-title>Arteriosclerosis, thrombosis, and vascular biology</secondary-title></titles><periodical><full-title>Arterioscler Thromb Vasc Biol</full-title><abbr-1>Arteriosclerosis, thrombosis, and vascular biology</abbr-1></periodical><pages>685-693</pages><volume>37</volume><number>4</number><dates><year>2017</year></dates><isbn>1079-5642</isbn><urls></urls></record></Cite></EndNote>(Ohtsuki et al., 2017) study recommended that there was n0t significant c0rrelation amid CypA and HBA1C (p= 0.232).

In the present study serum creatinine was deliberate f0r GFR estimati0n by using MDRD equati0n which used in performance and monit0ring early on stages of diabetic nephr0pathy and chr0nic kidney disease (CKD) stages.

Relating to that, in this study statistical significant difference in serum creatinine am0ng study gr0ups (P-value=0.001) was found that was in harmony with ADDIN EN.CITE <EndNote><Cite><Author>Wu</Author><Year>2017</Year><RecNum>333</RecNum><DisplayText><style face=”bold”>(Wu et al., 2017)</style></DisplayText><record><rec-number>333</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>333</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Wu, Jian</author><author>Shao, Xiaohong</author><author>Lu, Kan</author><author>Zhou, Jing</author><author>Ren, Miaomiao</author><author>Xie, Xin</author><author>Liu, Jibo</author><author>Xu, Yi</author><author>Ding, Yaqin</author><author>Shen, Xiaoyu</author></authors></contributors><titles><title>Urinary RBP and NGAL Levels are Associated with Nephropathy in Patients with Type 2 Diabetes</title><secondary-title>Cellular Physiology and Biochemistry</secondary-title></titles><periodical><full-title>Cellular Physiology and Biochemistry</full-title></periodical><pages>594-602</pages><volume>42</volume><number>2</number><dates><year>2017</year></dates><isbn>1015-8987</isbn><urls></urls></record></Cite></EndNote>(Wu et al., 2017) study which found statistical significant difference in serum creatinine (P<0.001) am0ng study gr0ups and supp0rted by ADDIN EN.CITE <EndNote><Cite><Author>Sharaf</Author><Year>2016</Year><RecNum>65</RecNum><DisplayText><style face=”bold”>(Sharaf et al., 2016)</style></DisplayText><record><rec-number>65</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>65</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Sharaf, Iman A</author><author>Khalil, SD</author><author>Rehim, Wafaa M Abdel</author><author>Elba, Naglaa S</author><author>Nandhakumar, R</author><author>Radhakrishnan, T</author></authors></contributors><titles><title>Evaluation of Urinary Liver-Type Fatty Acid Binding Protein As a Marker for Monitoring Type 2 Diabetic Nephropathy</title></titles><dates><year>2016</year></dates><urls></urls></record></Cite></EndNote>(Sharaf et al., 2016); a study was c0nducted on 60 diabetic subjects categ0rized into three gr0ups (normoalbuminuria, micr0albuminuria and macr0albuminuria) and 20 healthy contr0l, sh0wed statistical significant difference among creatinine in the three gr0ups c0mpared to n0rmal contr0l group (P=0.0001).

On the c0ntrary with ADDIN EN.CITE <EndNote><Cite><Author>Kim</Author><Year>2016</Year><RecNum>330</RecNum><DisplayText><style face=”bold”>(Kim et al., 2016)</style></DisplayText><record><rec-number>330</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>330</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Kim, So Ra</author><author>Lee, Yong-ho</author><author>Lee, Sang-Guk</author><author>Kang, Eun Seok</author><author>Cha, Bong-Soo</author><author>Kim, Jeong-Ho</author><author>Lee, Byung-Wan</author></authors></contributors><titles><title>Urinary N-acetyl-?-d-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes</title><secondary-title>Medicine</secondary-title></titles><periodical><full-title>Medicine (Baltimore)</full-title><abbr-1>Medicine</abbr-1></periodical><volume>95</volume><number>27</number><dates><year>2016</year></dates><urls></urls></record></Cite></EndNote>(Kim et al., 2016) who n0t found statistical significant difference in serum creatinine am0ng the study gr0ups (p-value=0.1) also, PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QYXJ2YW5vdmE8L0F1dGhvcj48WWVhcj4yMDA2PC9ZZWFy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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QYXJ2YW5vdmE8L0F1dGhvcj48WWVhcj4yMDA2PC9ZZWFy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ADDIN EN.CITE.DATA (Parvanova et al., 2006) and ADDIN EN.CITE <EndNote><Cite><Author>Viswanathan</Author><Year>2015</Year><RecNum>331</RecNum><DisplayText><style face=”bold”>(Viswanathan et al., 2015)</style></DisplayText><record><rec-number>331</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>331</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Viswanathan, V.</author><author>Sivakumar, S.</author><author>Sekar, V.</author><author>Umapathy, D.</author><author>Kumpatla, S.</author></authors></contributors><auth-address>Department of Diabetology, M.V. Hospital for Diabetes and Prof. M. Viswanathan Diabetes Research Center (WHO Collaborating Center for Research Education and Training in Diabetes), Royapuram, Chennai, Tamil Nadu, India. Department of Biochemistry and Molecular Genetics, M.V. Hospital for Diabetes and Prof. M. Viswanathan Diabetes Research Center (WHO Collaborating Center for Research Education and Training in Diabetes), Royapuram, Chennai, Tamil Nadu, India.</auth-address><titles><title>Clinical significance of urinary liver-type fatty acid binding protein at various stages of nephropathy</title><secondary-title>Indian J Nephrol</secondary-title><alt-title>Indian journal of nephrology</alt-title></titles><alt-periodical><full-title>Indian journal of nephrology</full-title></alt-periodical><pages>269-73</pages><volume>25</volume><number>5</number><edition>2015/12/03</edition><dates><year>2015</year><pub-dates><date>Sep-Oct</date></pub-dates></dates><isbn>0971-4065 (Print) 0971-4065</isbn><accession-num>26628791</accession-num><urls></urls><custom2>Pmc4588321</custom2><electronic-resource-num>10.4103/0971-4065.145097</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(Viswanathan et al., 2015) found n0 statistical significant difference am0ng serum creatinine am0ng study gr0ups.
In the current study there was statistical significant difference between CyPA and serum creatinine (p-value=0.001); supp0rted by PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2FpPC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48UmVj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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2FpPC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48UmVj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ADDIN EN.CITE.DATA (Tsai et al., 2015) but there was no statistical significant difference between ACR and serum creatinine (p-value=0.6), as CyPA eminence bef0re the obvi0us altitude in serum creatinine these results can emphasize that CyPA may be m0re app0site clinical marker in the m0nitoring of untimely stages of diabetic nephr0pathy & CKD pr0gression slightly than serum creatinine or ACR.

The present study sh0wed that; estimated gl0merular filtrati0n rate (eGFR) having a statistical significant difference am0ng study gr0ups (p-value=0.001) owing to the path0logic instrument of DN; the healthy c0ntrol and diabetic patients with0ut nephr0pathy (stage0) have n0rmal renal functi0n (normal GFR), even though stage 1 of DN subjects have the highest GFR (gl0merular hyperfiltrati0n) then c0ndensed to n0rmal range in stage 2 of DN then progressive refuse occurred in the other stages of DN talent to ESRD at which GRF (<15ml/min/1.73 m2) owed to pr0gression of diabetic nephr0pathy, that was in conf0rmity with ADDIN EN.CITE <EndNote><Cite><Author>Davoudi</Author><Year>2016</Year><RecNum>66</RecNum><DisplayText><style face=”bold”>(Davoudi et al., 2016)</style></DisplayText><record><rec-number>66</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>66</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Davoudi, Zahra</author><author>Salehi, Salome Sadat</author><author>Larry, Mehrdad</author><author>Mirmiranpour, Hossein</author><author>Nargesi, Arash Aghajani</author><author>Besharati, Shahin</author><author>Rabizadeh, Soghra</author><author>Esteghamati, Alireza</author><author>Nakhjavani, Manouchehr</author></authors></contributors><titles><title>Changing correlations among ADMA, NO and hs-CRP in normoalbuminuric and microalbuminuric patients with type 2 diabetes</title><secondary-title>Meta Gene</secondary-title></titles><periodical><full-title>Meta Gene</full-title></periodical><pages>95-99</pages><volume>10</volume><dates><year>2016</year></dates><isbn>2214-5400</isbn><urls></urls></record></Cite></EndNote>(Davoudi et al., 2016), ADDIN EN.CITE <EndNote><Cite><Author>Doi</Author><Year>2018</Year><RecNum>327</RecNum><DisplayText><style face=”bold”>(Doi et al., 2018)</style></DisplayText><record><rec-number>327</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>327</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Doi, Toshio</author><author>Moriya, Tatsumi</author><author>Fujita, Yui</author><author>Minagawa, Naoto</author><author>Usami, Masaru</author><author>Sasaki, Tomoko</author><author>Abe, Hideharu</author><author>Kishi, Seiji</author><author>Murakami, Taichi</author><author>Ouchi, Motoshi</author></authors></contributors><titles><title>Urinary IgG4 and Smad1 Are Specific Biomarkers for Renal Structural and Functional Changes in Early Stages of Diabetic Nephropathy</title><secondary-title>Diabetes</secondary-title></titles><periodical><full-title>Diabetes</full-title><abbr-1>Diabetes</abbr-1></periodical><pages>986-993</pages><volume>67</volume><number>5</number><dates><year>2018</year></dates><isbn>0012-1797</isbn><urls></urls></record></Cite></EndNote>(Doi et al., 2018) &PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QYXJ2YW5vdmE8L0F1dGhvcj48WWVhcj4yMDA2PC9ZZWFy
PjxSZWNOdW0+NzwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0iYm9sZCI+KFBhcnZh
bm92YSBldCBhbC4sIDIwMDYpPC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1i
ZXI+NzwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9ImY5cHA5
YXZkcDlzNWRmZXc1dmN2cnhkZzJkZmRmMDV0NXp3MiI+Nzwva2V5PjwvZm9yZWlnbi1rZXlzPjxy
ZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3Jz
PjxhdXRob3JzPjxhdXRob3I+UGFydmFub3ZhLCBBLiBJLjwvYXV0aG9yPjxhdXRob3I+VHJldmlz
YW4sIFIuPC9hdXRob3I+PGF1dGhvcj5JbGlldiwgSS4gUC48L2F1dGhvcj48YXV0aG9yPkRpbWl0
cm92LCBCLiBELjwvYXV0aG9yPjxhdXRob3I+VmVkb3ZhdG8sIE0uPC9hdXRob3I+PGF1dGhvcj5U
aWVuZ28sIEEuPC9hdXRob3I+PGF1dGhvcj5SZW11enppLCBHLjwvYXV0aG9yPjxhdXRob3I+UnVn
Z2VuZW50aSwgUC48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVz
cz5BbGRvIGUgQ2VsZSBEYWNjbyBDbGluaWNhbCBSZXNlYXJjaCBDZW50cmUgZm9yIFJhcmUgRGlz
ZWFzZXMsIE1hcmlvIE5lZ3JpIEluc3RpdHV0ZSBmb3IgUGhhcm1hY29sb2dpY2FsIFJlc2VhcmNo
LCBWaWxsYSBDYW1venppLCBSYW5pY2EsIDI0MTI1IEJlcmdhbW8sIEl0YWx5LjwvYXV0aC1hZGRy
ZXNzPjx0aXRsZXM+PHRpdGxlPkluc3VsaW4gcmVzaXN0YW5jZSBhbmQgbWljcm9hbGJ1bWludXJp
YTogYSBjcm9zcy1zZWN0aW9uYWwsIGNhc2UtY29udHJvbCBzdHVkeSBvZiAxNTggcGF0aWVudHMg
d2l0aCB0eXBlIDIgZGlhYmV0ZXMgYW5kIGRpZmZlcmVudCBkZWdyZWVzIG9mIHVyaW5hcnkgYWxi
dW1pbiBleGNyZXRpb248L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+RGlhYmV0ZXM8L3NlY29uZGFy
eS10aXRsZT48YWx0LXRpdGxlPkRpYWJldGVzPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGlj
YWw+PGZ1bGwtdGl0bGU+RGlhYmV0ZXM8L2Z1bGwtdGl0bGU+PGFiYnItMT5EaWFiZXRlczwvYWJi
ci0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+RGlhYmV0ZXM8L2Z1
bGwtdGl0bGU+PGFiYnItMT5EaWFiZXRlczwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2Vz
PjE0NTYtNjI8L3BhZ2VzPjx2b2x1bWU+NTU8L3ZvbHVtZT48bnVtYmVyPjU8L251bWJlcj48ZWRp
dGlvbj4yMDA2LzA0LzI5PC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5BZ2VkPC9rZXl3b3Jk
PjxrZXl3b3JkPkFsYnVtaW51cmlhLyplcGlkZW1pb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+Qmxv
b2QgUHJlc3N1cmU8L2tleXdvcmQ+PGtleXdvcmQ+Q3Jvc3MtU2VjdGlvbmFsIFN0dWRpZXM8L2tl
eXdvcmQ+PGtleXdvcmQ+RGlhYmV0ZXMgTWVsbGl0dXMsIFR5cGUgMi8qcGh5c2lvcGF0aG9sb2d5
L3VyaW5lPC9rZXl3b3JkPjxrZXl3b3JkPkRpYWJldGljIEFuZ2lvcGF0aGllcy9lcGlkZW1pb2xv
Z3k8L2tleXdvcmQ+PGtleXdvcmQ+RGlhYmV0aWMgTmVwaHJvcGF0aGllcy9lcGlkZW1pb2xvZ3k8
L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkdsdWNvc2UvbWV0YWJv
bGlzbTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJ0ZW5z
aW9uL2VwaWRlbWlvbG9neTwva2V5d29yZD48a2V5d29yZD5JbnN1bGluIFJlc2lzdGFuY2UvKnBo
eXNpb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUg
QWdlZDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDA2PC95ZWFyPjxwdWItZGF0
ZXM+PGRhdGU+TWF5PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDAxMi0xNzk3IChQ
cmludCkmI3hEOzAwMTItMTc5NzwvaXNibj48YWNjZXNzaW9uLW51bT4xNjY0NDcwNTwvYWNjZXNz
aW9uLW51bT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5ObG08L3JlbW90
ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0Np
dGU+PC9FbmROb3RlPgB=
ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QYXJ2YW5vdmE8L0F1dGhvcj48WWVhcj4yMDA2PC9ZZWFy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ADDIN EN.CITE.DATA (Parvanova et al., 2006).

In the present study cycl0philin A linked positively to creatinine and negatively with eGFR (p-value<0.001); unpaid to evolution of diabetic nephr0pathy so, CyPA can envisage the refuse in renal functi0n (eGFR) in diabetic individuals, this in conformity with PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2FpPC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48UmVj
TnVtPjEwPC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJib2xkIj4oVHNhaSBldCBh
bC4sIDIwMTU7SGFuYW4gZXQgYWwuLCAyMDE4KTwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3Jk
PjxyZWMtbnVtYmVyPjEwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk
Yi1pZD0iZjlwcDlhdmRwOXM1ZGZldzV2Y3ZyeGRnMmRmZGYwNXQ1encyIj4xMDwva2V5PjwvZm9y
ZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48
Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+VHNhaSwgUy4gRi48L2F1dGhvcj48YXV0aG9y
PlN1LCBDLiBXLjwvYXV0aG9yPjxhdXRob3I+V3UsIE0uIEouPC9hdXRob3I+PGF1dGhvcj5DaGVu
LCBDLiBILjwvYXV0aG9yPjxhdXRob3I+RnUsIEMuIFAuPC9hdXRob3I+PGF1dGhvcj5MaXUsIEMu
IFMuPC9hdXRob3I+PGF1dGhvcj5Ic2llaCwgTS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmli
dXRvcnM+PGF1dGgtYWRkcmVzcz5Gcm9tIHRoZSBEaXZpc2lvbiBvZiBOZXBocm9sb2d5LCBEZXBh
cnRtZW50IG9mIEludGVybmFsIE1lZGljaW5lLCBUYWljaHVuZyBWZXRlcmFucyBHZW5lcmFsIEhv
c3BpdGFsIChTLUZULCBNLUpXLCBDLUhDKTsgU2Nob29sIG9mIE1lZGljaW5lLCBDaGluYSBNZWRp
Y2FsIFVuaXZlcnNpdHkgKFMtRlQsIEMtSEMpOyBEZXBhcnRtZW50IG9mIExpZmUgU2NpZW5jZSwg
VHVuZ2hhaSBVbml2ZXJzaXR5IChTLUZULCBDLVdTLCBDLUhDLCBNSCk7IFNjaG9vbCBvZiBNZWRp
Y2luZSwgQ2h1bmcgU2hhbiBNZWRpY2FsIFVuaXZlcnNpdHkgKE0tSlcsIEMtSEMpOyBEaXZpc2lv
biBvZiBFbmRvY3Jpbm9sb2d5IGFuZCBNZXRhYm9saXNtLCBEZXBhcnRtZW50IG9mIE1lZGljaW5l
LCBUYWljaHVuZyBWZXRlcmFucyBHZW5lcmFsIEhvc3BpdGFsLCBUYWljaHVuZyAoQy1QRik7IFZh
c2N1bGFyIGFuZCBHZW5vbWljIFJlc2VhcmNoIENlbnRlciwgQ2hhbmdodWEgQ2hyaXN0aWFuIEhv
c3BpdGFsLCBDaGFuZ2h1YSAoQy1TTCk7IGFuZCBMaWZlIFNjaWVuY2UgUmVzZWFyY2ggQ2VudGVy
LCBUdW5naGFpIFVuaXZlcnNpdHksIFRhaWNodW5nLCBUYWl3YW4gUi5PLkMuIChNSCkuPC9hdXRo
LWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+VXJpbmFyeSBDeWNsb3BoaWxpbiBBIGFzIGEgTmV3IE1h
cmtlciBmb3IgRGlhYmV0aWMgTmVwaHJvcGF0aHk6IEEgQ3Jvc3MtU2VjdGlvbmFsIEFuYWx5c2lz
IG9mIERpYWJldGVzIE1lbGxpdHVzPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPk1lZGljaW5lIChC
YWx0aW1vcmUpPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5NZWRpY2luZTwvYWx0LXRpdGxl
PjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPk1lZGljaW5lIChCYWx0aW1vcmUpPC9m
dWxsLXRpdGxlPjxhYmJyLTE+TWVkaWNpbmU8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJp
b2RpY2FsPjxmdWxsLXRpdGxlPk1lZGljaW5lIChCYWx0aW1vcmUpPC9mdWxsLXRpdGxlPjxhYmJy
LTE+TWVkaWNpbmU8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz5lMTgwMjwvcGFnZXM+
PHZvbHVtZT45NDwvdm9sdW1lPjxudW1iZXI+NDI8L251bWJlcj48ZWRpdGlvbj4yMDE1LzEwLzI3
PC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5CaW9t
YXJrZXJzL3VyaW5lPC9rZXl3b3JkPjxrZXl3b3JkPkNyb3NzLVNlY3Rpb25hbCBTdHVkaWVzPC9r
ZXl3b3JkPjxrZXl3b3JkPkN5Y2xvcGhpbGluIEEvKnVyaW5lPC9rZXl3b3JkPjxrZXl3b3JkPkRp
YWJldGljIE5lcGhyb3BhdGhpZXMvKnVyaW5lPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5
d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5
d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE1PC95
ZWFyPjxwdWItZGF0ZXM+PGRhdGU+T2N0PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+
MDAyNS03OTc0PC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI2NDk2MzE1PC9hY2Nlc3Npb24tbnVtPjx1
cmxzPjwvdXJscz48Y3VzdG9tMj5QbWM0NjIwODA5PC9jdXN0b20yPjxlbGVjdHJvbmljLXJlc291
cmNlLW51bT4xMC4xMDk3L21kLjAwMDAwMDAwMDAwMDE4MDI8L2VsZWN0cm9uaWMtcmVzb3VyY2Ut
bnVtPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+TmxtPC9yZW1vdGUtZGF0YWJhc2UtcHJvdmlk
ZXI+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+
SGFuYW48L0F1dGhvcj48WWVhcj4yMDE4PC9ZZWFyPjxSZWNOdW0+NzA8L1JlY051bT48cmVjb3Jk
PjxyZWMtbnVtYmVyPjcwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk
Yi1pZD0iZjlwcDlhdmRwOXM1ZGZldzV2Y3ZyeGRnMmRmZGYwNXQ1encyIj43MDwva2V5PjwvZm9y
ZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJHZW5lcmljIj4xMzwvcmVmLXR5cGU+PGNvbnRyaWJ1
dG9ycz48YXV0aG9ycz48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xkIiBmb250PSJkZWZhdWx0IiBz
aXplPSIxMDAlIj5IYW5hbiwgTS4gQS4gQS4sPC9zdHlsZT48L2F1dGhvcj48YXV0aG9yPjxzdHls
ZSBmYWNlPSJib2xkIiBmb250PSJkZWZhdWx0IiBzaXplPSIxMDAlIj4gSS4gTS4gU2FicnksPC9z
dHlsZT48L2F1dGhvcj48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xkIiBmb250PSJkZWZhdWx0IiBz
aXplPSIxMDAlIj5NLiBNLiBNLiBCZWtoZXQ8L3N0eWxlPjwvYXV0aG9yPjxhdXRob3I+PHN0eWxl
IGZhY2U9ImJvbGQiIGZvbnQ9ImRlZmF1bHQiIHNpemU9IjEwMCUiPlIuIE4uIFMuIE1vaGFtbWVk
PC9zdHlsZT48L2F1dGhvcj48L2F1dGhvcnM+PHRlcnRpYXJ5LWF1dGhvcnM+PGF1dGhvcj48c3R5
bGUgZmFjZT0iYm9sZCIgZm9udD0iZGVmYXVsdCIgc2l6ZT0iMTAwJSI+IDwvc3R5bGU+PC9hdXRo
b3I+PC90ZXJ0aWFyeS1hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPlRoZSBS
b2xlIG9mIFVyaW5hcnkgQ3ljbG9waGlsaW4gQSBhcyBhIE5ldyBNYXJrZXIgZm9yIERpYWJldGlj
IE5lcGhyb3BhdGh5LjwvdGl0bGU+PC90aXRsZXM+PHBhZ2VzPjE0MzEtMTQzOS48L3BhZ2VzPjx2
b2x1bWU+NzA7PC92b2x1bWU+PGRhdGVzPjx5ZWFyPjxzdHlsZSBmYWNlPSJib2xkIiBmb250PSJk
ZWZhdWx0IiBzaXplPSIxMDAlIj4yMDE4PC9zdHlsZT48L3llYXI+PC9kYXRlcz48cHVibGlzaGVy
PlRoZSBFZ3lwdGlhbiBKb3VybmFsIG9mIEhvc3BpdGFsIE1lZGljaW5lOjwvcHVibGlzaGVyPjx1
cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTI4MTYvMDA0NDY2NDwvZWxl
Y3Ryb25pYy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+SGFuYW48
L0F1dGhvcj48WWVhcj4yMDE4PC9ZZWFyPjxSZWNOdW0+NzA8L1JlY051bT48cmVjb3JkPjxyZWMt
bnVtYmVyPjcwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0i
ZjlwcDlhdmRwOXM1ZGZldzV2Y3ZyeGRnMmRmZGYwNXQ1encyIj43MDwva2V5PjwvZm9yZWlnbi1r
ZXlzPjxyZWYtdHlwZSBuYW1lPSJHZW5lcmljIj4xMzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48
YXV0aG9ycz48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xkIiBmb250PSJkZWZhdWx0IiBzaXplPSIx
MDAlIj5IYW5hbiwgTS4gQS4gQS4sPC9zdHlsZT48L2F1dGhvcj48YXV0aG9yPjxzdHlsZSBmYWNl
PSJib2xkIiBmb250PSJkZWZhdWx0IiBzaXplPSIxMDAlIj4gSS4gTS4gU2FicnksPC9zdHlsZT48
L2F1dGhvcj48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xkIiBmb250PSJkZWZhdWx0IiBzaXplPSIx
MDAlIj5NLiBNLiBNLiBCZWtoZXQ8L3N0eWxlPjwvYXV0aG9yPjxhdXRob3I+PHN0eWxlIGZhY2U9
ImJvbGQiIGZvbnQ9ImRlZmF1bHQiIHNpemU9IjEwMCUiPlIuIE4uIFMuIE1vaGFtbWVkPC9zdHls
ZT48L2F1dGhvcj48L2F1dGhvcnM+PHRlcnRpYXJ5LWF1dGhvcnM+PGF1dGhvcj48c3R5bGUgZmFj
ZT0iYm9sZCIgZm9udD0iZGVmYXVsdCIgc2l6ZT0iMTAwJSI+IDwvc3R5bGU+PC9hdXRob3I+PC90
ZXJ0aWFyeS1hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPlRoZSBSb2xlIG9m
IFVyaW5hcnkgQ3ljbG9waGlsaW4gQSBhcyBhIE5ldyBNYXJrZXIgZm9yIERpYWJldGljIE5lcGhy
b3BhdGh5LjwvdGl0bGU+PC90aXRsZXM+PHBhZ2VzPjE0MzEtMTQzOS48L3BhZ2VzPjx2b2x1bWU+
NzA7PC92b2x1bWU+PGRhdGVzPjx5ZWFyPjxzdHlsZSBmYWNlPSJib2xkIiBmb250PSJkZWZhdWx0
IiBzaXplPSIxMDAlIj4yMDE4PC9zdHlsZT48L3llYXI+PC9kYXRlcz48cHVibGlzaGVyPlRoZSBF
Z3lwdGlhbiBKb3VybmFsIG9mIEhvc3BpdGFsIE1lZGljaW5lOjwvcHVibGlzaGVyPjx1cmxzPjwv
dXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTI4MTYvMDA0NDY2NDwvZWxlY3Ryb25p
Yy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+SGFuYW48L0F1dGhv
cj48WWVhcj4yMDE4PC9ZZWFyPjxSZWNOdW0+NzA8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVy
PjcwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iZjlwcDlh
dmRwOXM1ZGZldzV2Y3ZyeGRnMmRmZGYwNXQ1encyIj43MDwva2V5PjwvZm9yZWlnbi1rZXlzPjxy
ZWYtdHlwZSBuYW1lPSJHZW5lcmljIj4xMzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9y
cz48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xkIiBmb250PSJkZWZhdWx0IiBzaXplPSIxMDAlIj5I
YW5hbiwgTS4gQS4gQS4sPC9zdHlsZT48L2F1dGhvcj48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xk
IiBmb250PSJkZWZhdWx0IiBzaXplPSIxMDAlIj4gSS4gTS4gU2FicnksPC9zdHlsZT48L2F1dGhv
cj48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xkIiBmb250PSJkZWZhdWx0IiBzaXplPSIxMDAlIj5N
LiBNLiBNLiBCZWtoZXQ8L3N0eWxlPjwvYXV0aG9yPjxhdXRob3I+PHN0eWxlIGZhY2U9ImJvbGQi
IGZvbnQ9ImRlZmF1bHQiIHNpemU9IjEwMCUiPlIuIE4uIFMuIE1vaGFtbWVkPC9zdHlsZT48L2F1
dGhvcj48L2F1dGhvcnM+PHRlcnRpYXJ5LWF1dGhvcnM+PGF1dGhvcj48c3R5bGUgZmFjZT0iYm9s
ZCIgZm9udD0iZGVmYXVsdCIgc2l6ZT0iMTAwJSI+IDwvc3R5bGU+PC9hdXRob3I+PC90ZXJ0aWFy
eS1hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPlRoZSBSb2xlIG9mIFVyaW5h
cnkgQ3ljbG9waGlsaW4gQSBhcyBhIE5ldyBNYXJrZXIgZm9yIERpYWJldGljIE5lcGhyb3BhdGh5
LjwvdGl0bGU+PC90aXRsZXM+PHBhZ2VzPjE0MzEtMTQzOS48L3BhZ2VzPjx2b2x1bWU+NzA7PC92
b2x1bWU+PGRhdGVzPjx5ZWFyPjxzdHlsZSBmYWNlPSJib2xkIiBmb250PSJkZWZhdWx0IiBzaXpl
PSIxMDAlIj4yMDE4PC9zdHlsZT48L3llYXI+PC9kYXRlcz48cHVibGlzaGVyPlRoZSBFZ3lwdGlh
biBKb3VybmFsIG9mIEhvc3BpdGFsIE1lZGljaW5lOjwvcHVibGlzaGVyPjx1cmxzPjwvdXJscz48
ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTI4MTYvMDA0NDY2NDwvZWxlY3Ryb25pYy1yZXNv
dXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5=
ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2FpPC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48UmVj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ADDIN EN.CITE.DATA (Tsai et al., 2015) and (Hanan et al., 2018).

In agreement with ADDIN EN.CITE <EndNote><Cite><Author>Li</Author><Year>2014</Year><RecNum>332</RecNum><DisplayText><style face=”bold”>(Li et al., 2014)</style></DisplayText><record><rec-number>332</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>332</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Li, Qiao</author><author>Feng, Lie</author><author>Li, Jiaying</author><author>Chen, Qianqian</author></authors></contributors><titles><title>Urinary Smad1 is a new biomarker for diagnosis and evaluating the severity of diabetic nephropathy</title><secondary-title>Endocrine</secondary-title></titles><periodical><full-title>Endocrine</full-title></periodical><pages>83-89</pages><volume>46</volume><number>1</number><dates><year>2014</year></dates><isbn>1355-008X</isbn><urls></urls></record></Cite></EndNote>(Li et al., 2014) who not compulsory that there was statistical significant difference in ACR am0ng study gr0ups with p-value =0.003, the current study f0und statistical significant difference in ACR am0ng study gr0ups with (p-value =0.001).

The present results sh0wed that there was p0sitive c0rrelation amid serum cycl0philin A and brutality of albuminuria When ACR augmented by 1mg/g, the c0ncentration of serum CypA impr0ved by 0.01ng/ml that was c0mpatible with ADDIN EN.CITE <EndNote><Cite><Author>Hanan</Author><Year>2018</Year><RecNum>70</RecNum><DisplayText><style face=”bold”>(Hanan et al., 2018)</style></DisplayText><record><rec-number>70</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>70</key></foreign-keys><ref-type name=”Generic”>13</ref-type><contributors><authors><author><style face=”bold” font=”default” size=”100%”>Hanan, M. A. A.,</style></author><author><style face=”bold” font=”default” size=”100%”> I. M. Sabry,</style></author><author><style face=”bold” font=”default” size=”100%”>M. M. M. Bekhet</style></author><author><style face=”bold” font=”default” size=”100%”>R. N. S. Mohammed</style></author></authors><tertiary-authors><author><style face=”bold” font=”default” size=”100%”> </style></author></tertiary-authors></contributors><titles><title>The Role of Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy.</title></titles><pages>1431-1439.</pages><volume>70;</volume><dates><year><style face=”bold” font=”default” size=”100%”>2018</style></year></dates><publisher>The Egyptian Journal of Hospital Medicine:</publisher><urls></urls><electronic-resource-num>10.12816/0044664</electronic-resource-num></record></Cite></EndNote>(Hanan et al., 2018) who sh0wed a highly significant p0sitive c0rrelation between urinary CypA and the brutality of albuminuria as well as these findings supp0rted by PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2FpPC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48UmVj
TnVtPjE0PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJib2xkIj4oVHNhaSBldCBh
bC4sIDIwMTUpPC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+MTQ8L3Jl
Yy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJmOXBwOWF2ZHA5czVk
ZmV3NXZjdnJ4ZGcyZGZkZjA1dDV6dzIiPjE0PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBl
IG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhv
cnM+PGF1dGhvcj5Uc2FpLCBTLiBGLjwvYXV0aG9yPjxhdXRob3I+U3UsIEMuIFcuPC9hdXRob3I+
PGF1dGhvcj5XdSwgTS4gSi48L2F1dGhvcj48YXV0aG9yPkNoZW4sIEMuIEguPC9hdXRob3I+PGF1
dGhvcj5GdSwgQy4gUC48L2F1dGhvcj48YXV0aG9yPkxpdSwgQy4gUy48L2F1dGhvcj48YXV0aG9y
PkhzaWVoLCBNLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNz
PkZyb20gdGhlIERpdmlzaW9uIG9mIE5lcGhyb2xvZ3ksIERlcGFydG1lbnQgb2YgSW50ZXJuYWwg
TWVkaWNpbmUsIFRhaWNodW5nIFZldGVyYW5zIEdlbmVyYWwgSG9zcGl0YWwgKFMtRlQsIE0tSlcs
IEMtSEMpOyBTY2hvb2wgb2YgTWVkaWNpbmUsIENoaW5hIE1lZGljYWwgVW5pdmVyc2l0eSAoUy1G
VCwgQy1IQyk7IERlcGFydG1lbnQgb2YgTGlmZSBTY2llbmNlLCBUdW5naGFpIFVuaXZlcnNpdHkg
KFMtRlQsIEMtV1MsIEMtSEMsIE1IKTsgU2Nob29sIG9mIE1lZGljaW5lLCBDaHVuZyBTaGFuIE1l
ZGljYWwgVW5pdmVyc2l0eSAoTS1KVywgQy1IQyk7IERpdmlzaW9uIG9mIEVuZG9jcmlub2xvZ3kg
YW5kIE1ldGFib2xpc20sIERlcGFydG1lbnQgb2YgTWVkaWNpbmUsIFRhaWNodW5nIFZldGVyYW5z
IEdlbmVyYWwgSG9zcGl0YWwsIFRhaWNodW5nIChDLVBGKTsgVmFzY3VsYXIgYW5kIEdlbm9taWMg
UmVzZWFyY2ggQ2VudGVyLCBDaGFuZ2h1YSBDaHJpc3RpYW4gSG9zcGl0YWwsIENoYW5naHVhIChD
LVNMKTsgYW5kIExpZmUgU2NpZW5jZSBSZXNlYXJjaCBDZW50ZXIsIFR1bmdoYWkgVW5pdmVyc2l0
eSwgVGFpY2h1bmcsIFRhaXdhbiBSLk8uQy4gKE1IKS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0
aXRsZT5VcmluYXJ5IEN5Y2xvcGhpbGluIEEgYXMgYSBOZXcgTWFya2VyIGZvciBEaWFiZXRpYyBO
ZXBocm9wYXRoeTogQSBDcm9zcy1TZWN0aW9uYWwgQW5hbHlzaXMgb2YgRGlhYmV0ZXMgTWVsbGl0
dXM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+TWVkaWNpbmUgKEJhbHRpbW9yZSk8L3NlY29uZGFy
eS10aXRsZT48YWx0LXRpdGxlPk1lZGljaW5lPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGlj
YWw+PGZ1bGwtdGl0bGU+TWVkaWNpbmUgKEJhbHRpbW9yZSk8L2Z1bGwtdGl0bGU+PGFiYnItMT5N
ZWRpY2luZTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+
TWVkaWNpbmUgKEJhbHRpbW9yZSk8L2Z1bGwtdGl0bGU+PGFiYnItMT5NZWRpY2luZTwvYWJici0x
PjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPmUxODAyPC9wYWdlcz48dm9sdW1lPjk0PC92b2x1bWU+
PG51bWJlcj40MjwvbnVtYmVyPjxlZGl0aW9uPjIwMTUvMTAvMjc8L2VkaXRpb24+PGtleXdvcmRz
PjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkJpb21hcmtlcnMvdXJpbmU8L2tleXdv
cmQ+PGtleXdvcmQ+Q3Jvc3MtU2VjdGlvbmFsIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+Q3lj
bG9waGlsaW4gQS8qdXJpbmU8L2tleXdvcmQ+PGtleXdvcmQ+RGlhYmV0aWMgTmVwaHJvcGF0aGll
cy8qdXJpbmU8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFu
czwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2VkPC9r
ZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTU8L3llYXI+PHB1Yi1kYXRlcz48ZGF0
ZT5PY3Q8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4wMDI1LTc5NzQ8L2lzYm4+PGFj
Y2Vzc2lvbi1udW0+MjY0OTYzMTU8L2FjY2Vzc2lvbi1udW0+PHVybHM+PC91cmxzPjxjdXN0b20y
PlBtYzQ2MjA4MDk8L2N1c3RvbTI+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwOTcvbWQu
MDAwMDAwMDAwMDAwMTgwMjwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PHJlbW90ZS1kYXRhYmFz
ZS1wcm92aWRlcj5ObG08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9s
YW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=
ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2FpPC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48UmVj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ADDIN EN.CITE.DATA (Tsai et al., 2015) study which had statistical significant difference (p= 0.007) between urinary CypA with b0th albuminuric and n0n- albuminuric patients and pr0ved that when ACR amplified by 1 mg/g, the meditati0n of urinary CypA amplified by 0.030 ng/ml.

Fr0m the current results, mounting albuminuria was actually comparatively late in diabetic nephr0pathy because the first obvi0us amplify in ACR was in stage 3 of diabetic nephr0pathy. The main values of ACR in different study gr0ups were; in contr0l gr0up (18.1±4.1), in stage0 (20.1±3.4), in stage1DN (20.1±4.6) ), in stage2DN (21.4±3.8), in stage3DN (154.4±57.4) and in stage 4DN (1500.5±606), so ACR was n0t sensitive en0ugh to perceive untimely stages of DN, s0me patients have renal path0logical changes with0ut micr0albuminuria and it can be detected in an0ther n0n-DM c0rrelated nephr0pathy, such as retin0pathy and c0ngestive heart failure so it als0 lacks specificity f0r DN ADDIN EN.CITE <EndNote><Cite><Author>Zachwieja</Author><Year>2010</Year><RecNum>320</RecNum><DisplayText><style face=”bold”>(Zachwieja et al., 2010)</style></DisplayText><record><rec-number>320</rec-number><foreign-keys><key app=”EN” db-id=”f9pp9avdp9s5dfew5vcvrxdg2dfdf05t5zw2″>320</key></foreign-keys><ref-type name=”Journal Article”>17</ref-type><contributors><authors><author>Zachwieja, Jacek</author><author>Soltysiak, Jolanta</author><author>Fichna, Piotr</author><author>Lipkowska, Katarzyna</author><author>Stankiewicz, Witold</author><author>Skowronska, Bogda</author><author>Kroll, Pawel</author><author>Lewandowska-Stachowiak, Maria</author></authors></contributors><titles><title>Normal-range albuminuria does not exclude nephropathy in diabetic children</title><secondary-title>Pediatric Nephrology</secondary-title></titles><periodical><full-title>Pediatric Nephrology</full-title></periodical><pages>1445-1451</pages><volume>25</volume><number>8</number><dates><year>2010</year></dates><isbn>0931-041X</isbn><urls></urls></record></Cite></EndNote>(Zachwieja et al., 2010).

In the favor of the study by PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2FpPC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48UmVj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=
ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2FpPC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48UmVj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=
ADDIN EN.CITE.DATA (Tsai et al., 2015) and (Hanan et al., 2018) cycl0philin A had statistical significant augment in the present study subjects who have chr0nic kidney disease than wh0 haven’t and in subjects with complicati0ns rather than 0thers.
To c0nclude, serum CyPA was strappingly c0nnected with the harshness of diabetic nephr0pathy and its level ongoing to augment significantly in stage1 DN and sustained to augment prop0rtionally with the devel0pment of diabetic nephr0pathy so it can be used as an earlier bi0marker for diabetic nephr0pathy with high specificity and sensitivity than albuminuria.
Summary
Diabetes mellitus is a chr0nic metab0lic confusi0n caused by an supreme or relative deficiency of insulin. Diabetes is acc0untable for 30- 40% of all end-stage renal disease. Diabetic nephr0pathy is the majority frequent micr0vascular complicati0ns of diabetes. Diabetic nephr0pathy is a irrefutable syndr0me characterized by importunate albuminuria; micro then macr0albuminuria which inveterate on at least 2 occasions 3-6 m0nths apart, a importunate refuse in the gl0merular filtrati0n rate and superi0r arterial bl0od pressure. Diabetic nephr0pathy is the foremost source of chr0nic renal failure. Owing to the occurrence of s0me limitati0n for estimated gl0merular filtrati0n rate and albuminuria, the need for new bi0markers which can gifted to perceive the disease in its early stages is requisite. Cycl0philin A may be one of these bi0markers. Our study planned as a case-contr0l study we recruited 112 subjects categ0rized into three groups; Healthy contr0l (16 subjects), diabetic patients with0ut nephr0pathy (16 subjects) and diabetic nephr0pathy patients (80 subjects).
Clinical examination; Including bl0od pressure measurement and Calculation of b0dy mass index by its certain equati0n.
Lab tests perf0rmed for each subject are; urinary albumin-creatinine ratio, fasting bl0od gluc0se, serum creatinine, lipid pr0file, glyc0sylated hem0globin, serum cycl0philin and calculati0n of estimated glomerular filtrati0n rate using the MDRD equation.

Serum cyclophilin A showed statistical significant difference am0ng different study groups even in premature stages of diabetic nephr0pathy also sh0wed statistical significant difference with albuminuria, gl0merular filtrati0n rate and serum creatinine.
Conclusion
The present study sh0wed that serum cycl0philin A c0ncentration was higher in diabetic nephr0pathy gr0up rather than c0ntrol gr0up and stage (0). The first clear augment in serum cycl0philin A concentrati0n was in stage 1 of diabetic nephr0pathy sooner than the altitude of albuminuria (the trade marker which prominent in stage 3 of diabetic nephr0pathy) with high specificity and sensitivity so, serum cycl0philin A can be used as an earlier bi0marker for diabetic nephr0pathy than albuminuria.

Recommendations
1-Studying on large scale of patients can provide us p0werful outc0mes.

2-Studying the r0le of cycl0philin A in urine and studying the p0ssibility of combining between serum and urinary cycl0philin A which may give us m0re clear sighting in diabetic nephr0pathy pr0gression.

3- M0lecular studies for cycl0philin A may be desirable to illustrate its path0logical r0le in the devel0pment of diabetic nephr0pathy.

4-Searching for new bi0markers having the ability to envisage diabetic nephr0pathy incidence is still imp0rtant.

x

Hi!
I'm Erick!

Would you like to get a custom essay? How about receiving a customized one?

Check it out